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The List of Abbreviations 
°C Degree celsius 
µm  Micrometer 
µM  Micromolar 
AA  Ascorbic acid 
AD  Alzheimer’s Disease 
ATCC  American Type Culture Collection 
ATP  Adenosine Triphosphate 
Amp                              Ampicillin 
BLBP  Brain lipid binding protein 
BMP  Bone morphogenetic protein 
BSA  Bovine Serum Albumin 
CH Cortical Hem 
ChAt  Choline Acetyltransferase 
CMV  Cytomegalovirus 
CMV Cyto Megalo Virus 
CNS  Central nervous system 
CP  Cortical plate 
D, d  Day 
DAPI  4', 6-diamidino-2-phenylindole 
DCX                             Doublecortin 
DKK                             Dickkopf-related protein 
DG Dentate Gyrus 
db-cAMP Dibutyryl cAMP 
DMEM  Dulbecco’s Modified Eagle Medium 
DMSO  Dimethylsulfoxid 
DNA  Desoxyribonucleic acid 
DnaseI                          Deoxyribonuclease I 
DMF                             Dimethylformamide                          
dNTPs  Desoxynucleosid-triphosphate mix 
DTT  Dithiotreitol 
E Embryonic day 
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EB  Embryoid body 
E. coli                            Escherichia coli 
ECM  Extracellular matrix 
EDTA  Ethylenediaminetetraacetic acid 
EDTANa2 Ethylenediaminetetraacetic Acid, disodium 
EGF  Epidermal growth factor 
EGFP Enhanced Green Fluorescent Protein 
ELISA  Enzyme Linked Immunosorbent Assay 
ESC                              Embryonic stem cells 
Emx2                            Empty spiracles homolog 2 
FACS  Fluorescence-activated cell sorting 
FBS Fetal Bovine Serum 
FCS  Fetal calf serum 
FGF  Fibroblast growth factor 
Fig.  Figure 
FoxG1                           Forkhead box protein G1 
g  Gram 
G                                   Gravity 
GCL  Granule cell layer 
GDF  Growth differentiation factor 
GFAP  Glial fibrillary acidic protein 
h  Hour 
HEK cells                     Human Embryonic Kidney cells 
HEPES  Hydroxyethylpiperazine Ethane Sulfonic acid 
HES5                             Hairy and Enhancer of Split 5 
ICM  Inner cell mass 
iPSC induced Pluripotent Stem cells 
iPS-DF iPS-Derived Fibroblasts 
ITSFn Medium containing insulin, transferrin, sodium-selenite 
Kan  Kanamycin 
KO/SR  Knockout Serum Replacement 
l  Liter 
LB Lysogeny Broth 
LIF  Leukemia inhibitory factor 
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Lt Lenti 
Lt-Tet-EGFP Lenti-Tet-EGFP 
Lt-Tet-Emx2                 Lenti-Tet-Emx2 
Lt-Tet-NeuroD1            Lenti-Tet-Neurod1 
M                                   Molar 
MAP                              Microtubule-associated protein 
MEF   Mouse Embryonic Fibroblasts 
MEM   Minimum Essential Media 
mESC  Mouse embryonic stem cells  
mL                                 Milliliter 
mg                                 Milligram 
min                                Minute 
MOI                              Multiplicity of Infection  
mM  Millimolar 
ng  Nanogram 
NeuroD1                       Neurogenic differentiation 1 
NeuN                            Neuronal nuclei 
NPC                              Neuroprogenitor cell   
ORF                              Open Reading Frame 
P  Posterior 
P  Promoter 
P Postnatal day 
Pax-6                            Paired box protein 
PBS  Phosphate Buffered Saline 
PC  Pyramidal cell layer 
PCR  Polymerase Chain Reaction 
PCR  Polymerase chain reaction 
PD Parkinson’s Disease 
PFA  Paraformaldehyde 
Prox1 Prospero-related homeobox 1  
qPCR quantitative PCR 
qRT-PCR quantitative Real Time PCR 
RA  Retinoic acid 
RE Restriction Enzyme 
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RNA Ribonucleic acid 
ROCK Rho-associated Kinase 
rpm  Rounds per minute 
RT Room Temperature 
RT-PCR Reverse Transcription PCR 
RtTAs reverse tetracycline Transactivators 
Sec    Second 
SBI    System Biosciences 
Sox1    Sex determining region Y-box 1 
SV40     Simian virus 40 
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TAE    Tris Acetate 
Tbr2     T-box brain protein 2 
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TGF    Transforming growth factor 
tetO     tet operator sequence 
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1. Introduction 
 
Over the past decade, the field of neural stem cell has witnessed a rapid development in many 
respects including embryonic development, cellular reprogramming and differentiation, and 
regenerative therapeutic techniques such as cell replacement, organoids and drug screening.  
Meanwhile, the basic and clinical research involving the human brain physiology and 
pathophysiology, as well as neuro-developmental diseases face several major challenges due to 
inaccessibility to the human brain from embryo to adult stage. 
 
To tackle these problems, stem cell scientists have turned to the generation of in vitro biological 
models that capture some major aspects of the normal or abnormal human brain development, 
yet simpler, less variable and highly accessible. The differentiation of pluripotent stem cells 
(PSCs) towards specific glial and neuronal brain cells are used to improve our knowledge by 
providing mechanistic insights into human brain development, maturation and neurological 
diseases.  In order to design the artificial architecture of the brain ex vivo, a fair control over 
directed neuronal differentiation of stem cell resembling critical events of brain development is 
a critical step for brain research. 
 
1.1 Stem Cells 
 
In 1868, the German biologist Ernst Haeckel coined the term “stem cell” to describe a fertilized 
oocyte. Twenty years later, a fellow of him, Theodor Boveri, refined the usage of the term stem 
cell to describe roundworm embryo cells capable of duplicating themselves (self-renewal) and 
of specializing (differentiating) into any other cells.  Boveri’s description comprises the 
essential characteristics of an embryonic stem (ES) cell. In 1909, the Russian biologist 
Alexander Maximow theorized that a set of “stem cells” in bone marrow could differentiate 
into red and white blood cells. In effect, he described adult stem cells which renew themselves 
and serve as a means of repairing and maintaining tissues like the breast, brain, and bone 
marrow. 
By some decades later, scientists made considerable progress in understanding how stem cells 
function.  The functionality of stem cells was not fully understood but until 1981, when Gail 
Martin at the University of California in San Francisco, and Martin Evans at the University of 
Cambridge plucked the inner cell mass from a mouse embryo and coaxed it to grow in a petri 
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dish (Martin 1981). With a steady supply of mouse ES cells, scientists could provide a cellular 
platform for the study of development, maturation, and disease of these cells. 
Another breakthrough was due to James Thomson and his colleagues at the University of 
Wisconsin in 1998, who employed a similar technique to grow human ES cells in the lab 
(Thomson, Itskovitz-Eldor et al. 1998). The scope of their progress was so promising that it 
was advertised by some as the means for an immediate treatment of most intractable 
degenerative diseases — and at the same time unleashed serious controversies involving moral 
issues such as the destruction of human embryo. 
Stem cells are undifferentiated cells with the capacity of unlimited self-renewal and long-term 
viability. After cell division, the daughter cells can divide and form more precursor cells or cells 
that are functionally specialized matured cells. There are various types of stem cells based on 
their differentiation capacity: stem cells from zygotes (fertilized oocytes), stem cells isolated 
from embryo, stem cells isolated from adult body organs, and stem cells specified for a special 
organ or tissue. 
The stem cells from zygotes are totipotent cells capable of differentiating into all kinds of cells 
which make up the embryo and cells necessary for the development of all tissues and organs in 
the adult body along with the placenta and umbilical cord. 
The stem cells isolated from an embryo are pluripotent and can create all kinds of cells, except 
the umbilical cord and the placenta  (Thomson, Itskovitz-Eldor et al. 1998); (Evans and 
Kaufman 1981). 
The stem cells isolated from a particular tissue, organ, or physiological system are multipotent 
cells. An example of such are the hematopoietic stem cells which are also single cells. These 
cells can create all types of blood cells. The stem cells isolated from a specified tissue such as 
testis give rise to a single mature cell type (e.g., spermatogenic cells).  
 
1.2 Embryonic and reprogrammed stem cells 
 
ES Cells (hereafter ESCs) are either derived from the inner cell mass (ICM) of one blastocyst 
or early stage of morula, or they are generated by somatic cell reprogramming which is called 
iPSCs (an acronym for Induced Pluripotent Stem cell). The iPSCs can provide a potential source 
of cells for research, regenerative medicine or tissue bioengineering (Guo, Murthy et al. 2012). 
The term pluripotency has been assigned to different cell types with a wide range of functional 
capacities. Roughly speaking, pluripotency describes an aspect of a cell that can generate cell 
types from any of the three following embryonic germ layers: the endoderm, the mesoderm, 
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and the ectoderm. The exact definition for pluripotency, however, describes a cell that can 
create an entire organism, generating every cell type within that organism (Thomson, Itskovitz-
Eldor et al. 1998); (Vallier and Pedersen 2005). 
The study of ESCs seemed to offer unlimited possibilities, such as the understanding of early 
human development, tissue formation, and differentiation in vitro. 
Moreover, this is particularly appealing to model previously untreatable conditions by 
uncovering the causing mechanisms which is eventually applicable to cell therapy (Niclis, 
Trounson et al. 2009); (Niclis, Trounson et al. 2009); (Vallier and Pedersen 2005); (Reubinoff, 
Pera et al. 2000). The derivation of embryonic stem cells from the human embryo, however, 
sparked a controversial ethical debate on the application of hESCs in clinical research. There 
are other limitations that must be overcome, such as the immune rejection as well as the 
technical obstacles concerning the use of human embryo as a source of ESCs for clinical 
application (Thomson, Itskovitz-Eldor et al. 1998); (de Wert and Mummery 2003); (Giacomini, 
Baylis et al. 2007); (Saric, Frenzel et al. 2008); (Elstner, Damaschun et al. 2009). 
Although it is clear that functional neurons can be generated with the help of iPSCs, it remains 
a formidable task to stablish better differentiation strategies for generating more specific 
neurons and disease relevant neuronal subtypes. So far by iPSC technology, populations of 
ventral midbrain dopaminergic neurons for Parkinson disease (Perrier, Tabar et al. 2004); (Roy, 
Cleren et al. 2006); (Di Giorgio, Boulting et al. 2008); (Ma, Liu et al. 2011), spinal motor 
neurons for amyotrophic lateral sclerosis (Dimos, Rodolfa et al. 2008); (Marchetto, Muotri et 
al. 2008); (Kriks, Shim et al. 2011), cortical pyramidal neurons (Shi, Kirwan et al. 2012); 
(Vanderhaeghen 2012), and forebrain interneurons (Maroof, Keros et al. 2013); (Nicholas, 
Chen et al. 2013) could be achieved. 
 
Recently, 3D culture models termed cerebral organoids have been developed which recapitulate 
some aspects of brain development such as the organization of discrete cortical regions 
(Lancaster, Renner et al. 2013); (Renner, Lancaster et al. 2017).  These organoids include 
organized germinal zones, and both radial and tangential migration of cortical neuron 
subpopulations and cortical organizers such as the WNT secreting CH. The fact that they are 
not patterned by externally added growth factors or morphogens suggests that their 
development relies purely on self-organization by building neuronal microenvironments. 
Although the development of dorsal forebrain structures such as the hippocampus is still limited 
in these organoids, they build a foundation for designing the histological architecture of the 
hippocampus and the dentate gyrus (DG).  
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1.3 Development of the DG: Molecular Mechanism, Transcription factors, Growth factors 
 
The DG formation is quite peculiar in its development. During development, the following 
zones can be distinguished: 
 
1) Neuroephitelium (ventricular zone, primary matrix)  
2) Subventricular zone 
3) Radial migration path 
4) Tangential migration path 
5) Tertiary matrix (hilus and sub granule zone) 
6) Granule cell layer (with ventral and dorsal striatum) 
The neuroepithel and the subventricular zones together coin the term “germinative zone”. The 
subventricular zone as well as the migration pathways form the secondary matrix. The adjacent 
structures of the CH and the hippocampal fissure with Cajal Retzius cells constitute important 
developmental regulations by the release of growth factors. 
 
 
 
 
 
 
 
 
 
 
  
Fig. 1.1 Schematic representation of DG development from E12.5 up to postnatal stage. 
DNE: Dentate Neuroepitelium; CH: Cortical Hem; MS: Migrational Stream;  
CR: Cajal Retzius; TM: Tertiary Matrix; HF: hippocampal fissure  
DG precursor cells (small dark blue) start to develop in DNE, adjacent to CH and migrate along 
MS (light blue) towards TM and build up granule cell layer. The migration and differentiation 
of granule cells is controlled by CH, glial scaffold and CR cells aligning the hippocampal 
fissure.  Modified from Urban and Guillemot, 2014. 
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The dentate neuroepithelium (DNE)- also called primary matrix-belongs to the medial pallium 
VZ. This medial pallium immediately contacts the CH, can be perceived as early as embryonic 
day 14.5 and gives rise to the DG (Figs. 1.1A, B). The progenitor cells leave the DNE in the 
direction of medial cortex’s pial side at the late-stages of gestation. This continuing 
development is subject to the Cajal-Retzius cells are originated from the hem and migrate to 
the hippocampal fissure (Rickmann, Amaral et al. 1987); (Del Rio, Heimrich et al. 1997). The 
DG progenitors are formed as a mixture of neuronal precursors and stem cells at distinct 
differentiation stages. They move towards the hippocampal fissure-away from the VZ and thus 
comprise a new migratory progenitor population, which is also named the secondary matrix 
(Figs. 1.1 B, C). The glial scaffold and bypasses simultaneously evolves from the fimbria to the 
pial side of the cortex and the hippocampal fissure. During DG development, glial scaffold and 
Cajal-Retzius cells stay in place and maintain all essential functions for migration and 
organization of dentate precursor cells and granule neurons. When arriving at the hippocampal 
fissure, neural progenitors gather and shape another junction of proliferating cells – the so-
called tertiary matrix (Figs. 1.1 C, D). The GCL is generated by granule cells which are evolved 
during DG development from the precursors of all three matrices. Its contour with two blades 
is significant and predetermined by the Cajal-Retzius cells that encompass the hippocampal 
fissure and the pial surface (Fig. 1.1 D). The matrix becomes the only source of dentate 
progenitors and granule cells in early postnatal stages, while proliferation gets even more 
limited during postnatal week two. In the postnatal period, the extra proliferative zone continues 
to operate and grow to become SGZ, the site of adult hippocampal neurogenesis (Altman and 
Bayer 1990); (Bayer 1980) (Bayer 1980); (Khalaf-Nazzal and Francis 2013); (Pleasure, Collins 
et al. 2000); (Sugiyama, Osumi et al. 2013) (Fig. 1.2). 
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Fig. 1.2 Neurogenesis of DG granule cells from postnatal stage onwards. The neurogenic 
lineage of DG neurons consists of quiescent and active NSCs. Granule neurons form the 
granule cell layer with dentrites extending into the molecular layer and axons, building the 
Mossy fibre tract. (From Urban and Guillemot, 2014 with minor modifications). 
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The notch receptors and their ligands belong to molecules which generally participate in the 
cortical differentiation (Lee 1997). These molecules control the timely course of neurogenesis. 
The proteins connected after the notch receptors include a number of molecules with common 
motives, including basic transcriptional regulation domain and HLH-protein interaction 
domain. These proteins are called basic helix-loop-helix-proteins (bHLH). To this family 
belong anti-neurogenetic members, like the homologues to drosophila hairy and enhancer of 
split (Hes1 and Hes5) and extramacrochaete (Id1, Id2, Id3, Id4). Subsequent to the Notch 
activation, the Hes genes are upregulated and block the differentiation of precursor cells in their 
neuronal stage. These pro-neurogenetic bHLH genes contain homologues of drosophila atonal 
and are divided in two groups. The first group, referred to as the group of neuronal 
determination genes, is involved in the introduction of the neuronal differentiation process and 
includes genes like Neurogenin 1, 2 (Ngn1, Ngn2). The second group comprises neuronal 
differentiation genes and includes other atonal homologues, like NeuroD/BETA2, 
NeuroD2/NDRF, Meth2/Nex1 and Math3. It is assumed that this group regulates the later 
outcomes of neuronal differentiation. 
Pleasure and his team (Pleasure, Collins et al. 2000) developed a model of sequential expression 
of transcription factors in the development of the DG. The DG neuroepithel is primarily 
characterized by the expression of the genes Id2, Id3, Hes5, and Mash1. In the sequence of 
expression and topography, the granule cells generating the neuroepithel of the DG primarily 
express the genes Ngn2, Hes5, Id2, and Id3. Subsequently, the expression of Mash1, Mash3, 
Notch1 and further Hes5, Id2, Id3 can be observed in the subventricular zone. It is generally 
known that Mash1 is expressed in mitotic precursor cells of the nervous system. After leaving 
the subventricular zone, the first granule cells express NeuroD. According to Pleasure et al., it 
is unclear whether NeuroD-positive cells emerge directly from the neuroepithel or via a 
precursor stage. It must be assumed that the cells involved in the migration towards the later 
DG consist of a mixture of precursor cells and newborn neurons with different molecular 
profiles. According to Pleasure  et al., the genes Mash1, Notch1 and NeuroD1 are expressed in 
the migration pathway and in the tertiary matrix, whereas Prox1 and NeuroD2 are expressed in 
the developing granule layer of the DG. This means that cells which have reached their 
destination, express the granule cell specific homeobox protein Prox1, and NeuroD2 for final 
differentiation. Cells that have maintained their precursor stage continue to express Mash1 and 
form the tertiary matrix after reaching the DG anlage. In this tertiary matrix, further granule 
cells are being generated from Mash1 positive precursor cells within the sub-granular zone. 
These newborn granule cells then migrate radially to the inner segment of the granule layer, 
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thereby expressing first NeuroD, then NeuroD2, and at last Prox1. This common expression 
pattern is kept up in the adult system (Kunze, Grass et al. 2006). 
 
Structures adjoining the DG 
 
Structures adjacent to the DG, the CH, and the hippocampal fissure are of major importance for 
the normal development due to existing interdependencies and are thus outlined here.  
 
Cortical hem signals: BMP and WNT 
 
About embryonic day 14, the hippocampal formation is initiated in the mouse, reacting to 
signals that come forth from the cortical hem (CH). The CH is a dorsomedial structure of the 
telencephalon systematizing, the hippocampus, and the choroid plexus (Grove, Tole et al. 
1998); (Mangale, Hirokawa et al. 2008). The active secretion of BMP and WNT molecules is 
a distinct feature of the hem, as it lacks TF Lhx2 expression. The function studies have made it 
evident that the hem has a decisive role in the hippocampal formation. A failure in hem’s 
formation results in an improper development of the hippocampus (Yoshida, Assimacopoulos 
et al. 2006). The WNT signals of CH affect the proliferation of hippocampal neural precursor 
cells (Furuta, Piston et al. 1997); (Galceran, Farinas et al. 1999); (Lee, Tole et al. 2000); 
(Caronia, Wilcoxon et al. 2010). A number of WNT proteins like WNT2a, WNT2b, WNT3a, 
and WNT5a are generated in the embryonic CH, as these proteins are vital in their roles in 
systematizing the hippocampus. A disruption of WNT3a, for instance, would hinder the 
hippocampal formation, which is an obligatory step in the development of WNTs (Lee, Tole et 
al. 2000). Wnt3a is a gene, which is expressed very early and exclusively in CH (Grove, Tole 
et al. 1998); (Lee, Tole et al. 2000). Wnt3a mutants have a developmental disorder with a 
significant mediolateral and longitudinal gradient. At the medial border of the hippocampus 
formation, the DG is missing. CA3, CA1, and the subiculum, however, are missing rostral and 
are strongly reduced caudally. Severe defects of the hippocampus are also engendered by a 
disruption of the main downstream effector of canonical WNT signaling, Lef1, or a disruption 
of the WNT receptor Lrp6 (Galceran, Farinas et al. 1999); (Yoshida, Assimacopoulos et al. 
2006). In LEF1-deficient embryos, the granule cells of the DG are missing (Galceran, 
Miyashita-Lin et al. 2000). 
Furthermore, for characterizing specific hippocampal domains, the ectopic expression of Lef1 
is adequate and it exhibits the sufficiency of WNT activation for conferring hippocampal 
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identity (Machon, Backman et al. 2007). In addition, the formation of the glial scaffold is vital 
for the neural precursor cell migration from the VZ into the medial pallium to their final 
hippocampal location. WNTs are instrumental in this glial scaffold formation (Zhou, Zhao et 
al. 2004). 
At an early stage, the telencephalic roof plate generates multiple BMPs (BMP4, BMP5, BMP6 
and BMP7), as does the CH at a later stage (Furuta, Piston et al. 1997); (Grove, Tole et al. 
1998); (Hebert, Mishina et al. 2002). The total loss of BMP signaling causes a lack of medio-
dorsal structures, the choroid plexus, and the CH, which again results in the absence of the 
hippocampus (Cheng, Hsu et al. 2006); (Fernandes, Gutin et al. 2007). Upon CH formation, 
BMPs appear not to be required any longer for defining characteristics of the hippocampal cells 
(Hebert, Mishina et al. 2002). The influence of BMPs on neural precursors is various, which 
might result from distinct type 1 BMP receptor activities (BMPR-I and BMPR-Ia). BMPR-Ia 
furthers embryonic telencephalon proliferation and BMPR-Ib induces cell cycle arrest and 
differentiation (Panchision, Pickel et al. 2001). BMPs are also vital in the adult DG for 
sustaining the quiescent condition of NSCs (Mira, Andreu et al. 2010). Granule neurons and 
NSCs themselves continually secret bone morphogenetic proteins (BMPs). In the hippocampal 
niche, also BMP inhibition by Noggin and Chordin exists (Scott, Steiglitz et al. 2000); (Fan, 
Xu et al. 2003); (Bonaguidi, McGuire et al. 2005); (Bonaguidi, Peng et al. 2008). When BMP 
signaling is lost due to destruction of the BMPR-Ia receptor subunit, there occurs an over-
activation of adult NSCs, thus reducing their population (Mira, Andreu et al. 2010). The 
quiescence in NSCs in culture may as well be induced by BMPs, which supply a study model 
for detailed examination of molecular pathways that control stem cell behavior (Mira, Andreu 
et al. 2010, Sun, Hu et al. 2011, Martynoga, Mateo et al. 2013). BMPs are as well capable of 
furthering the astrocytic gene expression in vitro, thus making the induction of a selection of 
astroglial features of adult NSCs feasible (Gross, Mehler et al. 1996); (Sun, Hu et al. 2011). 
BMPs are vital for the quiescence of NSCs as well as granule cell differentiation and maturation 
(Bond, Peng et al. 2014). The differential expression of BMPR-I receptors can expound these 
two different roles of BMPs. BMPR-Ia, that is downregulated in IPCs, can be expressed by 
neural stem cells in the adult DG. On the contrary, BMPR-Ib is expressed by neuroblasts and 
neurons (Mira, Andreu et al. 2010). For this reason, neuroblasts and NSCs either receive BMP 
signals that each are explained as quiescence and differentiation cues. In the VSVZ, the results 
of BMP signaling on adult neurogenesis are comprehended poorly (Lim, Tramontin et al. 
2000);(Colak, Mori et al. 2008). The role of BMPs in supporting the quiescence of V-SVZ stem 
cells is not transparently proven yet. The BMP inhibitor Noggin has no effect on the behavior 
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of V-SVZ-derived stem cells; however, it furthers the expansion of DG-derived stem cells in 
vitro (Bonaguidi, Peng et al. 2008).  
Reelin is expressed by Cajal-Retzius cells and has an impact on the radial glia migration in the 
hippocampus. In Reelin mutants, the granule cells of the DG are formed morphologically; 
however, they do not generate a tightly packed granule layer and show a mal-positioning in the 
hilus area (Drakew, Deller et al. 2002). In these mice, a sharp demarcation between hilus and 
granule layer is missing. ApoER2/VLDR mutants have a similar phenotype. Furthermore, it 
could be proven that Reelin, disabled1, and β1-Integrin are involved in the formation of radial 
glia starting from the hilus in the DG marginal zone (Forster, Tielsch et al. 2002). Moreover, 
mutants of the genes Cdk5 (Ohshima, Ward et al. 1996), P35 (Chae, Kwon et al. 1997) and 
Pafah1b1/Lis1 (Hirotsune, Fleck et al. 1998) display a similar phenotype with abnormal 
neuronal cell migration and a thus result in the ectopic positioning of cells in CA and DG. 
Transcription factors controlling the development of DG 
The dorsomedial telencephalon embraces the dorsal pallium (isocortex) and the medial pallium 
(hippocampus proper or Cornu Ammonis (CA) and the DG). These morphologically and 
functionally distinct regions of the cortex are determined and differentiated during the 
development of a series of sub steps, starting with the growth of the open undifferentiated neural 
plate. 
At the beginning of this process, signal molecules of the telencephalic centers of patterning are 
secreted (Rubenstein and Beachy 1998), which deliver positional information and regulate the 
regional growth in the cortex anlage. The interpretation of these signals by the cortex anlage 
gives rise to a species-specific proto-map (Fukuchi-Shimogori and Grove 2003). As of today, 
the following molecules are recognized for their involvement in patterning: “bone 
morphogenetic proteins” (BMPs), “growth differentiation factors” (GDFs), and “fibroblast 
growth factor” (FGF), “sonic hedgehog” (SHH), “epidermal growth factor” (EGF) and 
“wingless-type MMTV integration site family” (WNT) proteins (Tole, Christian et al. 1997, 
Grove and Tole 1999). So far, the anterior pole of the cortex anlage, the hem and the so-called 
Anti-Hem are defined as centers of patterning (Grove and Fukuchi-Shimogori 2003). 
These signals activate or suppress the expression of transcription factors, which are regulating 
the further sequence of cortical regionalization, among others by controlling the cell 
proliferation (Rakic 1995), lamination, formation of radial glia, and the topographically limited 
evolving neuronal components of each specific area. 
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So far, a number of regulatory genes have been isolated and characterized, functioning in the 
constitution and maintenance of the identity of anterior telencephalon areas (Shimamura and 
Rubenstein 1997). Some of these genes are homeobox genes, which again belong to different 
gene families.  
The transcription factors Gli3- a conserved zinc finger-transcription regulator- is responsible 
for the development of the dorsal telencephalon (Theil, Alvarez-Bolado et al. 1999). In XtJ/ XtJ 
mice, the complete hippocampus is missing, including the CA, the DG, and the plexus 
choroideus of the lateral ventricles. Furthermore, there is a loss of expression in Emx1 and 
Emx2 genes. 
These two Emx genes define a certain region during telencephalon development, due to their 
limited expression in the dorsal prosencephalon (Simeone, Acampora et al. 1992). Emx2 is 
expressed in the dorsal and ventral neuro ectoderm of the forming prosencephalon, with a 
posterior demarcation within the diencephalon roof. The experiments with segment-specific 
hippocampal marker genes (Tole, Goudreau et al. 2000) hypothesized that Emx2 is responsible 
for normal growth and maturation of the hippocampus and the proximal medial neocortex, but 
not for cell specification of various hippocampal segments. This applies to the DG region as 
well. The DG cells exist in their appropriate anatomic position (neuroepithel migration path); 
however, they do not form a morphologically recognizable DG. The cortical neurogenesis in 
mice is normally completed at about E16.5 (Angevine 1965). For Emx2 mutants in contrast-at 
the same time-the marked ventricular zone still takes up a major part of the entire diameter of 
the embryonal cortex, similar to control animals about 2 – 3 days earlier. This could mean a 
delay of the cortical neurogenesis in Emx2 mutants, or that the cells do not leave the cell cycle 
on time, in order to be able to migrate to the ventricular zone. Accordingly, the incidence of 
another hippocampal region (CA3) in Emx2-/- mutants is delayed. In summary it can be stated 
that Emx2 is not only indispensable for the determination of the DG, but also for its 
differentiation. 
Emx2 is not only expressed by proliferating cortical cells, but also by Cajal-Retzius cells of the 
marginal zone (Pellegrini, Mansouri et al. 1996, Yoshida, Suda et al. 1997, Mallamaci, Iannone 
et al. 1998). Cajal-Retzius cells are a transiently occurring cell population functioning in 
coordination with cortical neuron migration along the radial glia including the Reelin gene 
(Marin-Padilla 1998). In the cortex, there exist at least two populations of Cajal-Retzius cells, 
which can be differentiated due to their chronological occurrence. The later appearing Cajal-
Retzius cells are missing in the cortex of Emx2 knockouts (Mallamaci, Iannone et al. 1998, 
  
21 
Mallamaci, Muzio et al. 2000). Consequently, the late development is influenced by radial glia, 
and thus, later born cells of the neuronal plate do not migrate through the earlier born (“inside-
out layering”), so that the cortical laminating is disturbed (Mallamaci, Muzio et al. 2000). 
Furthermore, Bagri et al. could demonstrate the influence of the cytokine SDF-1-which is 
expressed by Cajal-Retzius cells-on the migration of granule precursor cells from the 
neuroepithel to the granule layer of the DG as a chemo attractive factor (Bagri, Gurney et al. 
2002). In CXCR4-/- mutants, the DG is diminished and does not develop its typical horseshoe 
form. The number of proliferating cells in the migration path and in the DG is limited here, and 
the cells seem to differentiate too early. Thus, not enough precursor cells populate the 
developing DG, to ensure its normal formation (Lu, Grove et al. 2002). In Emx2-/- mutants, a 
morphologically identifiable DG is missing (Pellegrini, Mansouri et al. 1996); (Yoshida, Suda 
et al. 1997). At a closer observation, at E14.5 to E18.5 Emx2-/- mutants histologically display 
the ventricular zone-which gives rise to the hippocampus and the DG-is diminished, while the 
subventricular zone, a migration path, and a vestigial tertiary proliferation zone develop. At 
last, the granule layer of the DG is completely missing in mutants. Since homozygous embryos 
decease perinatal due to major changes of the urogenital system (lacking of kidneys, ureter, 
gonads and genital tract), see also (Miyamoto, Yoshida et al. 1997), however, as the complete 
development of the DG was achieved postnatally, it was yet impossible to examine the complete 
DG development in vivo. 
(Tole, Goudreau et al. 2000) hypothesized, that the mutant DG is specified correctly, however, 
it suffers from a developmental problem that affects the whole medial cortex. Accordingly, the 
CA region of the Emx2-/- hippocampus, for example, shows a reduced and eventually immature 
hippocampal plate. It is indicated that this problem may be a defect in the cortical positional 
information-signal cascade, transmitted by Fgf8 (Fukuchi-Shimogori and Grove 2001); 
(Shimogori, Banuchi et al. 2004) and possibly by WNT proteins as well (Muzio, Di Benedetto 
et al. 2002); (Ligon, Echelard et al. 2003). 
In Lhx5 knockout, the precursor cells for the hippocampal anlage are specified, but do not 
emerge from the cell cycle and differentiate. The disturbed migration of these cells causes a 
lack of DG granule cells (Zhao, Sheng et al. 1999).  Lhx5-/- mutants display a broadened 
hippocampal neuro epithel with more proliferated cells at E18.5 as a wild type. Fimbria and 
hippocampal commissures are lacking. 
As a bHLH TF with proneural activity in the embryonic brain, Neurog2 not only furthers the 
neuronal commitment of multipotent stem cells, but also induces the gene expression of other 
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neuronal differentiation genes like the NeuroD family of TFs (Seo, Lim et al. 2007, Wilkinson, 
Dennis et al. 2013). In the embryonic brain, it functions in a primary role characterizing 
glutamatergic neurons (Schuurmans, Armant et al. 2004, Berninger, Costa et al. 2007, 
Wilkinson, Dennis et al. 2013). Precursor cells in every proliferative matrix express Neurog2 
while the DG evolves (Pleasure, Collins et al. 2000, Galichet, Guillemot et al. 2008). The 
analysis of Neurog2 in null mutant mice, which showed a severely atrophic DG at birth-a 
severely minimized upper blade and a lacking lower blade-, provided an evidence for the vital 
role of Neurog2 in DG formation (Galichet, Guillemot et al. 2008). Proliferation as well as 
differentiation defects are shown by progenitors in the Neurog2 mutant DG. Despite progenitor 
cells expressing Ascl1 during DG morphogenesis, Ascl1 does not make up for Neurog2 loss, 
compared with examinations in the embryonic telencephalon (Nieto, Schuurmans et al. 2001, 
Galichet, Guillemot et al. 2008). Moreover, the Neurog2 mutant DG has a disorderly glial 
scaffold, which implies a disrupted progenitor migration (Galichet, Guillemot et al. 2008). The 
atrophic DG and the disorganized glial scaffold remind of phenotypes found in WNT mutant 
embryos. It was stated that WNT signaling regulates Neurog2 expression in the embryonic 
brain, and thus, during the formation of DG, Neurog2 possibly functions as an effector of WNT 
signaling (Hirabayashi, Itoh et al. 2004, Zhou, Zhao et al. 2004, Galichet, Guillemot et al. 2008).  
T-box TF Tbr2 is a further principal regulator of embryonic DG neurogenesis. In the cortex, it 
promotes the intermediate progenitors’ generation and proliferation, which originate the 
pyramidal glutamatergic neurons in the cerebral cortex generation (Englund, Fink et al. 2005, 
Arnold, Huang et al. 2008, Sessa, Mao et al. 2008). In the emerging DG, proliferating progenitor 
cells express in all three matrices Tbr2 – like Neurog2 – (Hodge, Nelson et al. 2012). A deletion 
of Tbr2 hinders the IPC and granule neuron generation and increases the stem cell proliferation 
in the developing DG. This finding suggests that Tbr2 is vital for the transformation of stem 
cells into late differentiating IPCs. It was postulated that Tbr2 exerts its functions by directly 
down-regulating the stem cell TF Sox2 (Hodge, Nelson et al. 2012). Furthermore, the hem-
derived Cajal-Retzius cells express Tbr2, as needed for their migration. A malfunctioning 
proliferation of Cajal-Retzius cells enhances defects in DG morphogenesis in Tbr2 mutant mice 
(Hodge, Garcia et al. 2013). 
Various types of neuronal progenitors and post-mitotic cells express the transcription factor 
Prox1, including the newborn granule cells in the evolving DG’s tertiary matrix (Oliver, Sosa-
Pineda et al. 1993, Li, Kataoka et al. 2009). Despite its low expression in some hippocampal 
interneurons, Prox1 is often applied as a dentate granule neuron lineage marker (Rubin and 
Kessaris 2013). During the development of DG, Prox1 is vital for neuronal progenitor 
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proliferation and granule cell specification, as the examination of Prox1 null mutant mice made 
evident (Lavado, Lagutin et al. 2010). It is noticeable that knocking-out Prox1 especially in 
post-mitotic granule neurons causes a modification in cell identity – they become CA3 
pyramidal neurons (Iwano, Masuda et al. 2012). During embryonic/postnatal hippocampal 
development in the adult DG, Tbr2 and Prox1 either function in an analogous manner in granule 
cell generation. This finding implies that, from DG development to adulthood, a similar genetic 
program, which includes the same key TFs (Neurog2 > Tbr2 > NeuroD1 > Prox1), furthers the 
differentiation of IPCs into glutamatergic DG cells (Hodge, Kowalczyk et al. 2008, Hodge, 
Nelson et al. 2012). Yet, this fact does not pertain to influential elements of the previous granule 
cell lineage, as described in the paragraph below.  
The further differentiation of precursor cells depends on the NeuroD expression. Without this 
gene, no initial granule cell is synthesized. In the NeuroD knockout, the DG is lacking (Miyata, 
Maeda et al. 1999). 
In the DG, proliferation of granule cells becomes limited to the tertiary matrix, which 
incrementally evolves into the SGZ, and the DG blades are already formed at postnatal day 14 
(P14) (Pleasure, Collins et al. 2000, Sugiyama, Osumi et al. 2013). Simultaneously, the first 
presumptive GFAP- and Nestin-positive NSCs chose their specific location, while the nucleus 
remains in the SGZ and the basal prolongs extends through the GCL (Li and Pleasure 2005, 
Martynoga, Mateo et al. 2013). As lately proven, the NSCs need the transcription factor NFIX 
for adopting their exact location in the forming DG (Martynoga, Mateo et al. 2013). In two 
interesting mouse lines that carry null mutations in the CcnD2 and Tlx genes, explicit defects 
in adult neurogenesis are first observed about the ending of postnatal week two (Kowalczyk, 
Filipkowski et al. 2004, Shi, Chichung Lie et al. 2004, Ansorg, Witte et al. 2012). During 
embryonic and early postnatal life, these two mutants showed a quite normal DG formation and 
development; however, in their late postnatal stages and adulthood, the stem cells did not keep 
up their granule neuron production. The conditional deletion of the proneural gene Ascl1 caused 
a total hindrance of adult neurogenesis, although it is not imperative for embryonic and early 
postnatal neurogenesis in the DG (Galichet, Guillemot et al. 2008, Andersen, Urban et al. 2014). 
During development of the hippocampus, the transcription factors of the Nuclear Factor 1 (NFI) 
family have been implied to the neuronal and glial cell generation. More specifically, as early 
as E14, NFIX is strongly expressed in the DNE, the future DG primordium. Simultaneously, 
the DG formation of NFIX null mutant mice shows intense defects (Campbell, Piper et al. 2008, 
Heng, McLeay et al. 2014). In NFIX mutants, there is an impeded neuronal and glial 
differentiation. These animals show a reduced number of Prox1 granule neurons and have a 
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disordered glial scaffold and a DG morphogenesis defect (Heng, McLeay et al. 2014). NFIX 
mutant mice live through P20. By this time, NSCs are in place in the DG at an ordinary 
concentration; however, with misplaced cell bodies and misaligned basal processes their 
location is unusual (Martynoga, Mateo et al. 2013). An increased proliferation rate occurs 
simultaneously with their abnormal position of NFIX mutant NSCs. It is of great interest, that 
cell adhesion and motility, or the generation of an extracellular matrix, are controlled by an 
important fraction of NFIX-regulated genes (Martynoga, Mateo et al. 2013). For this reason, it 
might be necessary that NFIX trigger NSCs migration to the exact SGZ area and NSCs act 
reciprocally with various DG niche elements. NSCs may be unable to receive the needed signals 
for sustaining quiescence, if NFIX is lacking. The role of NFIX in adult neurogenesis has not 
been discovered yet. 
The orphan nuclear receptor Tlx, also known as Nr2e1, functions in modelling the embryonic 
telencephalon and is expressed throughout the telencephalic VZ. Tlx is not expressed in the 
dorso-medial region in which the hippocampus has its origin. In late embryonic and postnatal 
stages, Tlx is less expressed in the neurogenic regions, and is upregulated merely during adult 
stages (Monaghan, Grau et al. 1995, Shi, Chichung Lie et al. 2004). The DG and olfactory bulbs 
of Tlx mutant mice are unusually undersized. This condition is the consequence of a disturbed 
adult neurogenesis from the SGZ and V-SVZ.  Adult Tlx mutant mice DGs display an 
inadequate progenitor proliferation and new neuron generation. This defect is invertible through 
re-expression of Tlx in mutant NSCs (Shi, Chichung Lie et al. 2004, Zhang, Zou et al. 2008, 
Niu, Zou et al. 2011, Murai, Qu et al. 2014). A Tlx overexpression in wild-type mice DGs can 
not only excite neurogenesis but also intensify memory and learning performances (Murai, Qu 
et al. 2014). Tlx furthers the shift from quiescence to activation in NSCs, as implied in these 
studies. A few downstream pathways have been involved in this process, in the induction of 
WNT signaling, Ascl1 expression, and the downregulation of BMP signaling (Shi, Chichung 
Lie et al. 2004, Elmi, Matsumoto et al. 2010, Qu, Sun et al. 2010, Qin, Niu et al. 2014) .  
 
As a key component of the cell cycle mechanism, CcnD2 (Cyclin D2) regulates cell cycle 
transition between G1- and S-phases in combination with the other Cyclin D proteins (CcnD1 
and CcnD3) and the Cyclin-dependent kinases (CDKs) (Sherr 1994, Ekholm and Reed 2000). 
CcnD1 and CcnD2 further cell cycle progression during embryonic development; however, 
they also trigger the neural progenitors’ neuronal differentiation (Lukaszewicz and Anderson 
2011, Pauklin and Vallier 2013). CcnD genes are quite alike in their structure, yet they can 
generally replace each other in their functions, and their expression profiles. For the 
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proliferation and differentiation of distinct progenitor populations, a variety of CcnD genes are 
required. It was proven that CcnD2 is especially needed for the proliferation of intermediate 
precursors in the embryonic cerebral cortex (Komada, Iguchi et al. 2013). Important functions 
in progenitor proliferation such as neuronal commitment anddifferentiation are fulfilled by 
Ascl1, a proneural bHLH transcription factor (Bertrand, Castro et al. 2002, Castro, Martynoga 
et al. 2011, Imayoshi and Kageyama 2011). Its overexpression in astrocytes, fibroblasts, and 
other cell types renders the capability to re-program these cells into neurons (Berninger, Costa 
et al. 2007, Yang, Ng et al. 2011, Wapinski, Vierbuchen et al. 2013). Progenitor cells in the 
three matrices express Ascl1 during the development of the DG; however, Ascl1 is not essential 
in DG formation during embryonic stages (Pleasure, Collins et al. 2000, Galichet, Guillemot et 
al. 2008). Additionally, in early postnatal stages, a conditional Ascl1 abscission has no 
influence on stem cell proliferation. This finding implies that other factors can further 
progenitor proliferation in the emerging DG when Ascl1 is lacking (Andersen, Urban et al. 
2014). 
 
Table 1: Important genes affecting telencephalic including DG development. See also 
Appendix Figs. 10.1-10.6. 
Gene /  
pathway 
Effect during development 
Wnt Promotes proliferation and neuronal differentiation of neural precursors 
BMPR-Ia Promotes the proliferation of neural precursors 
Gli3 Important for dorsal telencephalic development 
Emx2 Important for dorsal telencephalic development 
Notch Maintains the NSC pool by preventing premature differentiation 
Neurog2 Determines the glutamatergic differentiation of NSCs 
Tbr2 Essential for the proliferation and differentiation of IPCs 
Prox1 Promotes differentiation and determines granule cell identity 
NeuroD In NeuroD knockout DG is missing 
NFIX Required for correct positioning of NSCs in the postnatal DG 
Tlx Does not have an important role in development of the DG 
CcnD2 Does not have an important role in development of the DG 
Ascl1 Does not have an important role in development of the DG 
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Preliminary studies on the directed differentiation of telencephalic precursors and 
hippocampal/DG neurons from ESCs. 
  
The subjects of telencephalic differentiation and hippocampus development have been 
motivating for a number of research teams across the world.  The earliest attempts and 
accomplishments were carried out and reported by two independent teams led by Sasai and 
Gage to generate dorsal telencephalic neurons, including hippocampal, and DG-like neurons 
from ESCs (Watanabe, Kamiya et al. 2005); (Sakaguchi, Kadoshima et al. 2015); (Yu, Di 
Giorgio et al. 2014). Their ideas were based on manipulating the molecular signaling pathways 
in different stages of telencephalon and embryonic hippocampal development. In general, the 
EB and single culture systems with the addition of growth factors up to brain transplantation 
were used to differentiate these specific cell types.  
Watanabe et al. from the Sasai group through an independent study in 2005 reported an 
optimized serum-free suspension culture by replacing KO/SR with the fetal bovine serum and 
treating with WNT antagonist DKK1 to induce efficient generation of FOXG1-positive 
telencephalic cells. The treatment with WNT3a during the late fate of culture lead to an increase 
of PAX6 and EMX1 positive typical dorsal telencephalic markers.   
Later on, a member of the same lab (Sakaguchi, Kadoshima et al. 2015) produced FOXG1-
positive from hESCs with suspension culture and reduced oxygen conditions immature 
NeuroD-, Prox1- and Tbr1-positive neurons with the addition of BMP and WNT growth factors. 
Here again, the method of self-organizing dorsal medial telencephalic organ cultures was 
implemented and a low number of Prox1 positive granule cells produced. Only a limited set of 
DG markers was used to characterize these cells, which weakened the results. These authors 
were unable to generate CA1 pyramidal neurons or recapitulate DG formation or any regionally 
specific hippocampal tissues. This would be necessary to reconstruct the primary hippocampal 
neuronal circuitry. 
In parallel, Yu et al. (Yu, Di Giorgio et al. 2014) from the Gage’s lab could produce small 
amounts of electrophysiologically more mature human functional Zbtb20/Prox1 positive 
granule and ZBtb20/K1 pyramidal-like neurons by trying to recapitulate key steps mimicking 
hippocampal development. Embryoid bodies generated from hESCs were initially treated with 
anti-caudalizing factors DKK1 (WNT antagonist), Noggin (BMP-antagonist), the ALK5 (TGF-
β-pathway) inhibitor SB31432, and the sonic hedgehog inhibitor Cyclopamine followed by 
WNT3a plus BDNF and then co-cultured as a single cell suspension on hippocampal astrocytes. 
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Yu et al. also transplanted the DG-like precursor cells in the hippocampal formations in vivo 
and observed integration and further maturation of the cells. This group also performed no co-
localization studies with DG markers to prove the final differentiation phenotype of the DG-
like cells, which weakens the results as well. 
Both groups have developed in vitro models to recapitulate hippocampal development with the 
production of limited amounts of hippocampal/DG-like neurons from ESCs. While the model 
by Sakaguchi et al. represents an early hippocampal developmental stage, the cultivation 
procedure of Yu et al. seems to gain electrophysiologically more mature neurons only after 
transplantation in vivo. 
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1.4 Aims of this study 
 
The ultimate goal of stem cell research in tissue engineering and regenerative medicine is the 
creation of safe and functional biological models. These models can be applied to cell, tissue, 
and organ replacements, or be used in drug development and design of other therapeutic 
techniques. A key point in this field is the functional efficacy of tissues derived from iPSCs, for 
which a deeper understanding of the molecular singling pathways and involving factors during 
cell differentiation or tissue development is necessary. 
The DG is a highly organized brain with several distinct types of cells underlying learning and 
memorizing. The ability to model DG development in vitro represents an important step in our 
study of developmental processes and neurological disorders such as AD. 
Making tissues grow three dimensionally in the lab has been challenging across the board. This 
is especially problematic for structures in the nervous system. In addition to producing neuronal 
growth at all, the neurons must be connected in a very particular manner in order to function. 
A team from RIKEN Center for Developmental Biology in Japan have taken a substantial step 
forward on this front. They have successfully grown a 3D functional brain tissue which 
developed with proper patterning1 . 
In the present study, the major purpose was to establish new protocols by considering in vivo 
embryonic development processes for the generation of enriched DG neural cells from ESCs 
by applying both of growth and transcription factors. 
The growth factors are involved in the differentiation of telencephalon embryonic development 
in different embryonic stages. The most famous ones are Noggin, which inhibits bone 
morphogenetic protein (BMP), SB431542, which inhibits the transforming growth factor-b 
(TGF-b), DKK1 and possibly DKK3, which block the WNT signaling pathway, and 
Cyclopamine, an antagonist of the Sonic Hedgehog pathway. The interaction of these several 
pathways in the telencephalon, contributes to obtaining telencephalic neural precursor cells and 
the enrichment of primordium medial progenitor cells. 
The key transcription factors such as Emx2, Prox1, NeuroD1, when triggered by the growth 
factors, also push the cells to differentiate to specific neural progenitor cells belonging to the 
DG. 
The aim of this study is the generation of ESC-derived neural DG precursor cells for basic 
research and presumably future transplantation approaches. For both applications, protocols 
                                                 
1 http://www.riken.jp/en/pr/press/2015/20150130_1/ 
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leading to highly enriched neural DG precursor cells are key prerequisites. For therapeutic 
approaches, neural precursors have promising capacities due to their ability to differentiate into 
granule cells. 
For basic research, neural differentiation protocols performed under defined conditions offer 
various applications for the recapitulation of telencephalon (dorsomedial) developmental 
processes in the brain. To this end, strategies for the generation of enriched neural precursors 
were explored. 
The first part of this study addresses the question whether growth factors play any roles in 
telencephalic differentiation induction protocols such as those established for murine ESCs 
could be developed for human ES cells, and whether cells generated by such an approach can 
differentiate upon transplantation into host CNS tissue. 
The second part is dedicated to the establishment of ESCs which were manipulated with 
transcription factors under control of Tet inducible system and investigation of the role 
transcription factors in DG induction and granule neurons differentiation. 
In what follows, we shall summarize one of the best-studied and most frequently modeled 
aspects of in vivo brain development in rodents and humans, the formation of the DG, and 
describing to which extent stem cell-derived cultures can reproduce the DG development in 
vivo.  
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2. Materials and Methods 
Nearly all the cell culture devices and equipment including plates, gloves, dishes, flasks, 
pipettes, centrifugation tubes, cell strainer, filters and filter insert-ready to use and disposable- 
were obtained from the central storage at the facility center of Heidelberg University (Table 
2.1).  
 
2.1 Technical Equipment 
 
Table 2.1: Technical Equipment 
Material Company 
4, 6, 24, 48, 96  well-plates RennerGmbH, Dannstadt-
Schauernheim 
AggreWell™ 400Plates EX Stemcell™ Technologies 
Cell Strainer (100 µm) Easystrainer™ 
Cell Strainer (70 µm) BD Falcon 
Cell Strainer (70 µm) Easystrainer™ 
Centrifugation tubes 
 
Greiner bio-one GmbH, 
Frickenhausen 
Coverslip Manzel GmbH, Braunschweig 
Cryo tubes 2mL Greiner bio-one GmbH, 
Frickenhausen 
DNAase / RNAase free tube 1.5 mL nerbe plus GmbH 
Eppendorf tubes0.2mL,0.5mL, 1.5 mL, 2 mL Eppendorf AG, Hamburg 
Filter Cups  Greiner bio-one GmbH, 
Frickenhausen 
Filter Thininsert; Transparent,pore:0,4µm Greiner bio-one  
FlaskT75 cm Renner GmbH, Dannstadt- 
Schauernheim 
Microscope slides Marienfeld GmbH, Germany 
Pipettes 1 mL, 2 mL, 5 mL, 10 mL, 25 mL Greiner GmbH, Frickenhausen 
Sterile filter 0.2 μM Millipore (USA) 
Sterile Syringe Filter, CA membrane 0.2µm Berrytec 
Sterile Syringe Filter, MCE membrane 0.2µm Millex®-GS 
Sterile Syringe Filter, PES membrane, 0.45 μm TPP,74995 
Sterile syringe Filter, RC membrane 0.2µm Corning Incorporated 
Ultra centrifuge tube SW32 
 
Beranke labour  Seton 
secientific7052 
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2.1.1 Instruments 
All of the instruments used in this study are listed in the following Table.  
 
Table 2.2: Instruments 
Material Company 
Balance Sartorius AG, Göttingen 
Bio photometer Eppendorf AG 
Biological Safety 
Cabinet 
Thermo Scientific™ Herasafe™ KSP Class II 
Biological Safety 
Cabinet 
Thermo Scientific™ MSC-Advantage™ Class II  
Biomark 
Realtime 
quantitative PCR 
(qPCR) system 
(Fluidigm) 
Step One Plus 
Centrifuge Eppendorf 5415R 
Centrifuge Eppendorf 5415C 
CO2 Incubator  Heraeus D-6450,Series 6000 Gas Jacket  
 
Confocal 
Microscope 
Zeiss  LSM700  
AIM-System,2601000579 
 
Electronic Scale 
Balance  
Mettler Toledo PL601-S 
Electrophoresis 
power supply  
GiBCO, ST304 
Electrophoresis 
Power Supply 
Bio-Rad, PowerPac 300 
Geltray UV-
transparent 
Renner GMBH Dannstadt 
Incubator Thermo Scientific, HERA Cell 150 
Incubator Heraeus instruments 
Incubator CERTOMAT ® BS-1,B.Braun.Biotech international 
Incubator Shaker  B:Braun Biotch International Certomat BS1 
 
Minispin Eppendorf 
Mr. Frosty 
Freezing 
Container 
NALGENE™ Cryo 1˚C Freezing Container, Made in USA  
Power Supply Zeiss HB 0100 
Power Supply 
HXP120 
Kubler CODIX 
Shaker JANKE &KUNEL type VX7 
Shaker Heidolph Duomax 1030 
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Thermomixer 
Comfort 
Eppendorf 
Ultracentrifuge Beckman Coulter ,Optima TM LE-80K 
UV System 
Fluorescent 
Tables 
Renne GMBH 
Vortex Gene 2 Scientific Industry 
Water Bath GFL, Burgwedel 
 
2.1.2 Software 
In this study, the following softwares were used in writing, word processing, and data 
analysis.  
 EndNote web (Thomson Reuters) 
 MS-Office2014 SP2 (Microsoft) 
 GENEX 
 MS-Oce2014 SP2 (Microsoft) 
 GENEX 
 Biomark Data Collection Software 
 Real-time Analysis Software 
 StepOnePlus Software 
 LATEX Typesetting Software 
 Brain Allen Atlas2  
 Gene Paint Data Bank3 
 Pubmed4  
 ClustalW25 
 
 
 
 
 
 
 
 
                                                 
2 http://www.brain-map.org/ 
3 http://www.genepaint.org/ 
4 https://www.ncbi.nlm.nih.gov/pubmed 
5 http://www.ebi.ac.uk/Tools/msa/clustalw2 
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2.2 The Culture Media 
The culture media used in this study are divided in two major groups of bacteria and 
mammalian cells which are explained in details in following tables. 
 
2.2.1 Bacterial Culture Medium 
 
For LB and Agar media preparation, the following components were used according to the 
manufacturer instructions. In each case, appropriate antibiotics were added after autoclaving 
of LB-medium. For long-term bacterial storage, Glycerol 87% (ROCH 4043.1) was used for 
bacterial stocks.  
Table 2.3: LB and Agar Media Components 
Component Company Catalog No. 
Trypton/Pepton aus Casein 
Pankreatisch verdaut                                                
ROTH 8952.3 
Yeast extract ROTH 2363.3 
NaCl  SIGMA-ALDRICH 31434 
Agar-Agar ROTH 5210.2 
Kanamycin ROTH T83201 
Ampicilin ROTH K029.2 
´ 
2.2.2 Cell Culture Reagents and Material 
All the cell culture reagent media and components used in different stages of cell culture are 
listed below (Table 2.4).  
 
Table 2.4: The List of Cell Culture Reagent and Media 
Product Company Catalog No. 
0.05% Trypsin/EDTA(1X) gibco® by Life  
technologies™ 
25300-054 
2-Mercaptoethanol gibco® by Life  
technologies™ 
21985 
Acutase Cell Detachment Solution Capricorn scientific ACC-18 
B27 Supplement (50X) gibco® by Life  
technologies™ 
17504-044 
BrainPhys™ Neuronal Medium Stemcell™ 
Technologies 
05792 
Collagenase VI Sigma C5138 
Cyclopamine Stemcell™ 
Technologies 
72072 
Deoxy Ribonuclease I (DNase I) Sigma D4527 
Dimethyl Sulfoxide (DMSO) Sigma D1435 
Doxycyclin Hydroclorid  Sigma  D-9891 
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Dulbecco’s modified Eagle Medium 
(DMEM) high glucose  
gibco® by Life  
technologies™ 
41965-039 
 
Dulbecco’s modified Eagle Medium F-12 
Nutrient Mixture (Ham) DMEM/F-12 (1:1) 
(1X)  
gibco® by Life  
technologies™ 
21331020 
Dulbeco’s Phosphate Buffered Saline  
(PBS+ ) with Ca+2 and Mg+2 
 
gibco® by Life  
technologies™ 
14040-091 
Dulbeco’s Phosphate Buffered Saline (PBS) 
without Ca+2 and Mg+2 
 
gibco® by Life  
technologies™ 
14190-094 
Fetal bovine serum               Capricorn Scientific  FBS-12A 
Fetal Bovine Serum, Tetracycline Negative, 
Collected in South America 
Capricorn Scientific FBS-TET-12A 
Fetal calf serum (FCS) gibco® by Life  
technologies™ 
SH30072.03 
GlutaMAX™ -I CTS™ (100X) gibco® by Life  
technologies™ 
A12860-01 
Human Recombinant Brain-Derived 
Neurotrophic Factor BDNF 
Stemcell™ 
Technologies 
78005 
Knockout ™ DMEM (1X)                                
GIBCO; Life technologies ™  
gibco® by Life  
technologies™ 
10829-018 
 
KnockOut ™ SR                                                
GIBCO; Life technologies ™ 
gibco® by Life  
technologies™ 
10828-028 
Laminin Sigma L2020 
L-Glutamine 200Mm (100X) gibco® by Life  
technologies™ 
25030-024 
Lipofectamine™ 2000 Reagent  Invitrogen™ Thermo 
Fisher Scientific 
11668027 
Minimum Essential Medium (MEM) gibco® by Life  
technologies™ 
10829-018 
Minimum Essential Medium Non-Essential 
Amino Acids(MEM- NEAA)100X 
gibco® by Life  
technologies™ 
1140-035 
 
Mouse Dkk-1 Protein (His Tag) Sino Biological, Inc. 57248-M08H 
Mouse Recombinant Noggin Stemcell™ 
Technologies 
78061 
N-2 Supplement (100X) gibco® by Life  
technologies™ 
17502-048 
 
NeuroCult™ SM1 Neuronal Supplement Stemcell™ 
Technologies 
0571111 
OPTI-MEM®I gibco® by Life  
technologies™ 
31985-047 
Penicillin/ Streptomycin gibco® by Life  
technologies™ 
15140-122 
Penicillin/ Streptomycin gibco® by Life  
technologies™ 
15140-122 
Poly –L–Ornithine Sigma P4957 
Polybrene Sigma H9268 
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Poly-DL-ornithine hydrobromide Sigma P0671 
Posphate Buffered Saline (PBS)  gibco® by Life  
technologies  
14190-094 
Recombinant Dkk3 Sino Biological, Inc. 50247-M08H 
Recombinant Murine Wnt-3a PeproTech 315-20 
SB431542 Stemcell™ 
Technologies 
72232 
Tet System Approved FBS A Takara Bio 
Company;  
631106 
Trypsin 2,5 % gibco® by Life  
technologies™ 
15090046 
Y-27632 Stemcell™ 
Technologies 
72302 
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Table 2.5: Expression Plasmids used for Transfection of Cell Cultures. 
Plasmid Vector Size 
(bp) 
Addgene 
ID 
Resistance Reference 
Prokaryotic Eukaryotic 
FUW-M2rtTA 7979  20342 - - Rudolf 
Jaenisch, 
pcDNA3.1-Emx2 
cDNA 
5752 - Ampicillin Zeocin Invitrogen  
pCMV-Sport6.1-
Prox1 
 - Ampicillin - Soruce 
bioscience  
Tet-O-FUW-EGFP 9120  30130 Ampicillin Zeocin Marius Wernig 
Tet-O-FUW-NeuroD1 9471 30129 Ampicillin  Zeocin Marius Wernig 
 
 
 
 
Table 2.6: 3rd generation lentiviral packaging plasmid. 
Vector 
backbone 
Backbone 
size w/o 
insert 
(bp) 
Addgene 
ID 
Resistance Gene/Insert name 
 
Reference 
Prokaryotic 
pRSV-Rev 4180 12253 Amp Rev 
 
Didier Trono  
pMDLg/pRRE  8895 12251 Amp HIV-1 GAG/POL Didier Trono  
pMD2.G  5824 12259 Amp VSV-G; envelope 
expressing 
plasmid  
 
Didier Trono  
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2.2.3 Cell Lines and Primary Cell Culture Stocks 
 
During the project, several cell lines and animal sources were used. Below, some of their 
characteristics are listed in detail.  
 
Table 2.7: Cell Lines and Primary Cell Culture Used in this Thesis. 
Designation Source Organism/Tissue Characteristics 
E14 IVC  A gift from Austin 
Smith lab 
 Mouse Embryonic 
Stem Cells (P20) 
Adherent Culture 
HEK293  System Biosciences; 
Cat No. LV900A-1-
GVO 
TN Cell Line6 (P8-
12)  
Adherent Culture,  
Genetically Modified  
Cell Line 
Astrocytes  Heidelberg University, 
Animal Facility 
Cortex of ZP Mouse  
Postnatal Cortex of 
ZP Mouse Line 
Adherent Culture 
Fibroblast 
cells  
Heidelberg University, 
Animal Facility 
E12.5-E13 
ZP Mouse Line 
Adherent Culture 
 
2.2.3.1 Media and Solutions 
All cell culture media and reagents were sterile-filtrated through a Millipore Filtration Unit 
(Millipore; Billerica, USA) before application. 
 
 
2.2.3.1.1 Cell Culture medium  
2.2.3.1.1.1 Mouse Embryonic Fibroblast Medium 
The fibroblast medium was used for the expansion and culture of Mouse Embryonic 
Fibroblasts (MEFs) (E12.5-E13).  
 
                                                 
6 The 293TN cells stably express the SV40 large T antigen and neomycin gene products. 
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Table 2.8: Mouse Embryonic Feeder (MEF) Expansion Medium 
Medium Concentration Company 
Knockout  DMEM 87 % Life Technology  
L-glutamine  1% Life Technology 
Nonessential amino acids 1% Life Technology 
Penicillin-Sreptomycin 1% Life Technology 
2-mercaptoethanol 50 mM  Life Technology 
Heat Inactivated FBS  10 % Life Technology 
 
2.2.3.1.1.2 Mouse Embryonic Stem Cell Culture Medium 
Following the objective of this research and the genetic manipulation of ESCs by tetracycline 
inducible system, the normal ES Fetal Bovine Serum was replaced with tetracycline-free ES 
Fetal Bovine Serum or the Knockout-Serum replacement during cell culture and ESC expansion 
after ESC genetic manipulation. It is well known that one of the important factors for the 
maintenance of ESC in vitro cell culture is the mouse leukemia inhibitory factor (mLIF) which 
is added freshly to the cell culture media before use.  
 
Table 2.9: ES Medium Culture 
Medium and Supplement Concentration Company 
DMEM High Glucose  77 % gibco® by Life Technology  
L-glutamine  1% gibco® by Life Technology  
Nonessential Amino Acids 1% gibco® by Life Technology  
Penicillin- Streptomycin 1% gibco® by Life Technology  
2-mercaptoethanol 50 mM  Life Technology 
Heat Inactivated ES Fetal 
Bovine Serum (ES-FBS)7  
20 % Capricorn Scientific  
Recombinant Mouse 
Leukaemia Inhibitory Factor 
(mLIF) 
105 units per 100 mL Cell Guidance System  
 
 
 
 
 
                                                 
7 The ES-FBS was replaced by tetracycline-free serum. 
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2.2.3.1.1.3 Freezing Medium for Manipulated Mouse ES Cell Clones 
 
 
Table 2.10: Freezing medium 
Medium and Supplemet  Concentration (%) 
mESC Medium Containing FBS-Tet-Free  50% 
Heat Inactivated Tet negative Fetal Bovine Serum 40% 
DMSO 10% 
 
 
 
 
 
 
2.2.3.1.1.4 HEK293 NT Medium 
 
 
Table 2.11: HEK 293 Medium 
 
Medium and Supplement Concentration Company 
DMEM High Glucose  88 % gibco® by Life Technology  
Nonessential Amino Acids 1% gibco® by Life Technology  
Penicillin-Streptomycin 1% gibco® by Life Technology  
Heat Inactivated FBS 10 % Capricorn Scientific  
 
 
2.2.3.1.1.5 Differentiation medium I   
For the committed differentiation of stem cells, a particular cultivation medium is required. 
This medium has the capacity to conduct the differentiation potential of the cell towards a 
specified target. This specification is a step-by-step process, so that we implemented a medium 
which could induce neuro-ectodermal differentiation which is the primary step for a general 
neural differentiation. Moreover, since neural development and differentiation are progressive 
complex processes, some specific growth factors and inhibitors including Noggin, SB431542, 
Cyclopamine, Dkk1, and Dkk3 are required to more committed neuro-ectodermal lineages.  
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Table 2.12: Differentiation Medium I 
 
Component Concentration Company 
DMEM/F12 96 % gibco® by Life Technology 
GlutaMAX™-I CTS™ 
(100X) 
1% gibco® by Life Technology 
Nonessential Amino Acids 1% gibco® by Life Technology 
N2 Supplement  1% gibco® by Life Technology 
B27 Supplement  1 %  gibco® by Life Technology 
Mouse Recombinant Noggin   500 ng∕mL Stemcell™ Technologies  
SB431542  10 mM Stemcell™ Technologies 
Cyclopamine 1 mM  Stemcell™ Technologies 
Mouse Dkk-1 Protein 
(57248-M08H)  
100 ng∕mL Sino Biological, Inc. 
Recombinant Mouse Dkk-3 
Protein (50247-M08H) 
100 ng∕mL Sino Biological, Inc. 
2.2.3.1.1.6 Differentiation medium II   
For a deliberate differentiation of the neuro-progenitor cells, the differentiation medium II was 
applied. The main difference with the Medium I is the introduction of growth factors BDNF 
and WNT3a.  
Table 2.13: Differentiation Medium II 
Component Concentration Company 
DMEM/F12 96 % gibco® by Life Technology 
GlutaMAX™ -I CTS™ 
(100X) 
1% gibco® by Life Technology 
Nonessential Amino Acids 1% gibco® by Life Technology 
N2 Supplement  1% gibco® by Life Technology 
B27 Supplement  1 %  gibco® by Life Technology 
Human Recombinant Brain-
Derived Neurotrophic Factor 
(BDNF) 
20 ng∕mL Stemcell™Technologies 
Recombinant Murine 
WNT3a 
20 ng/mL PeproTech 
 
2.2.3.1.1.7 Differentiation medium III  
For a fully accomplished differentiation and the long-term maintenance of the neuronal 
culture, the differentiation medium III was utilized.  
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Table 2.14: Differentiation Medium III 
Component Concentration Company 
BrainPhys™ Neuronal 
Medium 
96 % Stemcell™ Technologies 
L-Glutamax   1% gibco® by Life Technology 
Nonessential amino acids 1% gibco® by Life Technology 
N2 supplement  1% gibco® by Life Technology 
NeuroCult™ SM1 Neuronal 
Supplement  
1 %  Stemcell™ Technologies 
Human Recombinant Brain-
Derived Neurotrophic Factor 
(BDNF) 
20 ng/mL  Stemcell™ Technologies 
Dibutyryl cAMP (db-cAMP) 1mM  Santa Cruz Biotechnology 
16980-89-5 
Sigma; D0260  
Ascorbic Acid (AA) 200 nM Sigma; A92902  
FBS  1%  Capricorn Scientific 
Recombinant Murine WNT-
3a  
20ng/mL PeproTech  
 
2.2.3.1.1.8 Astrocyte Medium 
The following medium was used for culture and expansion of the astrocyte culture 
Table 2.15: Astrocyte Medium 
Component Concentration Company 
IMDM 87% Stemcell™ Technologies 
L-Glutamax   1% gibco® by Life Technology 
Nonessential amino acids 1% gibco® by Life Technology 
Heat Inactivated Fetal 
Bovine Serum 
10% Capricorn Scientific 
Penicillin-Streptomycin 1 %  gibco® by Life Technology 
 
2.2.3.1.1.9 Astrocyte Freezing Medium 
Table 2.16: Astrocyte Freezing Medium 
Medium Company Catalog No. 
Cryostem  
Serum-Free  
Animal Components-Free  
Freezing Medium 
Biological Industries 05-710-1E 
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2.2.3.1.1.10 Immunocytochemistry Reagents  
Table 2.17: Immunocytochemistry Reagents 
Product Company Catalog No. 
Paraformaldehyde 4% in PBS ChemCruz SC-281692 
Triton X-100 Merck, Darmstadt 10170 
Goat Serum Gibco 1621024 
Donkey Serum Sigma  D9663 
Bovine Serum Albumin 
(Conzen, Conzen et al.) 
Sigma A9418 
Alexa Fluor® 546 goat anti 
mouse IgG (H+L) 
 
Thermofisher Scientific A11018 
Alexa Fluor® 568 goat anti 
rabbit IgG (H+L) 
 
Thermofisher Scientific A11011 
Alexa Fluor® 568 goat anti 
mouse IgG (H+L) 
 
Thermofisher Scientific A11004 
Alexa Fluor® 568  goat anti-
chicken  
Thermofisher Scientific A-11041 
Goat anti mouse chromeo™ 546 Abcam Ab60316 
Alexa Fluor® Donkey anti 
Rabbit 647 
 
Thermofisher Scientific 
or Biolegend  
A-31573 
406414 
 
4-6-diamidino-2-phenylindole 
(DAPI) 
Sigma-Aldrich D9542X 
 
2.2.3.1.1.11 Buffers 
Table 2.18: The List of the Used Buffers 
Buffer Contents Concentration 
6x  loading dye Tris-Hcl 
Bromphenolblue(Sigma-Aldrich)  
Xylene Cyanol (Sigma-Aldrich) 
Orange G (sigma-Aldrich) 
Glycerol 
EDT 
 
10mM 
 0.03% 
 0.03% 
 0.15% 
 60% 
 60mM 
50x TAE-buffer  
 
Tris-Base or Trizma base 
EDTA (0.5 M, pH 8) 
Glacial acetic acid (100%) 
H2O 
2M 
10M 
5.72% 
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                   Table 2.19: Wash Solution (0.1 M Phosphate Buffer, pH 7.3) 
 
 
 
Table 2.20: X-gal (5-Bromo-4-chloro-3-indolyl-β-D-galactopyranoside) Stain (125 mL) 
 
Chemical Component Concentration Concentration Vol. (mL) 
PBS  0.1M 107.875  
X-Gal8   40mg/mL in Dimethylformamid 
(DMF) 
1mg/mL 3.125 
K3Fe (CN)6 100mM 5mM 6.25 
K4Fe(CN)6 100mM 5mM 6.25 
MgCl2 2M 2Mm 125 
10%Deoxycholate  (0.01%) 0.01% 125 
NP-40 2% 0.02% 1.25 
Tot Vol.9  - - 122.875 mL 
 
2.2.3.1.1.12 Enzymes, Buffers, Kits and Transfection Reagents  
Table 2.21: Enzymes, Buffers, Kits and Transfection Reagents 
 
Product Company Catalog No. 
Lipofectamine 2000 transfection 
reagent 
Invitrogen™ | Thermo Fisher 
Scientific 
11668027 
Miniperp (250) Qiagen 27106 
 
Endotoxine free Maxi kit (Melief) Qiagen 12362 
GenElute™ Mammalian genomic 
DNA Miniprep Kits 
Sigma G1N70 
RNeasy® Mini kit(50) Qiagen 74104 
DNA Clean & Concentrator™-5 Zymo Reaserh D4014 
Nucleospin250  740615.250 
NucleoSpin® Plasmid quickPure Macherey-Nagel 740615.250 
                                                 
8 40 mg/mL X-gal in DMF can be stored at -20˚C. 
9 The solution was sterilized by filtration through a 0.2 µm filter.  
Component Concentration Amount 
Sodium phosphate, monobasic, anhydrous - 3.74 g 
Sodium phosphate, dibasic, heptahydrate - 10.35 g 
MgCl2 2 M 1mL 
Deoxycholate 10% 1 mL 
NP-40 2% 10 mL 
Total Vol.  - q.s. to 1 L w/ H2 O 
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QIA quick Gel Extraction kit(50) Qiagen 8704 
Lenti-X ™ Gostix™ TaKaRa Clontech 631243 
EcoRI Biolabs R0101S 
AseI Biolabs R0526S 
HindIII Biolabs R0104L 
XmaI Biolabs R0180S 
MLuI Biolabs R0198L 
BglII Biolabs R0143L 
PstI Biolabs R0140L 
XbaI Biolabs R0145L 
NheI Biolabs R0131L 
EcoRI Buffer  Biolabs B0101S 
NEB buffer2.1 Biolabs B7002S 
NEB buffer3.1 Biolabs B7203S 
CutSmart Biolabs B7204S 
Venor® GeM kit Minerva Biolabs GmbH Venor® GeM kit 
 
2.3 Methods 
The applied methods in our study include two major categories: 
• The molecular biological methods   
• The cell culture techniques 
2.3.1 Molecular Biological Methods 
To study the role of central transcription factors participating in the differentiation of 
hippocampus DG neurons, the mESCs were manipulated by applying the tetracycline inducible 
system. This system was primarily introduced by H. Bujard and M. Gossen in 1992 at 
Heidelberg University. The system has the ability to tightly control individual gene activities 
which would greatly facilitate the analysis of gene function, particularly in systems that are not 
prone to genetic dissection (Gossen, Freundlieb et al. 1995).  
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2.3.1.1 Bacterial Plasmids  
We investigated a list of transcription factors contributing to the development of the embryonic 
DG by using Brain Allen Atlas and Gene Paint data bank. Subsequently, three of the most 
important transcription factors were selected. These are Emx2, Prox1, and NeuroD1. Some 
previous studies have proven the reduction in size or even the loss of DG in the absence of these 
transcription factors (Pellegrini, Mansouri et al. 1996); (Yoshida, Suda et al. 1997); (Miyata, 
Maeda et al. 1999); (Heng, McLeay et al. 2014).  
For the genetic manipulation of the ESCs with the abovementioned transcription factors, the 
inducible tetracycline system was applied (Fig. 2.1).  
The plasmids Tet-O-FUW-NeuroD1 (Fig. 2.2a), Tet-O-FUW-EGFP (Fig. 2.3), FUW-M2rtTA 
(Fig. 2.4a) were purchased from Addgene.org. The plasmid pCMV-Sport6-Prox1 was 
purchased from Source Bioscience, and pcDNA3.1-Emx2-cDNA from Invitrogen (Fig. 2.5).  
In short, the bacterial plasmids were cultured overnight on an Agar plate containing Ampicillin 
50µg/mL at 37° C. Three to five single colonies were picked up from each bacterial culture 
separately and inoculated into 5 mL LB medium containing Ampicillin early in the evening and 
were shaken overnight at 37° C. 
 
2.3.1.2 Isolation of Plasmid DNA (Plasmid Mini Preparation) 
 
The small-scale Bacterial DNA plasmid extraction was carried out utilizing Qiagen Mini Kit. 
according to manufacturer instructions. 
 
2.3.1.3 DNA Concentration Measurement 
 
The concentration of DNA was measured using a spectrophotometer. The absorbance of the 
nucleic acid solution was measured at the wavelength of λ = 260 nm. 
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TRE CMV Transgene 
Transcription ON 
X 
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Transcription Factor Induction 
Emx2, Prox1, NeuroD1 
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b 
Fig. 2.1 The schematic Tet system. The Tet system can be used for conditional activate gene 
expression in the mouse. (A) the Tet-off system (tTA) will activate expression in the absence of its 
ligand doxycycline (DOX, shown as brown box). Upon addition of Dox, transcription of the gene of 
interest is extinguished. (B) in contrast, addition of Dox to the Tet-on system (rtTA) results in the 
transcriptional induction of the gene of interest. tTA, tetracycline-dependent transactivator; rtTA, 
reverse tetracycline-dependent transactivator; Dox, doxycycline (ligand); TRE, Tet-responsive 
element. 
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2.3.1.4 Plasmid Construct and Restriction Enzyme Digestion 
To find out whether the plasmid construction map during the bacterial culture remained intact 
or not (no recombination), it is necessary that after bacterial mini-prep, the plasmid DNA 
extraction be digested using specific restriction enzymes, as recommended by the manufacturer.   
To check the correct orientation and length of the inserted DNA, a sample of 0.5 μg/µL plasmid 
DNA was digested with 5 units of restriction enzyme (purchased from New England BioLabs). 
The digests were normally incubated in the appropriate buffer (Table 2.22b and 2.23b) at 37° C 
for 1-1.5 hours. Finally, the digested DNA fragments were analyzed by 0.8% Agarose gel 
electrophoresis (Figs. 2.2b and 4.2b).   
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RE Cutting Site 
5′ to 3´ 
Fragment Size (bp)  
AseI 30-5954,5955-6354,6355-7198, 
7199-7257,7258-8492,8493-29 
5925,400,844,59,1235,1008 
BglII 624-2365,2366-4690,4691-5064, 
5064-9255,9256-623 
1742,2325,374,4191,839 
EcoRI 2819-6304,6305-6500, 1090,8381 
XmaI 2677-6304,6305-6500,6501-2676 3628,196,5647 
SacI 8801-8800 9471 
 
      
 
 
 
Fig. 2.2a Lentivirus Addgene Plasmid; 
Tet-O-FUW- NeuroD1. 
 
Fig. 2.2b Tet-O-FUW-NeuroD1 (19471 bp) clone 1-4 
were digested with AseI, BglII, EcoRI, XmaI, SacI. 
First Row AseI (Line1-4), BglII (Line 6-9), EcoRI (Line 
11-14) 
Second Row XmaI (Line 2-5), SacI (Line 8-11), 
uncut(Line 12-15). 2-Log DNA Ladder. 
 
  
 
First Row AseI (Line1-4), BglII ( Line 6-9 ), EcoRI ( 
 
 
Table 2.22: The Overview of Tet-O-FUW-NeuroD1 restriction digestion 
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Fig.2.3 Lentivirus Addgene Plasmid; Tet-O-FUW-EGFP; Construction Map 
 
Table 2.23: Overview of FUW-M2rtTA restriction digestion 
 
 
 
 
 
 
 
 
 
 
 
 
 
RE Cutting Site 
5′ to 3´ 
Fragment Size 
BglII 14-852, 853-2614, 2615-5401, 5402-5775,  
5776-13 
839, 1762, 2787, 374, 2217  
 
AseI 259- 3850, 3851-7229, 7230-258 3592, 3379, 1008  
 
XmaI 3843-459, 4599-3842 756, 7223 
 
 
 
 
1       2       3      4      5 
 
Fig. 2.4b FUW-M2rtTA were digested with, BglII 
(Lane 2), XmaI (Lane 3), AseI (Lane 4), uncut 
(Lane 5), 2-log DNA ladder (Lane 1). 
Fig. 2.4a Lentivirus Trans-activator 
Adgene Plasmid; FUW-M2rtTA 
Construction Map. 
 
  
50 
2.3.1.5 Cloning of the Emx2 and Prox1-fragments into Tet-O-FUW-vector  
Dr. Zhou, a postdoctoral scholar at the group of Prof. Skutella assisted the author to construct 
the new plasmids Tet-O-FUW-Emx2 and Tet-O-FUW-Prox1. These new plasmids were 
constructed by direct cloning of Emx2 (extracted from pcDNA3.1-Emx2) and Prox1 (extracted 
from CMV-Sport6-Prox1) into the backbone of Tet-O-FUW-NeuroD1. 
In summary, Emx2 and Prox1 fragments were digested from the original plasmids, and were 
cut and extracted from 1.5 % Agarose gel. Then the target DNA plasmid was extracted from 
the gel and cleaned with clean-up-DNA-kit, according to the manufacturer instruction. 
Subsequently, the extracted DNA was amplified by PCR (Table 2.24). The molecular 
manipulations such as extraction, purification, digestion, and ligation as well as the bacterial 
culture and transformation were performed according to standard methods. 
 
Table 2.24:  Primer Sequences for Emx2 and Prox1-fragment Cloning 
Oligo Name Sequence (5'-3') 
AgeI_Prox1-f AACCGGTGCCACCATGCCTGACCATGACAGC 
MLuI_Prox1-r CGACGCGTCTACTCGTGAAGGAGTTCTTGTAG 
XmaI_Kozak_Emx2-f CCCCCGGGCCACCATGTTTCAGCCGGCGCCCAAGCGC 
MLuI_Emx2-r CGACGCGTAATCGTCTGAGGTCACATCTATTTCC 
MLuI_Emx2-f CGACGCGTCTAATCGTGAAAGATGGACTTAAG 
BglII_Prox1-f AGTTCGAGTGTGGAGATCTTCAAG 
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Fig. 2.5:  pcDNA3.1 Emx2 Plasmid Construction Map 
 
2.3.1.6 Bacterial Transformation  
The obtained DNA plasmids mentioned above were transformed in One Shot® Stbl3TM 
chemically competent E-coli strains. Then, five individual colonies were picked up and 
inoculated in a LB medium overnight, containing 50 µg/mL Ampicillin, at 31° C, while being 
shaken.  
Afterwards, the DNA plasmid extraction was performed with Qiagen mini kits. At the end, the 
DNA concentrations were estimated by measuring absorption at 260 nm using the 
spectrophotometer and analyzed by double restriction digestion and DNA sequencing. 
To check the correct orientation and length of the inserted DNA, a sample of 0.5 μg/µL plasmid 
DNA was digested with 5 units of restriction enzyme (purchased from New England Biolabs). 
The digests were normally incubated in an appropriate buffer (Table 2.25) at 37° C for 1-1.5 
hours. Afterwards, the digested DNA fragments were analyzed by 0.8% Agarose gel 
electrophoresis. 
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2.3.1.7 DNA Sequencing 
Fig. 2.6b Tet-O-FUW-Prox1 Plasmid 
Construction Map. 
 
Table 2.25: The Overview of Tet-O-FUW-Prox1 and Tet-O-FUW–Emx2 Double restriction 
digestion 
 
Fig. 2.6a The Result of Tet-O-FUW-Prox1 (10906 
bp) and Tet-O-FUW-Emx2 (9165bp), Double 
Digestion with MulI+Xba (Lane 3, 4) and MulI + 
NheI (Lane 2), log2DNAladder (Lane 1).  
 
 
Fig. 2.7 Tet-O-FUW-Emx2 Plasmid 
Construction Map. 
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The Eurofins MWG Operon performed all sequencing analyses using the primers mentioned in 
Table 2.26. The sequencing results were aligned with ClastalW2 database are shown below.  
 
Table 2.26: The Primers for DNA Sequencing 
Primer Sense (5′-to-3′) 
CMVb-F AGC TCG TTT AGT GAA CCG TC 
WPRE-R CAT ACG GGA AGC AAT AGC ATG 
Prox1-SF1 GGG TTG AGA  ATA TCA TTC GG 
Prox1-SF3 TCA GAG TCC ACT AGG TGC TC 
Prox1-SR2 GAA GAT CTC CAC ACT CAG AC 
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2.3.1.8 Gene Sequencing Alignment Data  
 
Prox1 
Tet-O-FUW-Prox1 Clone 4 Sequence Alignment 
 
Prox1_ORF       ------------------------------------------------------------  
Tet-Prox1       TCACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAGCCTCCGCGGCCCCGAA 60  
                                                                               
 
Prox1_ORF       ---------ATGCCTGACCATGACAGCACAGCCCTCTTAAGCCGGCAAACCAAGAGGAGA 51  
Tet-Prox1       TTCGCCACCATGCCTGACCATGACAGCACAGCCCTCTTAAGCCGGCAAACCAAGAGGAGA 120  
                         ***************************************************   
 
Prox1_ORF       AGGGTTGACATTGGAGTGAAAAGGACGGTAGGGACAGCATCTGCATTTTTTGCTAAGGCA 111  
Tet-Prox1       AGGGTTGACATTGGAGTGAAAAGGACGGTAGGGACAGCATCTGCATTTTTTGCTAAGGCA 180  
                ************************************************************   
 
 
Prox1_ORF       AGGGCAACATTTTTCAGTGCCATGAATCCCCAAGGTTCAGAGCAGGATGTTGAATATTCT 171  
Tet-Prox1       AGGGCAACATTTTTCAGTGCCATGAATCCCCAAGGTTCAGAGCAGGATGTTGAATATTCT 240  
                ************************************************************   
 
Prox1_ORF       GTGGTGCAACACGCAGATGGGGAAAAGTCGAACGTACTCCGCAAGCTGCTGAAGAGGGCG 231  
Tet-Prox1       GTGGTGCAACACGCAGATGGGGAAAAGTCGAACGTACTCCGCAAGCTGCTGAAGAGGGCG 300  
                ************************************************************   
 
Prox1_ORF       AACTCGTATGAAGATGCCATGATGCCTTTTCCAGGAGCAACTATAATTTCCCAGCTGTTG 291  
Tet-Prox1       AACTCGTATGAAGATGCCATGATGCCTTTTCCAGGAGCAACTATAATTTCCCAGCTGTTG 360  
                ************************************************************   
 
Prox1_ORF       AAAAATAACATGAACAAAAACGGTGGCACCGAGCCCAGTTTCCAAGCCAGCGGACTCTCT 351  
Tet-Prox1       AAAAATAACATGAACAAAAACGGTGGCACCGAGCCCAGTTTCCAAGCCAGCGGACTCTCT 420  
                ************************************************************   
 
Prox1_ORF       AGCACAGGCTCCGAAGTACATCAGGAGGATATATGTAGCAACTCTTCAAGAGACAGCCCC 411  
Tet-Prox1       AGCACAGGCTCCGAAGTACATCAGGAGGATATATGTAGCAACTCTTCAAGAGACAGCCCC 480  
                ************************************************************   
 
Prox1_ORF       CCAGAGTGTCTTTCCCCTTTTGGCAGGCCTACTATGAGCCAGTTTGATGTGGATCGCTTA 471  
Tet-Prox1       CCAGAGTGTCTTTCCCCTTTTGGCAGGCCTACTATGAGCCAGTTTGATGTGGATCGCTTA 540  
                ************************************************************   
 
Prox1_ORF       TGTGATGAGCACCTGAGAGCAAAGCGCGCCCGGGTTGAGAATATCATTCGGGGTATGAGC 531  
Tet-Prox1       TGTGATGAGCACCTGAGAGCAAAGCGCGCCCGGGTTGAGAATATCATTCGGGGTATGAGC 600  
                ************************************************************   
 
Prox1_ORF       CATTCCCCCAGTGTGGCATTAAGGGGCAATGAAAACGAAAGAGAGATGGCCCCGCAGTCT 591  
Tet-Prox1       CATTCCCCCAGTGTGGCATTAAGGGGCAATGAAAACGAAAGAGAGATGGCCCCGCAGTCT 660  
                ************************************************************   
 
Prox1_ORF       GTGAGTCCCCGAGAAAGTTACAGAGAAAACAAACGCAAGCAGAAGCTGCCCCAGCAGCAG 651  
Tet-Prox1       GTGAGTCCCCGAGAAAGTTACAGAGAAAACAAACGCAAGCAGAAGCTGCCCCAGCAGCAG 720  
                ************************************************************   
 
Prox1_ORF       CAACAGAGTTTCCAGCAGCTGGTTTCAGCCCGAAAAGAACAGAAGCGAGAGGAGCGCCGA 711  
Tet-Prox1       CAACAGAGTTTCCAGCAGCTGGTTTCAGCCCGAAAAGAACAGAAGCGAGAGGAGCGCCGA 780  
                ************************************************************   
 
Prox1_ORF       CAGCTGAAACAGCAGCTGGAAGACATGCAGAAGCAGCTGCGCCAGCTGCAGGAGAAGTTC 771  
Tet-Prox1       CAGCTGAAACAGCAGCTGGAAGACATGCAGAAGCAGCTGCGCCAGCTGCAGGAGAAGTTC 840  
                ************************************************************   
 
Prox1_ORF       TACCAGGTCTATGACAGCACAGACTCCGAAAATGATGAAGATGGCGACCTGTCTGAAGAC 831  
Tet-Prox1       TACCAGGTCTATGACAGCACAGACTCCGAAAATGATGAAGATGGCGACCTGTCTGAAGAC 900  
                ************************************************************   
 
Prox1_ORF       AGCATGCGCTCGGAGATCCTGGATGCACGGGCCCAGGACTCGGTGGGGCGCTCAGACAAT 891  
Tet-Prox1       AGCATGCGCTCGGAGATCCTGGATGCACGGGCCCAGGACTCGGTGGGGCGCTCAGACAAT 960  
                ************************************************************   
 
Prox1_ORF       GAGATGTGTGAGCTGGACCCAGGGCAGTTCATCGACAGGGCCCGAGCCCTAATCAGGGAG 951  
Tet-Prox1       GAGATGTGTGAGCTGGACCCAGGGCAGTTCATCGACAGGGCCCGAGCCCTAATCAGGGAG 1020  
                ************************************************************   
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Prox1_ORF       CAGGAGATGGCTGAGAACAAGCCTAAGCGAGAAGGCAGCAACAAAGAAAGAGACCACGGG 1011  
Tet-Prox1       CAGGAGATGGCTGAGAACAAGCCTAAGCGAGAAGGCAGCAACAAAGAAAGAGACCACGGG 1080  
                ************************************************************   
 
Prox1_ORF       CCAAACTCCTTGCAGCCAGAAGGCAAGCATCTGGCAGAGACCTTAAAACAGGAGCTGAAC 1071  
Tet-Prox1       CCAAACTCCTTGCAGCCAGAAGGCAAGCATCTGGCAGAGACCTTAAAACAGGAGCTGAAC 1140  
                ************************************************************   
 
Prox1_ORF       ACGGCCATGTCGCAGGTTGTGGACACGGTGGTCAAAGTCTTCTCAGCCAAACCCTCTCGC 1131  
Tet-Prox1       ACGGCCATGTCGCAGGTTGTGGACACGGTGGTCAAAGTCTTCTCAGCCAAACCCTCTCGC 1200  
                ************************************************************  
  
Prox1_ORF       CAGGTTCCTCAGGTCTTCCCACCTCTCCAGATCCCCCAGGCCAGATTCGCAGTCAACGGG 1191  
Tet-Prox1       CAGGTTCCTCAGGTCTTCCCACCTCTCCAGATCCCCCAGGCCAGATTCGCAGTCAACGGG 1260  
                ************************************************************   
 
Prox1_ORF       GAAAACCACAATTTCCACACGGCCAACCAGCGCCTGCAATGCTTTGGTGATGTCATCATT 1251  
Tet-Prox1       GAAAACCACAATTTCCACACGGCCAACCAGCGCCTGCAATGCTTTGGTGATGTCATCATT 1320  
                ************************************************************   
 
Prox1_ORF       CCGAACCCCTTGGACACCTTTGGCAGTGTGCAGATGCCTAGTTCCACAGACCAGACGGAA 1311  
Tet-Prox1       CCGAACCCCTTGGACACCTTTGGCAGTGTGCAGATGCCTAGTTCCACAGACCAGACGGAA 1380  
                ************************************************************   
 
Prox1_ORF       GCCCTTCCCCTGGTGGTCCGAAAAAACTCATCCGAGCAATCTGCCTCTGGCCCGGCCACT 1371  
Tet-Prox1       GCCCTTCCCCTGGTGGTCCGAAAAAACTCATCCGAGCAATCTGCCTCTGGCCCGGCCACT 1440  
                ************************************************************   
 
Prox1_ORF       GGCGGCCACCACCAGCCCCTGCACCAGTCACCCCTCTCCGCCACTGCAGGCTTCACCACC 1431  
Tet-Prox1       GGCGGCCACCACCAGCCCCTGCACCAGTCACCCCTCTCCGCCACTGCAGGCTTCACCACC 1500  
                ************************************************************   
 
Prox1_ORF       CCTAGCTTCCGCCATCCCTTTCCCCTGCCCTTGATGGCTTATCCATTTCAGAGTCCACTA 1491  
Tet-Prox1       CCTAGCTTCCGCCATCCCTTTCCCCTGCCCTTGATGGCTTATCCATTTCAGAGTCCACTA 1560  
                ************************************************************   
 
Prox1_ORF       GGTGCTCCCTCCGGCTCCTTCTCGGGGAAGGACAGAGCCTCTCCTGAGTCCTTAGACTTG 1551  
Tet-Prox1       GGTGCTCCCTCCGGCTCCTTCTCGGGGAAGGACAGAGCCTCTCCTGAGTCCTTAGACTTG 1620  
                ************************************************************   
 
Prox1_ORF       ACTCGGGACACAACAAGTCTGAGGACCAAGATGTCATCACACCATCTGAGCCACCACCCC 1611  
Tet-Prox1       ACTCGGGACACAACAAGTCTGAGGACCAAGATGTCATCACACCATCTGAGCCACCACCCC 1680  
                ************************************************************   
 
Prox1_ORF       TGTTCACCAGCACACCCACCCAGCACCGCAGAAGGACTCTCTTTGTCACTCATAAAGTCT 1671  
Tet-Prox1       TGTTCACCAGCACACCCACCCAGCACCGCAGAAGGACTCTCTTTGTCACTCATAAAGTCT 1740  
                ************************************************************   
 
Prox1_ORF       GAGTGTGGAGATCTTCAAGATATGTCCGACATCTCACCTTATTCAGGAAGCGCAATGCAG 1731  
Tet-Prox1       GAGTGTGGAGATCTTCAAGATATGTCCGACATCTCACCTTATTCAGGAAGCGCAATGCAG 1800  
                ************************************************************   
 
Prox1_ORF       GAAGGGCTATCACCCAATCACTTGAAAAAGGCAAAACTCATGTTCTTTTACACCCGCTAC 1791  
Tet-Prox1       GAAGGGCTATCACCCAATCACTTGAAAAAGGCAAAACTCATGTTCTTTTACACCCGCTAC 1860  
                ************************************************************   
 
Prox1_ORF       CCCAGCTCCAACATGCTGAAGACCTACTTCTCGGACGTGAAGTTCAACAGATGCATTACC 1851  
Tet-Prox1       CCCAGCTCCAACATGCTGAAGACCTACTTCTCGGACGTGAAGTTCAACAGATGCATTACC 1920  
                ************************************************************   
 
Prox1_ORF       TCGCAGCTCATCAAGTGGTTCAGCAATTTCCGTGAGTTTTACTATATCCAGATGGAGAAG 1911  
Tet-Prox1       TCGCAGCTCATCAAGTGGTTCAGCAATTTCCGTGAGTTTTACTATATCCAGATGGAGAAG 1980  
                ************************************************************   
 
Prox1_ORF       TATGCGCGTCAAGCCATCAATGATGGAGTCACCAGTACAGAAGAGCTCTCCATCACCAGG 1971  
Tet-Prox1       TATGCGCGTCAAGCCATCAATGATGGAGTCACCAGTACAGAAGAGCTCTCCATCACCAGG 2040  
                ************************************************************   
 
Prox1_ORF       GATTGTGAGCTATACCGAGCCCTCAACATGCACTACAACAAAGCAAATGACTTTGAGGTT 2031  
Tet-Prox1       GATTGTGAGCTATACCGAGCCCTCAACATGCACTACAACAAAGCAAATGACTTTGAGGTT 2100  
                ************************************************************   
 
Prox1_ORF       CCAGAGAGATTCCTGGAAGTTGCGCAGATCACGTTACGGGAGTTTTTCAATGCCATCATC 2091  
Tet-Prox1       CCAGAGAGATTCCTGGAAGTTGCGCAGATCACGTTACGGGAGTTTTTCAATGCCATCATC 2160  
                ************************************************************   
 
Prox1_ORF       GCGGGCAAAGATGTTGATCCTTCCTGGAAGAAGGCCATTTACAAGGTCATCTGCAAGCTG 2151  
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Tet-Prox1       GCGGGCAAAGATGTTGATCCTTCCTGGAAGAAGGCCATTTACAAGGTCATCTGCAAGCTG 2220  
                ************************************************************   
 
Prox1_ORF       GATAGTGAAGTTCCTGAGATTTTCAAATCCCCTAACTGCCTACAAGAACTCCTTCACGAG 2211  
Tet-Prox1       GATAGTGAAGTTCCTGAGATTTTCAAATCCCCTAACTGCCTACAAGAACTCCTTCACGAG 2280  
                ************************************************************   
 
Prox1_ORF       TAG--------------------------------------------------------- 2214  
Tet-Prox1       TAGTCTAGAGAATTCGATATCAAGCTTATCGATAATCAACCTCTGGATTACAAAATTTGT 2340  
                ***                                                            
 
Prox1_ORF       ------------------------------------------------------------  
Tet-Prox1       GAAAGATTGACTGGTATTCTTAACTATGTTGCTCCTTTTACGCTATGTGGATACGCTGCT 2400  
                                                                               
 
Prox1_ORF       ------------------------------------------------------------  
Tet-Prox1       TTAATGCCTTTGTATCATGCTATTGCTTCCCGTATGGCTTTCATTTTCTCCTCCTTGTAT 2460  
                                                                               
 
Prox1_ORF       -----------------------------------------------  
Tet-Prox1       AATCCTGGTTGCTGTCTCTTTATGAGGAGTTGTGGCCCGTTGTCAGC 2507 
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Emx2 
Emx2 Clone 13 Sequence Alignment           
Emx2            CACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAGCCTCCGCGGCCCCGAAT 60 
gene            ------------------------------------------------------------ 
                                                                             
 
Emx2            TCGCTAGCCACCATGTTTCAGCCGGCGCCCAAGCGCTGCTTCACCATCGAGTCGCTGGTG 120 
gene            ------------ATGTTTCAGCCGGCGCCCAAGCGCTGCTTCACCATCGAGTCGCTGGTG 48 
                            ************************************************ 
 
Emx2            GCCAAGGACAGTCCCCTGCCTGCCTCGCGCTCCGAGGATCCCATCCGTCCCGCGGCACTC 180 
gene            GCCAAGGACAGTCCCCTGCCTGCCTCGCGCTCCGAGGATCCCATCCGTCCCGCGGCACTC 108 
                ************************************************************ 
 
Emx2            AGCTACGCCAATTCCAGTCCCATAAATCCGTTCCTCAACGGCTTCCACTCGGCCGCCGCC 240 
gene            AGCTACGCCAATTCCAGTCCCATAAATCCGTTCCTCAACGGCTTCCACTCGGCCGCCGCC 168 
                ************************************************************ 
 
Emx2            GCCGCCGCCGCCGGCAGGGGCGTCTACTCCAACCCGGACTTGGTGTTCGCCGAGGCGGTC 300 
gene            GCCGCCGCCGCCGGCAGGGGCGTCTACTCCAACCCGGACTTGGTGTTCGCCGAGGCGGTC 228 
                ************************************************************ 
 
Emx2            TCGCACCCGCCCAACCCCGCCGTGCCGGTGCACCCGGTGCCGCCGCCGCACGCCCTGGCC 360 
gene            TCGCACCCGCCCAACCCCGCCGTGCCGGTGCACCCGGTGCCGCCGCCGCACGCCCTGGCC 288 
                ************************************************************ 
 
Emx2            GCCCACCCCCTGCCCTCCTCGCATTCGCCACACCCCCTCTTCGCCTCGCAGCAGCGGGAC 420 
gene            GCCCACCCCCTGCCCTCCTCGCATTCGCCACACCCCCTCTTCGCCTCGCAGCAGCGGGAC 348 
                ************************************************************ 
 
Emx2            CCGTCCACCTTCTACCCCTGGCTCATCCACCGCTACCGATATCTGGGTCATCGCTTCCAA 480 
gene            CCGTCCACCTTCTACCCCTGGCTCATCCACCGCTACCGATATCTGGGTCATCGCTTCCAA 408 
                ************************************************************ 
 
Emx2            GGGAACGACACAAGTCCCGAGAGTTTCCTTTTGCACAACGCTCTGGCCAGAAAGCCAAAG 540 
gene            GGGAACGACACAAGTCCCGAGAGTTTCCTTTTGCACAACGCTCTGGCCAGAAAGCCAAAG 468 
                ************************************************************ 
 
Emx2            CGGATTCGAACCGCCTTCTCGCCGTCCCAGCTTTTAAGGCTAGAGCACGCTTTTGAGAAG 600 
gene            CGGATTCGAACCGCCTTCTCGCCGTCCCAGCTTTTAAGGCTAGAGCACGCTTTTGAGAAG 528 
                ************************************************************ 
 
Emx2            AACCATTACGTGGTGGGAGCGGAAAGGAAGCAGCTGGCTCACAGTCTCAGTCTTACGGAA 660 
gene            AACCATTACGTGGTGGGAGCGGAAAGGAAGCAGCTGGCTCACAGTCTCAGTCTTACGGAA 588 
                ************************************************************ 
 
Emx2            ACTCAGGTAAAAGTATGGTTTCAGAACCGGAGAACGAAATTCAAAAGGCAAAAGCTAGAG 720 
gene            ACTCAGGTAAAAGTATGGTTTCAGAACCGGAGAACGAAATTCAAAAGGCAAAAGCTAGAG 648 
                ************************************************************ 
 
Emx2            GAAGAAGGCTCAGATTCTCAACAGAAGAAAAAAGGGACACACCACATTAACCGGTGGAGA 780 
gene            GAAGAAGGCTCAGATTCTCAACAGAAGAAAAAAGGGACACACCACATTAACCGGTGGAGA 708 
                ************************************************************ 
 
Emx2            ATTGCTACCAAGCAG-CGAGTCCGGAGGAAATAGATGTGACCTCAGACGATTAA TCTAAA 839 
gene            ATTGCTACCAAGCAGGCGAGTCCGGAGGAAATAGATGTGACCTCAGACGATTAA------ 762 
                *************** **************************************       
 
Emx2            GGGCGAATTCGATATCAAGCTTATCGATAATCAACCTCTGGATTA 884 
gene            --------------------------------------------- 
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2.3.1.9 Plasmid Mini & Maxi Preparation 
 
Following the sequencing alignment, the selected colonies were used as a reference point for 
the initial cultures (5 mL mini-prep plasmids in large scale production).  
The small- and large-scale plasmid preparations were carried out utilizing Qiagen mini kits and 
endotoxin-free Qiagen maxi kits.  
 
 
2.4 Cell Culture Methods  
In general, the cell culture was performed under sterile conditions in two steps; first, the pseudo 
lenti-virus particle production, and second, the ESC transduction and differentiation.  
 
2.4.1 Lentivirus Preparation, Titration and Usage 
In this study, the use of lentiviral vectors was in accordance with the guidelines of the Ethical 
Committee of Heidelberg University, Graduate School of Medicine. The  lentiviruses were 
prepared and tittered as described by Verma, IM et al. (Abeldano, Tiscornia et al. 2006) and 
(Anderson, Cohen et al. 2009) with minor modifications.  
2.4.1.1 Lentiviral Plasmids and Packaging Constructs 
The plasmids pMDL g/pRRE, pRSV-Rev, and pMD2.G were purchased from Addgene. 
To obtain enough lentiviral packaging plasmid DNA for the viral vector productions, the 
bacteria were cultivated overnight, as a streak culture on an Agar medium containing 50 µg/mL 
Ampicillin (50 µg/mL) at 37°C. The next day, the single bacteria colonies were picked up and 
inoculated in 5 mL LB medium supplemented with Ampicillin (50 μg/mL) whilst shaking 
overnight at 37°C. 
After 24 hours, the plasmids were isolated from 1 mL of bacterial culture using the mini kit 
(Qiagen mini kits) and analyzed by restriction digestion. 
The rest of the bacterial culture was utilized for large scale production of plasmids and 
inoculated in a 400 mL LB medium supplemented with Ampicillin (50 μg/mL) whilst shaking 
overnight at 37°C. Subsequently, plasmids were isolated with an endotoxin-free maxi kit 
(Qiagen kits) as specified by the manufacturer. 
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Packaging Plasmid 
pMDLg/pRRE (8890bp) 
(Plasmid #12251) 
Prsv-Rev (4180bp) 
(Plasmid #12253) 
 
RE Cutting Site 
 5’ to 3’ 
Fragment Size 
(bp) 
RE Cutting Site  
5’ to 3’ 
Fragment Size 
(pb) 
Pst 1 1928-3351 
3352-1927 
1424 
7466 
EoRI 2024-2334 
2335-2023 
311 
3869 
EcoRI 1277-5611 
5612-6012 
6013-1276 
4335 
401 
4154 
HindIII 697-1593 
1594-2220 
2221-6001 
6002-696 
897 
627 
3781 
3585 
AseI 606-1840 
1841-1899 
1900-605 
1235 
59 
2886 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.27: The Overview of Packaging Plasmid restriction digestion 
Fig.2.8b pMDLg-pRRE (8895 bp) digested with 
HindIII (Lane 3), EcoRI (Lane 4), Pst1 (Lane 5), 
Uncut (Lane 1).  
 
Fig. 2.8a pMDLg-pRRE Plasmid Construction Map. 
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Fig. 2.8c pRSV Rev Plasmid Construction Map 
Fig. 2.8d pRSV Rev digested with AseI (Lane 3), 
EcoRI (Lane 4). Uncut (Lane 2), 2log DNA 
Marker (Lane 1) 
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RE 
pMD2.G (5822 bp)  
(Plasmid # 12259) 
Cutting Site  
5’ to 3’ 
Fragment Size (bp) 
SwaI 1192-5270 
5271-1191 
4079 
1743 
BglII 1771-5115 
5116-1770 
3345 
2477 
AseI 2957-3889 
3890-2956 
933 
4889 
EcoRI 968-5121 
5122-967 
4154 
1668 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   1          2          3            4         5 
Table 2.28: The Overview of pMD2.G 
Digestion  
Fig. 2.9a The structure of pMD2.G DNA 
Plasmid  
Fig. 2.9b The result of pMD2.G digestion 
with SwaI (Lane 2), BglII (Lane 3), Asel 
(Lane 4), EcoRI (Lane 5) 
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2.4.1.2 HEK293 TN Cell Transfection 
 
For the production of recombinant lentiviral vectors, HEK 293TN (SBI) cells were used as virus 
packaging cells. A number of 1.8 − 2 ×  106 HEK cells with low passage number (P5-P8) 
were seeded and grown in 10 mL HEK medium inside a T75 flask just 48 hours before 
transfection. 
The HEK 293NT cells were split from one confluent T75 flask to the 6 × T75 flask. After 12-
16 hours, HEK 239TN cells had 50-70 % confluency. The transfection mixture was prepared 
in a 15 mL falcon tube by mixing 20 µg of the targeted lentiviral plasmids separately, as well 
as 22.5 µg packaging plasmid (3rd generation plasmids: pMDL g/pRRE-15µg+pRSV-Rev-7.5 
µg) and envelop plasmid (pMD2.G-9 µg) (Table 2.28). 
Afterwards, the complex mixture was added to OptiMEM very carefully and mixed by finger 
taps for a minute. Then, Lipofectamine reagent 2000 which had already been mixed with Opti-
MEM, was added to the first mixture and then incubated for 15 minutes in RT. The transfection 
mixture was applied gently to each T75 flask with HEK cells and was swirled for a 
homogeneous distribution of mixture. The cells were incubated at 37° C, 3 % CO2 overnight 
(12-15 hours). At this point, the cells were cultured in DMEM high glucose supplemented with 
10 % (Vol/Vol) Heat Inactivated FBS (Tet-free), 2Mm L-glutamine without antibiotics to allow 
an increased cell growth and viral production.  By the next morning, the medium was replaced 
with 10 mL of fresh HEK medium, supplemented with 10 % Tet-free as well as antibiotic (1% 
Pen/Strep) and incubated at 37° C, 5 % CO2 for 2 days (48-50 hours). Afterwards, the viral 
supernatants were collected and concentrated by ultracentrifugation. 
To remove cell debris, the viral supernatants were collected and centrifuged (Eppendorf 
centrifuge 5804R) for 5 min at 1500 rpm and 4° C. Afterwards, the rest of cell debris were 
removed by passing the supernatants through the 0.45 µm (TPP, 99745) low–protein–banding 
filter. 
Each SW32 centrifuge tube (Beranek Laborgeräte seton, 7052) was sterilized by 70 % alcohol, 
and then dried under “biosafety level2 tissue culture cabinet”. Afterwards, the tube was filled 
with filtrated vector–containing cell culture supernatant and adjusted very carefully to reach 
34 grams. 
The tubes were placed into a pre-cooled Beckman SW32 ultracentrifuge rotor. Then, the 
ultracentrifugation was performed at 4° C for 2 hours at 22.000 rpm Ultracentrifuge. Next, the 
tubes were removed carefully from the rotor, and the supernatants were aspirated by vacuum 
pumps. An amount of 120 µL PBS without Ca+2/Mg+2 was added to each tube, in which a min 
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A pellet was visible at its bottom. The tubes were sealed and incubated on ice for 2 hours. Then 
the virus plates were broken very carefully by finger tips. To avoid bubble formation, 80 µL of 
extra PBS without Ca+2/Mg+2 was added to each tube, and then the pellet was re-suspended by 
gently pipetting up and down. A liquid from all re-suspended pellets was combined in a single 
tube. Then, it was aliquoted in 0.5 mL Eppendorf microfuge tubes in 25-50 µL portions, and 
immediately was snap-frozen in a liquid nitrogen bath stored at –80°C. 
 
Table 2.28: Transfection Mixture per Each T75 Flask 
Lenti-Virus -3rd generation plasmids DNA(µg/T75 flask ) 
PMplg/RRE 15 
Prsv-Rev  7,5 
Envelop.MGD2 9 
Transfer vector 20 
Lipofectamine 2000 1µL /1 µg DNA 
Opti-MEM 1mL 
 
 
2.4.1.3 Determining Pseudo-Viral Titration by Real-time PCR  
 
After the lentiviral particle preparation, it is necessary to titer the infectivity of the virus 
particles. This can be determined in vitro by infecting HE2K 293 and target cells, which in the 
experiment were ES (E14). Consequently, 5 × 104 of the HEK293 cells and ES were seeded in 
two 24-well plates separately just 24 hours prior to viral infection (Each plates were pre-coated 
with 0.1 % gelatin for 2 hours at 37° C). For each well, 0.5 mL of DMEM-high glucose was 
supplemented with 10 % heat-inactivated fetal bovine serum (Tet-free) and penicillin-
streptomycin, and incubated at 37° C with 5 % CO2 overnight. The culture medium was 
removed from each well, and 0.2 mL of fresh medium including Polyene at 0.6 µg/mL was 
replaced. The medium was concentrated with the virus particles at serially prepared dilution 
ratios of 1:10, 1:100, and 1:1000.  Each dilution was repeated once more. After 24 hours, the 
old medium was replaced by the fresh medium and cultured for an extra 48 hours.  
Finally, the samples were collected for the virus titration by Lenti-X Provirus Quantitation Kit 
(Clonetech). The quantification process is described briefly in the following.  
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2.5.1.3.1 Provirus Quantification 
DNA-Extraction 
Kit: GenElute Mammalian Genomic DNA Miniprep Kit (Sigma, Cat. # G1N70) 
Extraction according to the manufacture’s protocol. 
Elution: 200 µL Elution Buffer pre-warmed to 55°C, incubated for 5 min at RT prior 
centrifugation.  
Concentration Measurement 
DNA concentration was measured on Spectrophotometer NanoDrop 2000c (Thermo 
Scientific). 
Concentrations were in the range of 62 to 161 ng/µL. Ratio A260/280 was in the range of 
1,77 to 1,96. 
Determination of integrated Provirus Copies 
Kit: Lenti-X Provirus Quantification Kit (Clonetech, Cat. # 631239) 
Determination was done according to manufacturer’s protocol. 
Using the provided control template, a dilution series with a defined copy number for a 
standard curve was prepared. Samples were diluted with EASY buffer to a final concentration 
in the range of 50 ng/µL. 
2 µL of samples and standards were assembled in duplicates on a 96-well fast qPCR plate 
together with reaction mix. The mix contained Lenti-X provirus forward and reverse primer, 
ROX Reference Dye LMP and SYBR Advantage qPCR premix in a total reaction volume of 
20 µL. Run was performed on a Thermo Fisher StepOne Plus qPCR system. Cycling 
conditions were: 
Initial denaturation: 95°C, 30 sec 
40 cycles: 95°C 5 sec 
Dissociation curve 
According to the user manual, the true provirus copy number per cell (MOI) was calculated. 
For transfection of mouse ES cells, a MOI of 50 – 100 is optimal as known from the 
literature.  
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Fig. 2.10 The viral titration qPCR analyses of HEK293 cell and mESCs 
 
2.4.1.4 Functional Titration  
For calculating the ratio of the transactivator virus particles to the target lenti-virus gene and 
investigating the expression of transcription factors, the functional titration was performed. For 
this purpose, the co-transduction mixture was performed with the combination of the 
transactivator and target lentivirus genes (Prox1, Emx2, and NeuroD1). This mixture was 
applied to the HEK 293 cells with three different serial virus particle dilutions of 1:10, 1:100, 
and 1:1000 as described earlier. Finally, the cells were fixed by using the 4% paraformaldehyde 
and the immunocytochemistry was performed (Fig. 12-14).  
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Fig. 2.11 The Tet-O-FUW-Prox1 Lentiviral Functional Titration. The infection efficiency was determined 
by obtaining the percentage of Prox1 immunocytochemistry in the infected culture with different 
supernatant dilutions: 1:10 (A), 1:100 (B), and 1:1000 (C) (Scale bar: 100µm).  
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Fig. 2.12 The Tet-O-FUW-Emx2 Lentiviral Functional Titration. The infection efficiency was 
determined by obtaining the percentage of Prox1 immunocytochemistry in the infected culture with 
different supernatant dilutions: 1:10 (A), 1:100 (B), and 1:1000 (C) (Scale bar: 100µm).  
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Fig. 2.13 The Tet-O-FUW-NeuroD1 Lentiviral Functional Titration. The infection efficiency was 
determined by obtaining the percentage of Prox1 immunocytochemistry in the infected culture with 
different supernatant dilutions: 1:10 (A), 1:100 (B), and 1:1000 (C) (Scale bar: 100µm).  
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2.4.2 Mouse Feeder Embryonic Cells 
2.4.2.1 MEF derivation and irradiation 
MEFs were utilized as feeder cells to maintain the mouse embryonic stem cells in an 
undifferentiated state. They were developed from dissociated ZP mouse embryos (13.5–14 d 
gestation). This mouse line had genetic manipulation and carried Zeocin antibiotic resistance 
gene. 
To isolate MEFs from mouse embryos, a pregnant mouse at a time was scarified by using CO2 
gas, placed on her back on autoclaved paper towels. After spraying the mouse with 75% ethanol 
peritoneal, the cavity was opened with a Y-incision. The uterine horns were dissected out, and 
washed with PBS - containing 1 % penicillin/streptomycin (Life Technologies). The uterine 
horns were placed on the culture plates and transferred to the sterile bench. The embryos from 
the uterus were dissected out, and all tissue surrounding each embryo, such as the placenta and 
the embryonic sac, was removed by using sterile forceps. Afterwards, head, tail, hind limbs, 
front limbs and internal organs were dissected out. Then, each embryo was transferred into a 
bacterial 6 mm dish and washed with PBS - containing 1 % penicillin/streptomycin -, and was 
cut into several pieces with a sterile razor blade. In order to collect a Neomycin resistance 
embryo, lacZ staining was done on each embryo tail individually. 
The tissue clumps were collected in a 60 mm bacterial culture plate, disassociated into cell-
suspension using a syringe 18G and pipetted up and down thrice. Afterwards, the cell 
suspension was incubated with 2 - 5 mL 0.25% Trypsin/EDTA (depending on the number of 
embryos; 0.5 - 1 mL Trypsin/EDTA per each embryo) (Life Technologies) for 15 minutes at 
37° C. After each 5 minutes of incubation, the cells were dissociated by pipetting up and down 
thoroughly. The trypsin was inactivated by adding a fresh MEF medium. The cell suspension 
was centrifuged at 300 g for 5 min, then the supernatant was taken off carefully, and the cell 
pellet re-suspended in a fresh and warm MEF medium. A number of cells equivalent to one 
embryo were plated onto T150 tissue culture flasks, pre-coated with 0.1 % gelatin. During this 
time, tail X-Gal staining was done, as described below. The fibroblast outgrowths were visible 
24 hours after culture. When the cells were 80 – 90 % confluent, they were expanded 1:3.  
After three passages, MEFs were collected and inactivated by γ-radiation 80G in the Heidelberg 
DKFZ facility.   
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Inactivation by γ-irradiation:  
MEFs were harvested as above, combined into one 15 mL tube and were irradiated with a dose 
of 80G in the Heidelberg DKFZ facility. The exposure time was 11 - 12 min. The inactivated 
MEFs were frozen in 10% DMSO/90%FBS at 1.6x106 per cryovial and stored in –80° C for 48 
hours for long term storage. For subsequent use, the vials were transferred into a nitrogen liquid 
tank.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.4.2.1.1 Genotyping by X-gal staining 
The mouse embryos’ tails were washed in cold PBS separately and cut into small pieces. A 
small piece from each embryo was transferred into a 0.5 micro tube (wrapped in foil) and 
incubated at 37° C for 30 - 60 minutes with freshly prepared X-gal staining solution. For a 
firmer confirmation of the resistance of the MEF to Neomycin, the X-gal staining was 
performed for the feeder cells taken from the mouse embryo (E13.5) by using standard protocol. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.14 Mouse Embryonic Feeder (MEF) Cells after 48 h 
Culture. Phase- contrast microscopy image (magnification 10x) 
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2.4.2.1.2 Mycoplasma Detection 
 
The mycoplasma contamination is a major problem in cell culture lab. Animal products and 
primary cell culture are two important source leading to mycoplasma contamination. 
Therefore, the MEF cells were checked for mycoplasma infection before applying them for ES 
cell culture and any purposes.  
 
2.4.2.1.3 Templates for PCR Analysis  
To detect mycoplasma contamination, 1 mL of cell culture supernatants were collected from 
cell culture after 48 and 72 hours in 1.5 mL centrifuge tubes and were stored at +2° - +8° C. 
500 µl of the supernatant of cell cultures were transferred to a micro centrifuge tube. Samples 
were incubated at 95° C for 10 minutes. Afterwards, the samples were centrifuged at 
13,000 rpm to pellet cellular debris, and 2 µl of each supernatant were transferred to 0.2 µl 
Eppendorf micro tubes directly for PCR by Venor® GeM kit. 
 
 
  
Fig. 2.15 X-Gal Staining of MEF Cells (ZP mouse line) after 48 h Culture 
as indicated by blue perinuclear Phase contrast microscopy (magnification 10x) 
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2.4.2.1.4 Antibiotic Selection in mouse ESC Line 
To generate stable homogenous ESC cell lines, un-transfected cells should be removed from 
the cell culture. Before generating a stable cell line which expresses the transcription factor 
from an expression construct, it is necessary to determine the minimum antibiotic concentration 
required to kill all un-transfected ESCs. For this purpose, all transcription factor constructs 
carry the Zeocin antibiotic resistant gene. 
Zeocin, belongs to the bleomycin/phleomycin family of antibiotics isolated from Streptomyces. 
The Zeocin gene encodes amino-glycoside 3’-phosphotransferase, an enzyme which admits 
resistance to G418 disulfate and neomycin.  
Zeocin is a routinely used antibiotic, which is administered for successful antibiotic selection 
of transfected mammalian cells. In fact, the transfected cells express a Zeocin resistance gene 
in addition to the gene of interest during the cell culture. Different cell lines have varying 
antibiotic sensitivity from 20 - 1000 μg/mL to Zeocin. 
To determine the optimal concentration, a prior experiment was performed for the killing of un-
transfected ESCs by implementing a serial concentration of 10 to 500 µg/ mL for 5 days. The 
optimal concentration is suitable for the selection of resistant mammalian clones and depends 
on cell lines, ionic strength, and growth rate. It is necessary to perform a kill curve for every 
new cell type and every new batch of Zeocin based on the following protocol: 
 
1.  1000-6000 ESCs were seeded in each well of the 96-well plate for 24 hours. 
2. After 24 hours, the medium was removed, and then a fresh medium with varying 
concentrations of Zeocin™ was added to the wells in a group of 11 concentrations 
ranging from 50 to 550 µg/mL in linear increments (50, 100, …, 550 µg/mL). 
3. The selective medium was replenished every second day, and the percentage of 
surviving cells was observed over time. Afterwards, the optimal concentration for 
killing the majority of cells in the desired number of days (within 5 days) was selected. 
For more clarity in distinguishing viable cells by observation, we employed counting 
the number of viable cells by standard WST-1 assay.    
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2.4.2.1.5 WST-1 Assay 
The WST-1 Assay was performed to check the antibiotic toxicity based on mitochondrial 
activity. To determine the optimal antibiotic concentration, we utilized the WST-1 assay and 
checked the cell proliferation rate during five days of cell culture. For this purpose, ESCs at day 
one, were seeded at the number of 1000, 2000, 3000, 4000, and 6000 cells in the 96 well plate 
and cultured for 48 hours. Thereafter, the cells were treated with different antibiotic 
concentrations. Each experiment was performed and triplicated for a group of 11 concentrations 
ranging from 50 to 550 µg/mL in linear increments. The cells were exposed to the same 
concentration and incubated in standard condition for four days. Over this period, the treatment 
was repeated every second day. Accordingly, the cell viability was analyzed with WST-1 assay 
by ELISA reader Sunrise™ at wavelength 480 nm, as outlined by the manufacturer. 
The obtained data was analyzed by Excel and we concluded that the optimal concentration for 
ESCs was varying between 80 and 100 µg/ml. This result was consistent with the microscopic 
observation. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.16 WST Assay Analysis to identify Killing Optimal Zeocin Concentration. 
 
 
2.4.3 ESC transduction 
As emphasized earlier, all of the steps for the utilization of pseudo lentivirus and ESC 
transduction in biosafety S2-level performed in accordance with the guidelines of the Ethical 
Committee of Heidelberg University, Graduate School of Medicine.  
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ESC culture:  ESCs are cultured according to standard procedures. The mESCs used in this 
study were derived from E14 IVC mice (from Austin Smith lab (P20)) and cultured, Zeocin 
resistant mouse fibroblasts.  The mESCs were cultured in ESC medium containing 20 % Tet–
free fetal bovine serum (FBS), 1 % nonessential amino acid (NEAA), 100 µM 2-
mercaptomethanol (ß-ME), 1 % penicillin-streptomycin, and 1000 U/mL leukemia inhibitory 
factor (Melander and Olsson).The ES culture medium was changed every day and ES cells were 
passaged every third day (Fig.18) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.4.3.1 Transduction 
ES cells from using two or three wells of a 6-well-plate were trypsinized in 0.25 % trypsin for 
3 minutes at 37° C.  The colonies were broken up by pipetting the cell suspension up and down 
for several times. The cells were spun down at 300 g for 3 minutes and re-suspended in 15 mL 
fresh ES cell media. The cells were then plated onto a gelatinized dish (100 mm) and placed in 
an incubator for 45 minutes to allow the feeder cells to settle and adhere.  After 45 minutes, the 
media (with ESCs) was removed and the cells were counted. The number of seeded cells is 
critical, because it should be possible to maintain individual colonies for picking up after 7 - 10 
days of antibiotic treatment. An unbalanced number of seeded cells reduce the chances of 
 
Fig. 2.17 Embryonic Stem Cells E14 IVC; P20. Phase contrast microscopy (magnification 10x). 
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identifying a good clone in either way: Too many cells are hard to pick up, while, very few of 
them would not grow desirably. An approximate number of 5 x 104 ESCs were used per each 
transduction well of a 6-well-plate. The lentivirus co-transduction was performed with virus 
particles of M2rTtA (trans-activator) and Tet-EGFP at MOIs of 50 – 100 in 1mL of ESC 
medium was frequently set up. The ESCs’ transduction was performed in a medium including 
polybrene at 8 µg/mL which incubated overnight at 37° C, 5 % CO2. 
After nearly 18 hours, 5 x 105 feeder cells resistant against Zeocin were added to each infected 
well. After 24 hours, the cell cultures were washed three times accurately to remove the excess 
of lentivirus particles and dead cells with warm phosphate buffered saline with Ca+2 and Mg+2 
(PBS+) The cell cultures were continued for 4 days in presence of Zeocin 100 mg/ml. 
 
2.4.3.1.1 Picking up  
Colonies were picked up by using standard techniques. Ninety-six colonies were picked 
“blindly” and transferred onto a 96-well-plate pre-coated with irradiated feeders cell separately. 
After 24 hours, the colonies were trypsinized in 30 - 50 µL of 0.25 Trypsin for 3 - 5minutes at 
37° C and then broken up by pipetting up and down 10 times with 200µL. This single cell 
suspension was kept and cultured in the same well for 10 - 12 hours, and then the media was 
changed to remove all traces of trypsin. 
 
2.4.3.1.2 Clone Maintenance/Selection 
The media was changed at least once a day for actively growing clones. After 3 - 5 days 
(depending on the growth rate), clones were split into two 96-well-plates, one filled with feeders 
and one free of it (but coated with gelatin).  Cells grown on the feeders were expanded and 
frozen down. Cells grown without feeders were expanded and screened by adding tetracycline 
500 ng/mL, in order to observe the EGFP expression after 19 – 24 hours. This expression is an 
indicator of a successful transduction of both plasmids.  
 
2.4.3.1.3 Cryopreservation of Lt-Tet-EGFP-transduced ES Cell Clones  
Undifferentiated Lt-Tet-EGFP-transduced ESC clones were frozen after 3 days of culture. The 
feeding of ES cells before cryopreservation is very important for their maintenance and 
prevention from post re-thawing differentiation. Meanwhile, the ES medium of Lt-Tet-EGFP-
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transduced ES cells clones were renewed 2 - 6 hours before cryopreservation by a fresh 
medium. Afterwards, Lt-Tet-EGFP ESC cultures were disassociated using 0.05 % 
trypsin/EDTA and re-suspended in the culture medium. Then, the cell suspension was 
centrifuged (300 x g, 3 min at RT). After centrifuging, the cell plate was re-suspended with 1 
mL fresh ESC medium. Its viability was determined by the trypan blue exclusion method using 
a 0.1 % (v/v) solution prepared in PBS and the cells counted in a Fuchs‐Rosenthal 
hemocytometer (Brand, Wertheim, Germany). The viability was more than 90 %, to ensure that 
the cells were healthy enough for freezing. The cells were once more re-suspended in the culture 
medium; the volume had a cell concentration of 1 × 106cells/mL.  
The pre-cooled cryovials were manually filled with 1mL of pre-cooled cryoprotective solutions 
and mixed gently with cell suspension solution (1:1). The cryovials were placed into a Freezing 
Container (Nalgene Nunc International) and were stored in a –80º C freezer overnight, then 
they were transferred in a nitrogen liquid tank for long-term storage until thawing. 
 
2.4.3.1.4 Fluorescence Activated Cell Sorting (FACS)                                        
To remove the some ES cell which had leaky expression and prevent the ES cells clone from 
differentiation during second or third transduction, FACS analysis was applied.   
FACS analysis was performed on BD LSR II (Becton Dickinson), BD Fortessa (Becton 
Dickinson) by Central Services - Flow Cytometry & FACS Core Facility (FFCF) in Heidelberg 
University (ZMBH). Cell sorting was performed with BD FACS Aria III (Becton Dickinson) 
cell sorter. The analysis of FACS data was done with FlowJo software (Tree Star Inc.). 
The ESC clone Lt-Tet-EGFP was dissociated with 0.25% Trypsin-EDTA and isolated from 
MEFs by standard protocol. The single cell suspension was sorted into artificial fractions (low, 
mid, and high) based on EGFP fluorescent signal intensity.  
After cell sorting, all cells expressing EGFP were removed and the rest of the cells were washed 
and re-cultured on MEF cells. In this experiment unmodified ES cells was applied as control 
group.  
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Fig. 2.18 Schematic illustration of transduction procedure of clonal expansion and banking of 
mESCs under antibiotic resistance 
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2.4.3.2 Second transduction 
After screening and clone banking, the Lt-Tet-EGFP clone G1 was selected randomly and re-
transduced by the following Lt-particles separately: Lt-Tet-Prox1, Lt-Tet-Emx2, and Lt-Tet-
NeuroD1. As in the case of abovementioned transduction, Lt-Tet-EGFP clone G1 (5 x 104 cells) 
was seeded and cultured on 0.1% gelatin with the ESC culture medium excluding antibiotic 
about 12 hours before the second re-transduction. 
The colony selection was performed like before, except for the clone screening which, the 
methods of immunocytochemistry and PCR were employed after treatment by Doxycycline. 
The cell cultures were continued for 4 days in the presence of Zeocin 100 µg/mL. 
The outcome of this procedure was the generation of clones as listed below: 
Lt-Tet-Prox1-EGFP 
Lt-Tet-Emx2-EGFP 
Lt-Tet-NeuroD1-EGFP 
  
2.4.3.3 Third transduction: 
 A third re-transduction of Lt-Tet-Prox1-EGFP with the pseudo-viral Lt-NeuroD1 particles was 
performed for the generation of Lt-Tet-Prox1-NeuroD1-EGFP.  
The whole process of transduction, clone banking and screening was performed based on the 
steps described in the last section.  
 
 
 
2.4.3.4 PCR: 
 
The integration of transcription factors and inducible stable cell line generation was 
confirmed by PCR analysis with the following primers. 
 
PCR Reagents and Primers  
Total DNA was extracted from all ESC clones after colony expansion by using the mammalian 
DNA extraction kit according to manufacturer instructions.  
The composition of the PCR-reaction was as follows: 
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2 µl DNA;  
0.5 µl dNTPs 
2.5µl PCR-buffer (10X) 
0.5 µl for each forward and reverse primer 
0.25 µl Taq polymerase 
18.75 ddH2O  
 
The PCR-reaction was performed in 0.25 mL-reaction tubes and a thermocycler with the same 
annealing temperature. The negative and positive control templates were included in each PCR-
reaction.  
After the PCR-reaction, 4 µl loading buffer (6x) was added to each tube. The samples were 
electrophoretically separated on an agarose-gel (1% agarose in TAE-buffer, at 120 V for 
approximately 40 – 50 min). The Agarose gels were stained in 10 μl ethidium bromide 
(10mg/mL) in 500 mL water and remained for 15 min and rinsed in water bath for an extra 15 
min. Then the gel was exposed to UV-light in a gel documentation system to visualize DNA-
bands.  
                                          Table 2.29: Primer sequence and products 
Gene          Primer sequence ( 5′ - 3′ ) Length (bp) 
Emx2 Emx2-F1: ACA GTC TCA GTC TTA CGG AAA CTC; 
WPRE-R1: AGC  CAT ACG GGA AGC AAT AGC ATG  
354 
NeuroD1 NeuroD1-F1: TGC CTT TAC CAT GCA CTA CCC TGC; 
WPRE-R1: AGC  CAT ACG GGA AGC AAT AGC ATG 
333 
Prox1 Prox1-F1: CAA GCC ATC AAT GAT GGA GTC ACC; 
WPRE-R1: AGC  CAT ACG GGA AGC AAT AGC ATG 
447 
M2rtTA M2rtTA-F1: ACT TAG ACA TGC TCC CAG CCG ATG; 
WPRE-R1: AGC  CAT ACG GGA AGC AAT AGC ATG 
250 
 
 
 
Product  Company Cat. Number  
Taq polymares Applied Biosystem M05768 
Pcr buffer Applied Biosystem M13037 
dNTP Applied Biosystem N8080260 
Agarose  Sigma A9539 
Caption: The PCR components 
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2.4.3.5 Immunocytochemistry 
The immunocytochemistry analysis was a second method used for a firmer confirmation of the 
expression and functionality of the transcription factors. For this purpose, the cell cultures were 
fixed in 4 % paraformaldehyde for 15 min. and. subsequently washed several times in PBS. 
The cells were then blocked for 10 min in a blocking solution containing 10 % goat serum and 
incubated with primary antibodies diluted overnight at 4° C. The primary antibodies were 
washed 3 times with PBS. The secondary antibodies were diluted in a blocking solution (with 
0.1 % Triton-X-100) and incubated for 30-45 min at RT. The cells were washed in PBS and 
subsequently stained with DAPI and washed twice in PBS for a total of 20 min. The nuclei were 
visualized by DAPI staining (1:10.000 in NaHCO3, 4 min incubation).         
                                                                                
 
2.4.3.6 Pilot studies 
At the beginning, several protocols for ES neural differentiation were investigated. These 
experiments revealed that ESCs were not only differentiated into pure neural precursors, but 
also into several types of cell populations, including all types of embryonic lineages. For 
example, they were containing beating cardiomyocyte cells of mesodermal origin, flattened 
epithelium-like cells but not a strong differentiation of neural homogenous precursor cells. 
The protocols suggested by Sasai and Gage (Watanabe, Kamiya et al. 2005, Yu, Di Giorgio et 
al. 2014) appeared more promising in relation with the neural differentiation conditions. The 
duration of the specific steps in differentiation and media constituents were modified and set 
up in our lab as a new protocol.  
The establishment of an EB protocol for the neural differentiation of ESCs in SFEB culture 
was a remarkable step in obtaining the neural homogenous precursor cells.  
Our study follows the EB formations, because we believe that the EBs as three dimensional 
structures are the reminiscent of the embryonic development.  
Considering the critical role of astrocyte cells in the neural differentiation and maintenance, 
the adherent co-culture was performed in parallel with our experiment. 
2.5 Astrocyte primary cell culture 
The astrocyte primary cell culture was prepared from cultures of cortical astrocytes. 
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A mouse pup (P1 - P4) was sacrificed (one at a time) by decapitation. The head was held with 
a laboratory tissue and washed with 70 % ethanol. The skin was cut longitudinally with scissors 
to expose the whole superior surface of the skull. The skull was carefully cut longitudinally 
with the scissors, then the brain was removed from the skull with a spatula and placed into a 
60 mm bacterial dish containing ice-cold L-15 medium. 
 
Inside of the hemispheres were scooped with the spatula. The surface of the cortical halves was 
cleaned of meninges by using small scissors and fine forceps. The cerebral cortex was dissected 
out and cut into pieces after incubation with 0.1 % trypsin and 0.01 % deoxyribonuclease I 
(DNase I). The whole procedure was performed at 37˚ C for about 10 min in water bath while 
being shaken every 3 min. 
The cell digestion was stopped with MEM including 20 % FBS, and were mechanically 
dissociated by being passed through a 5 mL pipette for 10 – 12 times. After trituration, the cell 
suspension was passed through Cell Strainer (70 µm) to remove cell clumps. 
The suspension was centrifuged at 300 x g for 10 min, and the pellet was re-suspended in an 
Eagle’s medium.  
The suspension was diluted to the optimal concentration, and the cells were plated on 75 cm2 
culture flasks pre-coated on poly-L-ornithine (5 µg/mL) at a density of 6.0 x 105 cells/cm2, and 
then cultivated at 37˚C in 5 % CO2. The dead cells were removed by changing the medium on 
the next day. The medium was exchanged with a complete medium every three days. The 
growth of the astrocyte culture was monitored by phase-contrast microscopy until it reached 80 
- 90 % confluency. 
At that day of confluency, the cell cultures were split 1:3 and incubated at 37° C for one week. 
Finally, the cultures freezed at -80°C for short-term- and kept in a liquid Nitrogen tank for long-
term storage.  
 
2.5.1 The astrocyte freezing process  
The astrocyte cell proliferation was done up to three passages. For a long-term storage, the cells 
were fed with astrocyte fresh medium 6-8 hours before freezing. Then the cells were trypsinized 
for 3-5 min based on standard protocol and centrifuged at 300 x g for 3 min. Afterwards, the 
cells were counted at 2 × 106 and quickly re-suspend by adding 1mL of freezing (cold 
Cryostem) media per cryovial. The cryovials were placed in Mr. Frosty freezing container and 
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kept at -80C for 48 hours. At the end, the vials were placed in the liquid Nitrogen tank for a 
long-term storage.  
 
a 
 
b 
 
c 
 
d 
 
e 
 
f 
 
 
 
 
 
 
 
 
 
 
 
B A 
C D 
Fig. 2.20 Co-staining of pure primary mouse astrocyte culture with the DAPI (A), GFAP (B), 
Nestin and (C), Merged (D): Scale bar=100µm. 
 
 
 
Fig. 2.19 a-f: Light microscope pictures of primary astrocyte culture. Letters A-F demonstrate 
the variety of morphologies observed using phase contrast microscopy (magnification 10x) 
 
 
 
  
83 
2.6 Differentiation  
The differentiation mechanism was accomplished in two general steps, first, the three 
dimensional (3D) culture, which is in turn divided into the EB formation and the EB induction, 
and second, the two dimensional (2D) culture which includes the adherent and astrocyte co-
cultures. In the following, we explain each step in more detail.  
 
2.6.1 Embryoid body (EB) formation  
 
The EB formation is a principle step in the differentiation of ESCs. In this study, the EBs culture 
is used to examine the neural differentiation potential of the genetically modified ESC clones. 
The term EB has been extensively addressed to describe the PSC aggregates induced to 
differentiate using a variety of different formation and culture methods, such as the suspension 
culture or the hanging drop technique. The EBs were capable of forming derivatives of all three 
germ lineages’ layers (ectoderm, mesoderm and endoderm) (Bratt-Leal, Carpenedo et al. 2009). 
By varying the culture media or growth factors, the EBs are desirably guided towards one of 
the abovementioned germ lineages’ layers. For instance, it has been recognized that relatively 
homogeneous EBs could be generated as a result of the serum-free culture responsible for 
ectodermal lineages, such as neural progenitors or neurogenic fate.  
 
 
 
 
 
 
 
 
 
The physical characteristics of EBs such as shape, size, and homogeneity are some of the typical 
reference points for differentiation. The size of EBs (cells aggregate) which depends on the 
number of ESCs (the constituent elements of EBs) is believed to be a critical factor which 
influences the proportion of differentiating cells turning into different lineages. Moreover, the 
size of EBs impacts other environmental parameters affecting differentiation such as the 
 
Fig.  2 
 
Fig. 2.21 The outermost layer (blue): Ectoderm Intermediate Layer (red): Endoderm Inner 
Layer (yellow). 
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diffusion of soluble molecules, the extent of ECM-cell, and cell–cell adhesive interactions 
(Bratt-Leal, Carpenedo et al. 2009). 
Our strategy was to generate an array of homogeneous and equal size EBs for neuronal 
differentiation. For this purpose, we implemented AggreWell™400 plate (Stemcell 
Technologies) in our study. The EBs were allowed to grow for several days or weeks and treated 
with the set of growth factors, tetracycline or both. Tetracycline was used to switch on the 
genetic expression of the different transcription factors. At different points in time, the samples 
had to be taken for genetic expression analysis by Fluidigm Real-Time PCR or 
immunohistochemistry. 
 
2.6.1.1 Generation of EBs Using AggreWell™: 
 
The details about generating homogeneous EBs for the telencephalic differentiation are 
provided in the manufacturer’s user guide of AggreWell™ plates (Stemcell Technologies). The 
tough cohesion between the EBs and the surface of microwells could result in the breakdown 
of EBs while picking up. To overcome this drawback, the AggreWell Rinsing Solution was 
applied in the amount of 0.5 mL and kept for one minute. Next, the plates were centrifuged at 
200 x g for 5 minutes in a swinging bucket rotor that was fitted with a plate holder to eliminate 
any small air bubbles. Then, the solution was removed from the wells and washed with 2 mL 
of DMEM/F-12 prior to adding to the cells. Afterwards DMEM/F-12 was gently removed and 
0.5 mL dosage from the differentiation medium (1) was placed into each microwell.  
Once again, the plates were centrifuged at 200 x g for 5 minutes at the same condition 
mentioned above.  
The ESCs were isolated from the MEFs by using 0.1% gelatin pre-coated dish and incubated 
for 45 minutes at 37° C, and then the supernatant collected and centrifuged at 300 x g for 3 
minutes. Then the cell plates were broken in 1 mL dosage of the differentiation medium (1) and 
added to each well at the concentration of 6 × 105 cells/mL, generating EBs with 500 cells. The 
plates were centrifuged once more at 100 x g for 3 minutes to capture the cells in the microwells. 
The aggregates were harvested 48 hours after adding the ESCs to the plates and at the end, the 
EBs were transferred to the suspension differentiation culture medium.  
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3D and 2D differentiation of ESC to DG neuroprogenitor cell 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.6.1.2 DG Differentiation of mESCs  
Fig. 2.23 The schematic representation of the differentiation protocols for DG granule 
cells  
 
Fig. 2.22 Homogeneous 2- day old EBs.10x 
magnification. Phase contrast microscopy image.  
 
Gage modified protocol 
 
  
86 
We established a new protocol by slight modification of Sasai and Gage protocols (Watanabe, 
Kamiya et al. 2005); (Sakaguchi, Kadoshima et al. 2015); (Yu, Di Giorgio et al. 2014) for the 
differentiation of ESCs in vitro into hippocampus-DG granule neurons.    
Our protocol is divided into five main stages, following the embryonic development of mice:  
 
Stage 1: Ectodermal induction 
Stage 2: Neuro-ectodermal induction 
Stage 3: Telencephalon induction 
Stage 4: Dentate gyrus induction 
Stage 5: Granule neurons full differentiation 
 
 
2.6.1.2. Ectodermal Induction: 
In vivo ectodermal formation is the first step for the generation and development of nervous 
system. To induce the ectodermal lineage, it is substantial for the cells to be cultivated in a 
serum-free environment. To this purpose, the serum-free EB (SFEB) culture medium was 
applied during the EB formation. This condition resulted in the elimination of endodermal and 
mesodermal cell lineage layers. As a result, we obtained a rich population of the earliest 
neuroectodermal cell lineages (see the “Results” section).   
 
2.6.1.3 Neuroectodermal Induction 
Basically, the ectodermal and neuro-ectodermal inductions in vivo occur almost synchronously. 
For the induction of ectodermal to earliest neuro-ectodermal differentiation, four principal 
signaling pathways are involved: FGF2, BMP, WNT-βcatenin, and Notch pathways. Under 
these circumstances, the first stage of induction is neuroectodermal differentiation, in which the 
supplement factors such as N2 and B27 in SFEB are utilized. This medium was named the 
differentiation medium I which included some generic neuro-ectodermal inductive factors such 
as insulin, apotransferrin, progesterone, and putrescin. To conduct the progress of the 
neuroectodermal differentiation towards the telencephalon progenitor cells, the model of brain 
signaling development in vivo is mimicked by inhibiting WNT-βcatenin, Nodal-Activin 
signaling pathways, BMP, and Shh pathway. 
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Thus we initially treated EBs with a cocktail of anti-caudalizing factors such as Dkk1 
(100ng/mL), Dkk3 (100ng/mL), Noggin (0.5µg/mL), and SB431542 (10mM) 
SB431542 is an Activin/BMP/TGF-β pathway inhibitor. On the day 7 of differentiation, the 
majority of EBs were positive for the neuroectodermal markers such as Sox1 and Pax6, and 
Nestin-GFAP. At the same day, the majority of EBs were also positive for FOXG1, the main 
marker for telencephalic progenitor cells.  
 
Table Overview of experimental groups used in this study 
 
 
 
 
 
 
 
 
 
 
2.6.1.4 Telencephalon induction 
This step is essentially related to the last one. In fact, whenever we used the cocktail of anti-
caudalization, the anterior forebrain fate was induced; and with the inhibition of ventralization 
(Shh pathway inhibition), the dorsal fate with FOXG1 expression was induced as well. 
Moreover, after the day 7, we switched on the inducible tetracycline system in modified 
transcription factor clones by adding tetracycline (500 ng/mL) to induce the transcription 
factors Emx2, NeuroD1, and Prox1, which are critical to direct telencephalic progenitor cells 
towards the hippocampus DG granule neurons.  
 
2.6.1.5 DG induction: 
Next, the telencephalic neural progenitor EBs were induced by WNT3a (20 ng/mL) and BDNF 
(20 ng/mL) treatment. These two main growth factors have key roles in DG formation.  
During embryonic development, WNT3a is secreted by the CH, which has a source of WNT 
and BMP signaling in the dorsomedial telencephalon.  
 
Group Name Treatment 
Group1 The Basal Medium of Differentiation Medium I 
Group2 The Differentiation Medium I plus Noggin , 
SB431542, and Cyclopamine 
Group3 The Differentiation Medium I plus Noggin , 
SB431542, Cyclopamine, and Dkk1 
Group4 The Differentiation Medium I plus Noggin , 
SB431542, Cyclopamine, and Dkk3 
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2.6.1.6 The full differentiation of DG neurons: 
In this stage, 50 individual EBs were collected in a bacterial dish (35 cm in diameter) and pre-
treated for 1 h with Y-27632 (5 µM). Then, EBs were placed in an enzymatic cocktail 
containing DNaseI (80U), Collagenase V (0.5mg/mL), and Accutase while being shaken and 
kept for15- 20 minutes in the incubator. Subsequently, the EBs were observed after about 10 
minutes to make sure that the cells are at the beginning of separation and release from their 
outermost layers in the cocktail. Afterwards, the cocktail was collected very gently, since the 
released cells in the cocktail were outermost layer cells (e.g., neurons or neuro-progenitor cells) 
which are very sensitive to mechanical trituration. Then, the rest of EB bodies were triturated 
immediately for 5-10 times in order to obtain fully dissociated EBs. The whole suspension was 
centrifuged at 300 x g for 3 min at 4˚C. At the end, the cell plate was re-suspended in a full 
differentiation medium and seeded on the poly-ornithine (5 µg) and Laminin (5 µg) 24-well 
plate.  
The co-culture with astrocytes was performed sequentially within 10-12 hours after seeding the 
suspension cell. In the co-culture sequential process, the astrocytes were pre-cultured inside of 
the thin filters only 3 days prior to use.  
During the culture, the differentiation medium III was applied and every three days, about one 
third of medium was replaced by a completely fresh medium. The process continued for 21 
days. At the final day, some cells were collected for RNA analysis by the Fluidigm system. The 
rest of the cells were analyzed for DG marker expression by immunofluorescence.  
 
2.6.1.7 Immunofluorescence technique 
For immunocytochemical analyses after 37 days of directed telencephalic and DG development, 
the cell cultures were fixed in 4 % PFA for 20 min at RT and washed with PBS at once. Cells 
were then blocked and permeabilized for 1 h with blocking solution containing 10 % goat serum 
for 1 hat RT. Subsequently, the cells were incubated over night with primary antibodies (Table 
2.30) diluted in blocking solution at 4° C. The cells were washed in PBS, subsequently stained  
 
 
 
 
 
 
  
89 
 
with DAPI and again washed twice in PBS for a total of 20 min.  
Afterwards, cells were washed two times with PBS. Secondary antibodies were diluted in 
blocking solution and incubated for 1h at room temperature. The nuclei were visualized by 
DAPI staining (1:10.000 in NaHCO3, 4 min incubation) with 0.05 % Triton-X-100 and 1% 
BSA. 
.  
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Table 2.30: Antibody list 
 
Ms = mouse, Rb = rabbit, GP = guinea pig 
 Product Host   Company  Cat. No S.Ab. Dilution 
1 Oct-4 
 
Rb polyclonal abcam 19857  1-5 µg/mL 
2 Nanog  
 
Rb polyclonal abcam 80892  1:150-1-700 
3 
 
Sox2 Rb polyclonal abcam 15830  3µg/mL 
4 
 
Pax6 
 
Ms monoclonal milipore MAB5552 
 
 1:100 
5 Nestin 
 
Rb polyclonal Sigma SAB4200394  1:100 
6 GFAP 
 
Rb polyclonal DAKO 20334  1:50-1:100 
7 BLBP 
 
Rb polyclonal  abcam ab32423  5 µg/mL 
8 Sox1 
 
Rb            polyclonal abcam ab87775  1:500 
9 Emx2 
 
Rb polyclonal abcam ab11849-50  1:50-1:100 
10 Prox1 
 
Ms 
 
monoclonal Novubiol NBP1-30045  1:500 
  11 NeuroD1 
 
Ms 
 
monoclonal abcam ab60704  1:500 
12 NeuN 
 
Rb monoclonal abcam ab177487  1:80 
13 Calretinin 
 
Rb monoclonal abcam ab16694  1:10 
16 DCX 
 
GP polyclonal Chemicon Ab5910  1:3000 
17 βIII-tubulin  Ms monoclonal Sigma T8660  1:500 
19 Map2(2a+2b) 
 
Ms monoclonal Sigma M1406  1:500 
22 Calbindin 
 
Rb polyclonal abcam ab11426  1:500 
23 
 
Foxg1 Rb  polyclonal Thermofisher 
Scientific  
PA5-26794  1:10-1:50 
24 Tbr2 Rb 
 
polyclonal milipore AB2283  1:250 
25 
 
Prox1  Rb polyclonal abcam AB5475  1:500 
26 
 
Nestin 
 
Ch  polyclonal Biolegend 
Novusbio 
NB100-
1604 
 1:1000 
27 βIII-tubulin  Rb monoclonal Biolegend 
Convence 
802001 
PRB-435p 
 1:500 
28 
 
βIII-tubulin  Ms  monoclonal Biolegend 
Convence 
801201 
MMS-435P 
 1:1000 
29 
 
NeuroD1 
 
Ms 
 
monoclonal SantaCruz Sc46684  1:200 
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2.6.1.8 DG Differentiation of mESCs by transcription factors induction  
For investigating the role of transcription factors in DG induction and differentiation, the same 
protocol mentioned above-except for the growth factor cocktails-was applied.  
 
2.7 DNA preparation and PCR analysis  
 
Sample Preparation (total RNA Extraction) for Fluidigm analysis  
 
- Cells: collected by trypsinization 
- EBs: collected by aspirating with pipette 
- Kit: RNeasy Mini-Kit (Qiagen) 
- Centrifugation 2 min at 1400 rpm (250 x g) 
- Removal of as much medium as possible 
- Disturbing the pellet by flicking 
- Addition of 100 µl RLT-Lysis buffer with ß-ME, mixing by flipping 
- Freezing of samples at -80°C until the sample set is complete 
 
- Samples were thawed 
- Addition of 250 µl RLT-buffer with ß-ME to a final volume of 350 µl 
- Homogenization by passing lysate 7 times through a 20G needle fitted to a 1 mL syringe 
- Extraction according to the manual including optional centrifugation step 
- Elution: 35 µl RNase free water 
- Concentration measurement with Spectrophotometer NanoDrop 2000c (Thermo 
Scientific) 
- Adjustment to a final RNA concentration of 20 ng/µl with RNase free water 
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2.8 Gene expression analyses by Fluidigm Biomark system 
The gene expression analysis of cells was performed using the Biomark Real-Time quantitative 
PCR (qPCR) system (Fluidigm) as described before in Conrad et al., 2016. In all cell samples 
the expression of the following genes was analyzed by TaqMan assays: 
Pluripotency genes: POU5F1, NANOG, SOX2  
Glial markers: GFAP, MBP, OLIG2  
Neural precursor and proliferation markers: NESTIN, KI67, PCNA  
Neuronal differentiation markers: NEUN, TUBB3, NCAM1, SYP, GABA, SLC1A3 
Markers of telencephalic induction: SOX1, HES5, PAX6, REST1, MASH1, NEUROG2, 
TBR2, SOX11 
Dentate gyrus induction and granule neuron differentiation: NEUROD1, FOXG1, EMX1, 
EMX2, GLI3, CREB, TBR1, NEUROD2, DCX, PROX1, ID3, FABP7, CALB1, CALB2, 
BMPR1A, NFIX, CCND2, NR2E1, LHX1, LHX2, LEF1, LRP6  
and the housekeeping genes GAPDH, HMBS and normalized with all housekeeping genes TBP.  
The inventoried TaqMan assays (Applied Biosystem) were pooled to a final concentration of 
0.2× for each of the assays. Cells to be analyzed were harvested directly into 9 μl RT-PreAmp 
Master Mix consisted of 5.0 μl CellsDirect 2× Reaction Mix (Invitrogen), 2.5 μl 0.2× assay 
pool, 0.2 μl RT/Taq Superscript III (Invitrogen) and 1.3 μl TE buffer. The harvested cells were 
immediately frozen and stored at −80°C. Cell lysis and sequence-specific reverse transcription 
was performed at 50°C for 15 min. The reverse transcriptase was inactivated by heating to 95° 
C for 2 minutes. In the same tube cDNA subsequently underwent through limited sequence-
specific amplification by denaturing at 95° C for 15 seconds, and 14 cycle-annealing and 
amplification at 60° C for 4 minutes. These pre-amplified products were 5-fold diluted prior to 
analysis with Universal PCR Master Mix and inventoried TaqMan gene expression assays 
(ABI) in 96.96 Dynamic Arrays on a BioMark System.  
 
GenEx statistical analysis 
 
Ct values obtained from the BioMark System were transferred to the GenEx software (MultiD) 
for analysis. Missing data in the Biomark system were assigned a Ct of 999 by the instrument 
software. These were removed in GenEx. Also Ct’s larger than a cut-off of 25 were removed, 
since high Ct’s in the Biomark 96.96 microfluidic card were expected to be false positives due 
to base-line drift or formation of aberrant products, since a sample with a single template 
molecule is expected to generate a lower Ct. The effect of setting cut-off to 25 was tested by 
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repeating the analysis with a slightly different cut-off and was found to have negligible effect 
on the analysis results. Technical repeats were then averaged and any remaining missing data 
were replaced by the highest Cq measured + an offset of 1 for each gene separately. Managing 
missing data is primarily required for downstream multivariate classification of the data. An 
offset of 1 corresponds to assigning a concentration to the samples with off-scale Cq values that 
is half of the lowest concentration measured for a truly positive sample. The magnitude of the 
offset does not influence p-values calculated with non-parametric methods, which were 
preferred when there were off-scale data, but it has small influence on p-values calculated by t-
test and on multivariate classification. In essence, the offset is tunes the weight of the off-scale 
measurement compared to the positive reading, larger offset gives higher weight to the off-scale 
measurement. We tested the importance of the offset by repeating the analysis using a higher 
offset up to +4, which corresponds to a concentration of 6% of a truly positive sample, and 
found negligible effect on the multivariate results. Linear quantities were calculated relative to 
the sample having lowest expression and data were then converted to log2 scale for analysis. 
Because of the very large and uncorrelated cell to cell variation of genes´ expressions 
normalization to the housekeeping genes is not meaningful. Instead, expression levels were 
presented “per 50 cell” average expression of the genes in different groups was calculated 
including .95% confidence interval and groups were compared using 1-way ANOVA (Tukey-
Kramer’s pairwise comparison) and unpaired 2-tailed T-Test. Expression of genes with 
multiple off-scale readings was compared with non-parametric Mann-Whitney’s test. For 
multivariate analysis to classify the samples based on the combined expression of all the genes 
data were either mean centered, i.e., subtracting the average expression of each gene, or 
autoscaled, which is mean centre data also divided by the standard deviation (so called z-score). 
Autoscaling gives all the genes equal weight in the classification algorithms making them 
equally essential. Hierarchical clustering (Ward’s Algorithm, Euclidean Distance Measure) 
including heatmap and principal component analysis (PCA) were performed. 
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Table 2.31:  Details of the TaqMan primers used in this study with gene, gene name, species 
and assay ID 
Gene Gene name Species 
 
Assay ID 
 
Pou5f1 
or Oct4 
POU domain, class 5, transcription factor 1 mouse Mm03053917_g1 
Nanog Nanog homeobox mouse Mm02384862_g1 
Sox2 SRY (sex determining region Y)-box 2 mouse Mm00488369_s1 
GFAP glial fibrillary acidic protein mouse Mm01253033_m1 
MBP myelin basic protein mouse Mm01266402_m1 
OLIG2 oligodendrocyte transcription factor 2 mouse Mm01210556_m1 
NESTIN nestin mouse Mm00450205_m1 
KI67 
antigen identified by monoclonal antibody 
Ki 67 
mouse Mm01278617_m1    
PCNA proliferating cell nuclear antigen Mouse Mm00448100_g1 
NEUN 
RNA binding protein, fox-1 homolog (C. 
elegans) 3 
Mouse Mm01248771_m1     
TUBB3 tubulin, beta 3 class III Mouse Mm00727586_s1 
NCAM1 neural cell adhesion molecule 1 Mouse Mm01149710_m1 
SYP synaptophysin Mouse Mm00436850_m1   
GABA 
gamma-aminobutyric acid (Hamrahian, 
Ioachimescu et al.) A receptor, subunit alpha 
6 
Mouse Mm01227754_m1 
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SLC1A3 
solute carrier family 1 (glial high affinity 
glutamate transporter), member 3 
mouse Mm00600697_m1 
SOX1 SRY (sex determining region Y)-box 1 Mouse Mm00486299_s1 
HES5 hairy and enhancer of split 5 (Drosophila) Mouse Mm00439311_g1    
PAX6 paired box 6 Mouse Mm00443081_m1  
REST1 RE1-silencing transcription factor Mouse Mm00803268_m1  
MASH1 
achaete-scute complex homolog 1 
(Drosophila) 
Mouse Mm03058063_m1 
NEUROG2 neurogenin 2 Mouse Mm00437603_g1 
TBR2 eomesodermin homolog (Xenopus laevis) Mouse Mm01351984_m1     
SOX11 SRY (sex determining region Y)-box 11 Mouse Mm01281943_s1 
NEUROD1 neurogenic differentiation 1 Mouse Mm01946604_s1 
FOXG1 forkhead box G1 Mouse Mm02059886_s1 
EMX1 empty spiracles homeobox 1 Mouse Mm01182609_m1 
EMX2 empty spiracles homeobox 2 Mouse Mm00550241_m1    
GLI3 GLI-Kruppel family member GLI3 Mouse Mm00492337_m1    
CREB CREB/ATF bZIP transcription factor Mouse Mm02525218_s1 
TBR1 T-box brain gene 1 Mouse Mm00493433_m1   
NEUROD2 neurogenic differentiation 2 Mouse Mm00440465_g1 
DCX doublecortin Mouse Mm00438400_m1    
PROX1 prospero homeobox 1 Mouse Mm00435969_m1   
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ID3 inhibitor of DNA binding 3 Mouse Mm00492575_m1 
FABP7 fatty acid binding protein 7, brain Mouse Mm00445225_m1  
CALB1 calbindin 1 Mouse Mm00486647_m1    
CALB2 calbindin 2 Mouse Mm00801461_m1    
BMPR1A 
bone morphogenetic protein receptor, type 
1A 
Mouse Mm00477650_m1 
NFIX nuclear factor I/X Mouse Mm00477791_m1    
CCDN2 cyclin D2 Mouse Mm00438070_m1   
NR2E1 
nuclear receptor subfamily 2, group E, 
member 1 
Mouse Mm00455855_m1 
LHX1 LIM homeobox protein 1 Mouse Mm01297482_m1    
LHX2 LIM homeobox protein 2 Mouse Mm00839783_m1 
LEF1 lymphoid enhancer binding factor 1 Mouse Mm00550265_m1 
LRP6 
low density lipoprotein receptor-related 
protein 6 
Mouse Mm00999795_m1     
GAPDH glyceraldehyde-3-phosphate dehydrogenase Mouse Mm99999915_g1 
HMBS hydroxymethylbilane synthase Mouse Mm01143545_m1     
TBP TATA box binding protein Mouse Mm01277042_m1 
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3. Results 
 
3.1 Preparatory work 
Before the establishment of a new strategy for the directed differentiation of mouse ES cells 
into DG neural precursor and completely differentiated cells, preparatory work had to be 
performed. 
By the use of mouse ES cell culture techniques and the application of molecular cloning 
techniques at the beginning of this work a tetracycline inducible EGFP expression system in 
mouse ES cells was generated in our lab (Fig. 3.1). We were able to generate stable mouse ES 
cell lines for tetracycline regulated gene expression with minimal leakiness and a high degree 
of tetracycline responsivity. These mouse ES cell lines were further engineered for the 
generation of a double and triple stable cell line, expressing central dentate gyrus transcription 
factors in an inducible manner. Importantly, the selected cell lines retained their inherent 
morphology, responded to differentiation signals and exhibited persistent and highly tunable 
tetracycline inducibility upon continuous culturing. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.1 Representative confocal images of generated mouse ES cells lines 
with inducible EGFP (left column, EGFP; medial column, phase-contrast; 
right column, merged. EGFP was turned on when treated with 500 ng/mL Dox 
for 12-19 hours. Scale bar: 100 μm. 
 
Generation of Stably Transduced, EGFP-Expressing mouse ES cell line 
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The expression of pluripotency factors such as Nanog and Sox2 in the generated cell lines Lt-
Tet-EGFP (G1 and G2) revealed their pluripotency (see Fig.3.2) which is a striking evidence 
of their capability to run through the full spectrum of neural differentiation ranging from 
neuroectodermal induction towards the dorsal telencephalic differentiation signaling roads. The 
telencephalic differentiation capacity of the generated cell lines was examined in pilot 
experiments (data not shown). 
 
 
 
 
In detail, the mouse ES cell line was established and propagated for multiple passages to ensure 
homogeneity and robustness among the cells. The ES cells were first examined for their 
sensitivity to the selection antibiotic Zeocin, by antibiotic killing curve assay. The optimal 
concentrations required for selection was 100 mg/ml Zeocin. 
 
Mouse ES cells were co-transduced with the M2rtTA and Tet-FUW- EGFP virus particles and 
then selected with Zeocin. The use of very low antibiotic concentrations accommodates for the 
sensitivity and slow growing nature of mouse ES cells, thereby allowing for efficient selection 
of transduced cells. The cells were examined for EGFP expression and as expected, all the 
clones were positive. Though the clones varied in the degree of EGFP expression, within a 
single clone there was a uniform intensity of EGFP fluorescence suggesting homogeneity 
among clonal populations. 
Fig. 3.2 ES:Lt-Tet-EGFP characterization by visualization of pluripotency 
transcription factors.  Homogeneous expression of pluripotency factors is observable 
in ES cells. (a) EGFP signal and immunofluorescence staining for (b) Sox2, (c) Nanog, (d) 
staining with DAPI and (e) merge of EGFP clone G1 and G2. Scale bar: 100 µm. 
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Two representative clones ES;Lt-Tet-EGFP G1 and G2 were chosen for further analysis. These 
clones were selected based on the criterion that they expressed uniform and high levels of EGFP 
throughout the cell population (Fig. 3.1 and 3.2). In addition, they displayed normal 
morphological characteristics and growth behavior similar to their parent not transduced ES 
cell line.  
 
3.2 Neuronal Differentiation of Mouse ES Cells via EB Formation  
The mouse ES cells have so far been noteworthy for their pluripotency, easy handling, and high 
differentiation capacity, along with the study of different molecular mechanisms which are 
responsible for the directed cellular differentiation.  
Several techniques have been proposed for the direct cellular differentiation of ES cells, trying 
to incorporate several elements such as enrichment, homogenization, and the progressively 
accurate specification of the differentiating cells.  
A well-known method in this category is the EB formation which has been primarily introduced 
by Ana Wobus (Strubing, Ahnert-Hilger et al. 1995) and D.G Mackey (Okabe, Forsberg-
Nilsson et al. 1996) for the generation of enriched neuronal progenitor cells.  
This method became popular over the years among numerous research groups around the world, 
including the research team led by Prof. Sasai which implemented this method along with a 
defined medium culture and they succeeded for the first time in the differentiation of mouse ES 
cells to the telencephalic progenitor cells (Watanabe, Kamiya et al. 2005).  
Gage and Colleagues in 2013 modified the Sasai’s approach to differentiate the hIPS cells 
towards hippocampus neuronal progenitor cells (Yu, Di Giorgio et al. 2014).  
In this study, we applied the homogeneous EB formation technique used for the inducible 
cocktail of growth factors and transcription factors contributing to the generation of DG during 
embryonic development. We investigated the effects of these factors in differentiation and the 
continuous enrichment of the mouse ES cells towards the development of DG progenitor and 
fully differentiated granule cells.  
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3.3 Differentiation of mouse ES cell into DG precursors in a two-step culture method  
3.3.1 Three-dimensional culture of neuroectodermal and telencephalic induction with 
growth factors treatment  
The 3D culture procedure was applied to simulate aspects of early and pre-gastrulation which 
has been optimized by applying several growth factors which have critical influence during DG 
development. The elimination of FBS Serum and KO/SR from the culture environment and the 
simultaneous application of N2 and B27 supplements induced a homogeneous population of 
neuro-ectodermal progenitor cells expressing Nestin and GFAP markers in all four treatment 
groups. Nestin and GFAP were located on cellular structures and radial processes in the EBs 
along an inside- outside gradient (Fig. 3.4). 
 
 
Fig. 3.4 Expression of neuroectodermal markers in 6 day-old EBs treated with a 
cocktail of growth factors and DKK1(group3). Scale bar: 50 µm. 
 
Fig. 3.3 Generation of EBs that are homogeneous in size and 
shape. Scale bar: 100 μm. 
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The simultaneous treatment of EBs by anti-caudalization and anti-ventralization factors 
Noggin, SB431542, and cyclopamine (growth factors cocktail) induced the neural telencephalic 
progenitor marker Sox 1 in the treatment group (group 2, 3, 4). 
To achieve the pure telencephalic progenitor cell, the EBs were treated with the Wnt signaling 
inhibitors Dkk1 and Dkk3 separately. The dorsomedial telencephalic markers Pax6 and Nestin 
were observed during this treatment. The results showed that the EBs which were treated with 
the growth factors cocktail and Dkk1 expressed the telencephalic marker Foxg1 more strongly 
than another the groups on day 10 (Fig. 3.5). 
During the study of these EBs, it seemed that the configuration of the Foxg1 positive cells 
followed a distinct specific being located in the middle layers of EBs, while earlier markers 
such as Sox1 and BLBP were more configured in the interior layers. These markers could not 
be observed in control groups at the same day.  
 
 
 
 
 
 
Expression of neural telencephalic progenitor markers in 10 day-old EBs treated with DKK1 
(group3) 
Fig. 3.5 Expression of telencephalic neural marker in 10 days old EBs treated with DKK1. 
Immunofluorescence analyses of 10-day old mouse ES cell-derived EBs with telencephalic progenitor 
markers Sox1, BLBP, Pax6 and Foxg1. Nuclei were visualized by DAPI-staining. Scale bar: 100 μm. 
B1 B2 B3 B
4 
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3.3.2 Two dimensional culture of telencephalon progenitor cells astrocyte co-culture 
system 
After 16 days, the neurospheres were triturated to a single cell suspension and re-plated on 
poly-L-Ornithine/laminin and co-cultured with astrocytes. Within 4 to 5days (on 20 to 21 of 
culture) a small putative neural progenitor cell (NPC) population was observed in the growth 
factors treatment groups. In these groups, the neuronal progenitor cells markedly exhibit 
colony-like structures.  It seemed that introduction of these growth factors resulted in a specific 
grouping of NPC on the culture surface. The NPC population started to proliferate and formed 
distinct borders. From around day 27, the colony-like structures were distinctively 
recognizable. 
The remarkable point about these NPC colony-like structures was that they had specified 
boundaries---which for the most part---during differentiation and even proliferation, the cells 
showed no tendency for migrating out from the colony-like structures and still remained in these 
coherent forms. The number of these structures in the treatment group by Dkk1 were higher 
than in the other treatment groups (Fig 3.6). On day 37, the morphological observation of NPC 
colonies under light phase-contrast showed that the NPC colonies features in the control group 
were obviously different than in the treatment groups. In the control, most of the neuro-
progenitor cells were sparsely distributed across the cell culture plate in comparison to the 
groups treated with anti-caudalization and anti- ventralization factors (Noggin, SB431542 and 
cyclopamine) (Fig. 3.6). The NPC markedly exhibited colony-like structures. It seemed that 
introduction of these growth factors resulted in a specific grouping of the neuro-progenitor cells 
in the culture. 
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Fig. 3.6 Evaluation of phase contrast and confocal microscopy of four different growth factor 
treatments in ES:Lt-Tet-EGFP. The first three rows demonstrate the phase contrast (A-A2, B-B2, C-
C2, D-D2), and the last row shows the confocal microscope images (A3-D3). Scale bar: 100 µm.   
Group1: (Differentiation medium I, no treatment): sparse distribution of NPC.  
Group2: (Differentiation medium I+ Noggin+SB431542+Cyclopamine treatment) towards to NPC 
colony aggregation. 
Group3: (Differentiation medium I+ Noggin+SB431542+Cyclopamine treatment+DKK1) the 
emergence of limited NPC colony aggregation and neural differentiation. 
Group4: (Differentiation medium I+ Noggin+SB431542+Cyclopamine treatment+DKK3) colonies 
morphologically similar to that of group3 were partially observed, but demonstrate considerably more 
heterogeneity. 
 
 
 
 
 
 
Group 2: Diff Medium I + 
Noggin+SB431542+Cyclomapine  
Group 3: Diff Medium I +Noggin  
+SB431542+Cyclopamine+DKK1  
A 
A1 
A2 
A3 
B 
B1 
B2 
B3 
C 
C1 
C2 
C3 
D 
D1 
D2 
D3 
Group 4: Diff Medium I +Noggin  
+SB431542+Cyclopamine+DKK3  
Group 1: Diff Medium I  
no treatment  
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A1 
A3 
B 
B1 
B2 
B3 
C 
C1 
C2 
C3 
D 
D1 
D2 
D3 
A2 
Group1: Diff Medium I 
no treatment 
Group 2: Diff Medium I + 
Noggin+SB431542+Cyclomapine  
Group 3: Diff Medium I +Noggin 
+SB431542+Cyclopamine+DKK1  
Group 4: Diff Medium I +Noggin 
+SB431542+Cyclopamine+DKK3  
A                          
Fig. 3.7 The EGFP expression of NPC derived ES:Lt-Tet-EGFP.  The cells were treated with cocktail 
of growth factors. Group1: sparse distribution of NPCs. Group2: towards NPC colony aggregation. 
Group3: the emergence of limited NPC colony aggregation and neural differentiation. Group4: colonies 
morphologically similar to that of group3 were partially observed, but demonstrate considerably more 
heterogeneity. Scale bar: 100 µm.   
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The obtained results by immunofluorescent technique showed that most of the cells in the 
control group expressed only Nestin and GFAP. But telencephalic markers or DG 
differentiation markers were absolutely not expressed. The immunofluorescent technique 
revealed that in the growth factors group these structures potentially expressed the specific 
markers of the DG such as Prox1, NeuroD1 and Tbr2 (see Table 3.1). We named these 
structures the DG progenitor-like colonies. The notable landmark in the study of these structures 
is that, for the most part, these structures did not proceed towards the neuronal-like structures 
with axon, dendrite formation and branching and remained at the stage of DG progenitors.  
 
 
 
The comparison of different DG markers on day 37 demonstrated that Dkk1 was more effective 
in the induction and production of ES cell to the DG progenitors (Fig. 3.6-3.10, Table 3.1). 
Specifically, Dkk1 caused an increased expression of the telencephalic neuronal progenitor 
markers including Foxg1, BLBP and Tbr-2. Emx2 expressing cells were rarely found. In 
comparison with other groups, the growth factors cocktail with Dkk1treatment had an inductive 
effect on the expression of several of the DG markers, like NeuN, NeuroD1, Prox1, Calretinin 
and Calbindin. But most of these cells were not fully differentiated. The limited differentiation 
was only observed inside the colonies.  
 
Nestin EGFP DAPIGFAP Merged
Sox1 EGFP DAPI Merged
A A1 A2 A4
B B1 B2 B5B4
Fig. 3.8 Expression of neuroectodermal markers in 37 day-old adherent cell culture, 
DKK1 treated (group3). A-A4 Sox1; B-B4 Nestin-GFAP. Nuclear staining with DAPI.  
Scale bar: 100 µm. 
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EGFP Foxg1 DAPI Merged 
A A1 A2 A3 
EGFP BLBP DAPI Merged 
EGFP TBR2 DAPI Merged 
EGFP Emx2 DAPI Merged 
B B1 B2 B3 
C C1 C2 C3 
D D1 D2 D3 
Fig. 3.9 Expression of Telencephalic Neural Progenitor markers in 37 days old adherent cell 
culture, DKK1 treated (group3). A-A3 Foxg1, B-B3 Emx2, C-C3 BLBP, D-D3 TBR2. Scale bar: 
100µm. 
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In the treatment groups # 1 and # 2, most of the cells were stage of the Sox1 negative progenitor 
cell phenotype, remained or differentiated towards gliogenesis.  
In comparison with Dkk1, the treatment by Dkk3 did not appear to be much effective.  This 
treatment in the early stages of cell culture had a similar role in the induction of markers like 
BLBP, GFAP, Nestin, and Sox1, but had no significant effect in the induction of specific DG 
markers such as NeuN, Prox1, Calretinin, Calbindin. None of the other treatment groups had 
any effects on the induction of Emx2. The neurotransmitter glutamate specific for differentiated 
DG neurons was not expressed under any of these growth factor conditions. 
Prox
1 
β- TubIII EGFP DAPI Merged 
A A1 A2 A3 A4 
B B1 B2 B3 B4 
C C1 C2 C3 C4 
Neur
oD1 
Emx2 EGFP DAPI Merged 
D D1 D2 D3 D4 
Fig. 3.10 Expression of DG Markers on treated cells with DKK1 on 37 days old astrocyte 
adherent co-culture. A-A4, B-B4, C-C4 Prox1/βIII-tubulin; D-D4 NeuroD1-Emx2. Nuclear co-
staining with DAPI. Scale bar: 100 µm. 
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3.4 The hippocampal transcription factor induction and DG differentiation  
Several studies had shown so far that growth factors---in most cases---due to the induction of 
neural differentiation genes and by affecting certain transcription factors associated with those 
genes can play a role in the differentiation and development of neuronal structures (Wilson and 
Rubenstein 2000); (Wilson and Houart 2004). 
Developmental biological research has shown the significant effect of transcription factors 
during differentiation and development. Because of this fundamental role, a variety of research 
models have so far investigated the transcription factors during the process of telencephalic and 
hippocampal development (Eiraku, Watanabe et al. 2008); (Hanashima, Fernandes et al. 2007). 
At this stage, we studied the role of the transcription factors Emx2, Prox1 and NeuroD1 
separately on the production and induction of the DG granule neurons.  
The mouse ES cell lines were further engineered for the generation of a double and triple stable 
cell line, expressing central DG transcription factors (Emx2, Prox1 and NeuroD1) in an 
inducible manner. In this regards, the ES; Lt-Tet-EGFP clone G1 was engineered for the 
D37 Neuroectodermal 
Marker 
  
Telencephalic 
Neural Progenitor 
Marker 
Dentate Gyrus Markers 
Sox1 Nestin GFAP Foxg1 Emx2 Blbp Tbr2 NeuN NeuroD1 DCX Prox1 Calretinin Calbindin βIII-
tubulin 
Glutamte 
G1 - ++ ++ - - - - - - - - - - + - 
G2 + ++ ++ + - - - - - - - - - + - 
G3 ++ ++ ++ ++ + ++ + + + + ++ + + + - 
G4 ++ ++ ++ + - ++ ++ - + ++ - - - + - 
Different marker expression of DG patterning in ES: Lt-Tet-EGFP, cloneG1 under 4 
different growth factor treatments on 37 differentiation  day  
Table 3.1: Comparative analysis of the expression of neuroectodermal, telencephalic 
progenitor and DG marker on 4 different growth factor treatment cell culture conditions. 
All results are expressed as percentages of the whole population: 0%–5%, negative (−); 6%–
39%, low level of marker expression (+); 40%–79%, moderate level of marker expression (++); 
80%–100%, high level of marker expression (+++). 
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generation of a double and triple stable cell line, expressing central DG transcription factors 
(Emx2, Prox1 and NeuroD1) in an inducible manner (Fig.3.11). 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.11 Immunocytochemistry of re-transduced clones. Retransduction of ES: Lt-Tet-EGFP with 
transcription factors (Emx2, Prox1 and NeuroD1). EGFP was negative without Dox treatment, and was turned 
on when treated with 500 ng/mL Dox for 12-19 hours. Scale bar: 100 μm. 
 
Generation of stably transduce, transcription factors -EGFP-Expressing mouse ES cell Line 
Lt-Tet-EGFP-Emx2 
Lt-TetEGFPNeuroD1  
Lt-Tet-EGFP-Prox1  
A A1 A2 A3 
B B1 B3 B4 
C C1 C2 C3 
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Fig. 3.12 Immunocytochemistry of ES: Lt-Tet-EGFP-NeuroD1-Prox1. Re-transduction of ES;Lt-Tet-
EGFP-NeuroD1 with Prox1.EGFP was turned on when treated with 500 ng/mL Dox for 12-19 hours. 
Scale bar: 100 μm. 
 
EGFP NeuroD1 
Prox1 DAPI 
A A1 
A2 A3 
Merged 
A4 
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In this part of the study, the role of exogenous transcription factor expression leading to 
differentiation towards the induction and generation of DG progenitor cells and DG granule 
neurons in the absence/presence of Dox was investigated.  
The microscopic observations on the day 8 showed that the EB structures at the stage of 
telencephalic induction by the addition of Dox revealed a strong EGFP expression (Fig. 3.14).  
 
 
 
 
 
 
 
Fig. 3.13 PCR analyses for plasmid integration in genomic DNA from the ES cell line                       
ES: Lt-Tet-Emx2 Clones (lane 1-4), ES:Lt-Tet- Prox1 Clones (lane 6,8,10),  ES:Lt-Tet- 
NeuroD1-Prox1 Colon (lane 9,10, 11), ES:Lt-Tet- NeuroD1 Clone ( Lane12,13); Controls 
(+):  Bacterial DNA plasmids: fuw-M2rTtA, Tet-o-FUW-NeuroD1, Tet-o-FUW-Emx2, Tet-
o-FUW-Prox1, Control (-), Water, Control (-), ESC (E14). 
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ES: Lt-Tet-EGFP-Emx2  
By the end of day 37, the cellular differentiation in different clones by the induction of Dox 
showed that a persistent and vigorous expression of Emx2 in LT-Tet-EGFP-Emx2                          
prohibited the induction of DG progenitor cells and neurogenesis. In fact, it seems that the high 
expression of Emx2 by the inducible tetracycline system as described above, suppressed the 
Fig. 3.14 Evaluation of EGFP expression on 8dayold EBs of transgenic clones. 
Representative confocal images (left column, EGFP; medial column, phase-contrast; right 
column, merged. 12 -19 h after Dox (500 ng/ml) and without treatment. Scale bar: 100 µm. 
Lt-Tet-EGFP-Emx2 
+Dox 
-Dox 
Lt-Tet-EGFP-NeuroD1 
Lt-Tet-EGFP-Prox1 
-Dox 
+Dox 
+Dox 
-Dox 
EGFP  Phase -contarst Merged 
EGFP  Phase -contarst Merged 
Merged Phase -contarst EGFP  
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differentiation of telencephalic neuronal progenitor cells to DG progenitor cells and DG granule 
neurons in comparison with other ES cell transcriptional inducible cell lines like Prox1 and 
NeuroD1 (Fig. 3.15 -3.16; Table 3.2). 
 
 
 
 
 
 
 
 
ES:Lt-Tet-EGFP-NeuroD1 clones  
The treatment of ES: Lt-EGFP-NeuroD1 clones resulted in the expression of Nestin and GFAP 
along with the telencephalic neuronal progenitor marker FoxG1. The observation of DG 
markers such as NeuN, NeuroD1, Prox1, βIII-tubulin, and Map(2a+2b) showed the existence 
of neurogenesis and gliogenesis. These results also showed that the transcription factor 
NeuroD1 alone was not capable for final DG differentiation. 
 
Fig. 3.15 DG differentiation of ES: Lt-Tet-EGFP-Emx2 on day37. Representative 
confocal images with Lt-FUW-EGFP-Emx2, the left column (A,B) phase-contrast, middle 
column (A1,B1) EGFP, and right column (A2,B2) merged. Scale bar: 100 μm.  
. 
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ES: Lt-Tet-EGFP-Prox1  
The treatment of the clone ES: Lt-Tet-EGFP-Prox1 on day 37 resulted in the expression of the 
markers Nestin and GFAP. It seems that the existence of these markers resembled the astrocyte 
rather than neuroectodermal cellular phenotype. Moreover, the expression of the telencephalic 
neuronal marker FoxG1 was positive. Also the DG marker NeuN, Prox1, Calretinin, βIII-
tubulin, Synaptophysin and Map (2a+2b) were expressed. In contrast in this group, the 
expression of NeuroD1, Calbindin, Glutamate, and Emx2 was not observed. 
Lt-Tet-EGFP-NeuroD1 
Fig. 3.16 Dentate gyrus differentiation of ES: Lt- Tet-EGFP -NeuroD1 on day 37. 
Representative confocal images with Lt- Tet-EGFP-NeuroD1 on astrocyte co-culture.  
Scale bar: 100 μm. 
. 
A A1 A2 A3 
A4 A5 A6 A7 
A8 
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ES:Lt-Tet-EGFP-Prox1-NeuroD1 
On day 37, the activation of ES: Lt-Tet-EGFP-Porx1-NeuroD1 resulted in a considerable 
increase in the expression of markers Prox1, NeuroD1, NeuN and βIII-tubulin compared with 
the growth factor and transcription factor alone groups. In fact, it seems that the combined 
overexpression of these transcription factors had also a synergic role in the induction of 
calbindin and calretinin. The morphological observations also clearly demonstrated a 
considerable increase in neurogenesis compared with other the groups, as well. 
Lt-Tet-EGFP-Prox1 
 
A A1 A2 A3 
A4 A5 A6 A7 
A8 A9 A10 
Fig. 3.17 Dentate gyrus differentiation of ES: Lt-Tet-EGFP –Prox1 on day 37 adherent 
astrocyte co-culture. Representative confocal images with the EGFP. Scale bar: 100 μm. 
. 
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A A1 A2 A3 
A4 A5 A6 A
7 
A8 
Lt-Tet-EGFP-NeuroD1 +Prox1 
Fig. 3.18 Dentate gyrus differentiation of Lt-Tet-EGFP–NeuroD1-Prox1 on 37 days old 
adherent astrocyte co-culture. Representative confocal images with EGFP. Scale bar: 100 μm. 
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Nestin Merged 
A A1 A2 A4 
Foxg1 EGFP DAPI 
A3 
Emx2 Merged EGFP DAPI 
B B1 B2 B3 
Fig. 3.19 Expression of telencephalic marker in 37 days old adherent cell culture in Lt-Tet-EGFP-
NeuroD1-Prox1 cell line. (A-A4) Foxg1/Nestin, (B-B3) Emx2/EGFP. DAPI co staining was used. Scale 
bar: 100µm. 
. 
Calretinin β- TubIII EGFP DAPI Merge 
A A1 A2 A3 A4 
Calbindin β- TubIII EGFP DAPI Merge 
ß- TubIII Prox1 EGFP DAPI Merge 
B B1 B2 B3 B4 
C C1 C2 C3 C4 
Lt-Tet-EGFP-NeuroD1+Prox1  
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Furthermore, in this group, the expression of synaptic and neurotransmitter marker 
synaptophysin and glutamate increased (Fig. 3.21, Table3.2). 
The length of the axons and dendrites in this group in comparison with other groups showed 
also a profound increase, the processes become amazingly long and branched. In other groups 
such a general development of these distinctive structures was not recognized.in the growth 
factor group the cells stayed mainly in progenitor state and only developed on the Dkk1 treated 
group partially. 
The results of the effects of the growth factors and comparing them with the transcription factors 
have shown that the growth factors will more lead to the induction of neuro-progenitor cells 
than the transcription factors. In vise versa the transcription factor and especially the combined 
overexpression of Prox1 and NeuroD1 pushed the cells to a neuronal phenotype. The colony-
like structures inducted by the growth factors were no longer observed in the transcription factor 
groups at all. 
Fig. 3.20 Expression of dentate gyrus markers in 37 days old adherent cell culture. A-
A4 Calretinin/ βIII-tubulin, B-B4 Calbindin/ βIII-tubulin, C-C4 βIII-tubulin /Prox1. DAPI 
co-staining. Scale bar: 100 µm. 
 
ß- TubIII 
Calretinin NeuN EGFP DAPI Merge 
Synaptophysin EGFP DAPI Merge 
Lt-Tet-EGFP-NeuroD1+Prox1  
Fig. 3.21 Expression of Dentate Gyrus Marker in ES:Lt-Tet-EGFP-NeuroD1-Prox1 cell 
line on 37 days old astrocyte adherent co-culture. DAPI co-staining. Scale bar: 100 µm. 
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3.5 Overall transcriptional profiling by nano-fluidic real–time PCR  
The set of markers for characterizing genes enriched in different stages of directed neuronal 
differentiation of mouse ES cells towards hippocampal-DG phenocytes included glial markers 
(GFAP, MBP, OLIG2), neural precursor and proliferation markers (NESTIN, KI67, PCNA), 
neuronal differentiation markers (NEUN, TUBB3, NCAM1, SYP, GABA, SLC1A3), markers 
of telencephalic induction (SOX1, HES5, PAX6, REST1, MASH1, NEUROG2, TBR2, 
SOX11), and genes typical for DG induction and granule neuron differentiation (NEUROD1, 
FOXG1, EMX1, EMX2, GLI3, CREB, TBR1, NEUROD2, DCX, PROX1, ID3, FABP7, 
CALB1, CALB2, BMPR1A, NFIX, CCND2, NR2E1 , LHX1, LHX2, LEF1, LRP6).  
These experimental groups with approx. 8000 data points obtained from Real-time PCR 
reactions in a Fluidigm system were readily compared and visualized in dendograms, heatmaps, 
bar graphs using descriptive statistics and statistical comparison were made using in the case of 
two groups, with either t-test, ANOVA and correlation analysis. The difference between the 
groups is shown in logarithmic scale and the confidence interval is indicated.  
 
d37 Neuroectodermal 
Marker 
  
Telencephalic 
Neural 
Progenitor 
Marker 
Dentate Gyrus Markers 
Nestin GFAP Foxg1 Emx2 NeuN NeuroD1 Prox1 Calretinin Calbindin βIII-
tubulin 
Glutamte synaptophysin Map2 
(a+b) 
Emx2 + + + +++ - - - - - - - - - 
Prox1 ++ ++ + - + - +++ + - + - + + 
NeuroD1 ++ ++ + - + +++ + -- - + - + + 
Prox1 
+NeuroD1 
++ ++ ++ +  +  +++  +++  +  +  +++  +  +++ +++ 
 
Table 3.2 Comparative analysis of the expression of neuroectodermal, telencephalic 
progenitor and dentate gyrus markers on transcription factors treatment cell culture 
condition . All results are expressed as percentages of the whole population: 0%–5%, negative 
(−); 6%–39%, low level of marker expression (+); 40%–79%, moderate level of marker expression 
(++); 80%–100%, high level of marker expression (+++).  
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Overall comparisons of experimental groups with growth factors, transcription factors 
and control groups 
When comparing the gene expression profiling of all different groups, it was revealed that in 
the dentogram and heatmap analysis, the different stages of neural in vitro development can be 
clearly separated. It became obvious that while at d0 and d2 most of the genes analyzed were 
missing from d7 onwards, the neuronal differentiation profile increased and reached its 
maximum during EB formation at d16, in single cell culture from d23 - d37 the hippocampal 
DG profiles increased again. The strongest profiles were achieved by the overexpression of the 
transcription factors, while with the only application of growth factors, including Dkk1 the 
degree of a DG specific expression profile of differentiation was reduced (see Fig 3.22). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.22 Gene expression profiling of all experimental groups with single applications of growth 
or transcriptions factors and control groups. Heat map showing array of neural differentiation 
associated genes with each column representing the experimental groups. Note that NeuroD show the 
strongest difference to all other groups. A clustering algorithm is used to group rows (samples) and 
columns (Sha, Zhou et al.) to produce two cluster trees. The samples and genes are arranged in the 
order given in the tree so that each data row in the data file corresponds to a column in the heat map 
and vice versa. The color of a cell in the heatmap relates to the expression of the gene in the sample 
that the cell corresponds to. 
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Correlation Analysis at d16 
In the comparison of the control groups, Tet EGFP G1 d16+ and Tet EGFP G1 d16- the 
expression profiles are very similar, most of the genes cluster inside the area of significance 
measured as distance from center 1. 
At d16, Tet-EGFP Emx2 clone 4 has a low impact on the expression profile of the analyzed 
genes, although Emx2 is strongly overexpressed. Many of the genes analyzed tend to minimally 
move towards the control group, however, no strong expression profile is shown by the Tet-
EGFP d16 control-group. 
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Fig. 3.23 Correlation analysis and data of transcription factors at d16. EMX2, Prox1 and 
NeuroD1 versus EGFP control. Both Prox1 and NeuroD1 overexpression reinforce dorsal 
telencephalic differentiation expression profiling.  
Fig. 3.24: t-test analysis of transcription factors at d16: EMX2, Prox1 and NeuroD1 in 
comparison to TET EGFP. 
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At d16, the Prox1 over-expression strongly upregulates NeuroD2 (strongest expression), 
followed by TBR1, CALB1. Also NFIX, SYP, NR2E1 are upregulated. Interestingly, Prox1 
overexpression also lead to an increase of the expression of Emx2 and NeuroD1. NeuroD1 
strongly upregulated NeuroD2, TBR1 and Emx1. Furthermore, LHX2 and Emx2 were 
increased. Prox1 was negatively regulated by NeuroD1. In comparing the overexpressions of 
Emx2 and Prox1, all genes were shifted to the side of Prox1. The strongest overexpression of 
NeuroD2 was followed by GFEP, DCX, TBR1, SYP, FABP7, NEUN, LHX1, FoxG1, NCAM1, 
TUBB3, SLC1A3 and NR2E1. In the comparison with Emx2, NeuroD1 strongly upregulated 
NeuroD2, GFAP, TBR1, Emx1, GABA, SYP and PAX6. No genes were upregulated by Emx2. 
While NeuroD1 and Prox1 overexpression lead to a strong regulation of hippocampal 
progenitor markers, an overexpression of Emx2 showed no influence. The regulation of Prox1 
and NeuroD1 similarly and strongly upregulated NeuroD2 and Emx1, Emx2. The comparison 
of Prox1, NeuroD1 und Emx2 showed that the most of hippocampal progenitors and 
differentiation genes were regulated by Prox1 and NeuroD1. The expression profiles of 
NeuroD1 and Prox1 were quite similar. 
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Fig. 3.25 Correlation analysis and t-tests of transcription factors at d16: EMX2/Prox1; 
Prox1/NeuroD1; EMX2/NeuroD1 
 
Comparison at d37   
In the comparison of growth factors and differentiation it became obvious, that DKK1 has the 
strongest influence on accomplishing a partial dorsal telencephalic phenotype. At d37, DKK1 
in comparison to DKK3 strongly regulated HES5, DCX and CALB2. TBR1, SYP, NeuN, 
LEF1, and CALB1 were weakly upregulated by DKK1. In contrast, DKK3 did not influence 
the differentiation pattern at all. At d37, Emx2 overexpression strongly upregulated HES5, 
moderately upregulated CALB2 and weakly NEUROG2, LEF1 and CALB1. SOX1 and 2, 
OLIG2, MBP and GFAP were negatively regulated by EMX2. The central gene regulated by 
EMX2 was HES5. HES5 is a negative regulator of neurogenesis. Prox1 moderately upregulated 
MASH1 and weakly CALB1, 2 and TBR1. Moderately downregulated were SOX1, 2, MBP 
and SOX11, weakly GFAP, NEUROG2, DCX and TUBB3. NeuroD1 strongly upregulated 
HES5, and moderately CALB2 and EMX1. SOX1, 2 and ID3 were weakly downregulated. In 
the direct comparison of Prox11 and EMX2 at d37, EMX2 overexpression overwrote Prox1. 
The strongest upregulated gene by EMX2 was HES5, followed by NEUROG2. In comparison 
  
125 
of NEUROD1 and PROX1 at d37, it appears that NEUROD1 strongly regulated HES5, also 
EMX1,2 were stronger influenced by NEUROD1. NEUROD1 overrode Prox1. Weakly 
upregulated by NEUROD1 were NR2E1 and SYP. PROX1 was only stronger regulating 
CALB1. 
The dentate granule cell is defined by the expression of a specific class of genes. None of the 
single experimental groups could reach the complete expression profile of the granule cell 
differentiation.  
The strongest regulated genes were GFAP, SOX1, HES5, EMX2, ECX, FABP7, and NR2E1. 
With the exception of HES5, which was also strongly regulated by EMX2 and NeuroD1, all 
other strongly regulated genes were achieved in the control group and with addition of DKK1 
or DKK3 respectively. DKK3 and Prox1 were strong negative regulators of HES5, and Prox1 
and EMX2 of EMX1. 
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Fig. 3.26 Correlation analysis with data of growth factors at d37: Dkk1 and Dkk3 versus TET EGFP-.  
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Fig. 3.27 Correlation analysis and data of EMX2, Prox1 and NeuroD1 transcription 
factor overexpression at d37: EMX2, Prox1 and NeuroD1 versus EGFP control. 
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The strongest granule cell differentiation expression profile was reached with the combined 
overexpression of PROX1 and NEUROD1. 
 
 
 
 
 
 
 
 
 
Fig. 3.28 Correlation analysis and data of EMX2, Prox1 and NeuroD1 transcription 
factors overexpression at d37: direct comparisons of EMX2/Prox1; Prox1/NeuroD1; 
EMX2/NeuroD1 
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Fig. 3.29 Gene expression profiling of NeuroD1/Prox1 with NeuroD1, Prox1, Emx2, and 
EGFP control groups. (A) Hierarchical clustering of NeuroD1/Prox1 with NeuroD1, Prox1, 
Emx2, and EGFP control groups and (B) Heat map showing array of neural differentiation 
associated genes with each column representing the experimental groups. Note that 
NeuroD1/Prox1 showed the strongest difference to all other groups. 
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Fig. 3.30 correlation and t-test analysis comparing NeuroD1/Prox1 with NeuroD1, 
Prox1, Emx2, and EGFP control. Fold-change differences in log scale and p- values are 
shown comparisons with p < 0.05 are significant. 
  
131 
The combined overexpression of NeuroD1 and Prox1 initiated an overexpression of neuronal 
differentiation markers and dentate gyrus specific genes including synaptophysin, DCX, 
NeuroD2, NeuN, Emx2, CALB2, FABP7, NCAM1 and βIII-Tubulin. 
 
4. Discussion 
 
The brain cortex consists of a highly complex network of different subtypes of specialized 
neurons and glial cells controlled by growth factors, transcription factors and guidance 
molecules. The neurons are localized in nuclei which contain functional intrinsic circuits 
connected to other brain regions within extrinsic circuits via axonal pathways. In the 
development of this complex differentiated network, the neuronal and glial cell type 
specification, patterning, arealization, and axonal and dendritic pathfinding constitute major 
constructional components.  
The pluripotent stem cells including ESCs and iPSCs make it possible to build up these neuronal 
networks in order to analyze the specification of neurons in the brain and their functional 
networks under normal and neuropathological conditions. 
Recent research in developmental neuroscience and in stem cells has witnessed a considerable 
progress in the differentiation of pluripotent stem cells (PSCs) to regionally and functionally 
specialized subtypes of neurons and glial cells. The manipulation and simulation of 
developmental processes in vitro enables the production of enriched neural precursor cells and 
differentiated neurons resembling those in the brain. The production of neurons based on the 
PSC could lay the foundation for the in vitro modeling of pathological processes including the 
identification of drugs and therapeutics for neurological malfunctions and defects in the cortex. 
 
The DG is the most primitive brain cortex area that develops most dorsally in the telencephalon. 
The principal neurons of the DG are the glutamatergic granular cells with a dendritic tree 
extending into the molecular layer and an axon building up the Mossy fiber tract which connects 
the DG to pyramidal cells of the CA.  
 
The neuronal differentiation in specific brain areas is controlled by coordinated morphogenetic 
processes, which involve the temporal and spatial axial distribution of growth factors along 
gradients. It has been postulated that the gradients of morphogenes define the transcriptional 
code and thereby the identity of the neural precursors in the adjacent areas. 
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The DG development of is controlled by a growth factor gradient of Wnt3a, BNDF, and Dkk1 
signaling combined with low SHH. The major transcription factors of the developing DG 
include EMX2, Prox1 and NeuroD1.  
 
In this research, we aimed at stimulating parts of the developmental program of DG neurons by 
establishing a new protocol with slight modifications of the protocols designed by Watanabe, 
Yu and Sakaguchi (Watanabe, Kamiya et al. 2005); (Yu, Di Giorgio et al. 2014); (Sakaguchi, 
Kadoshima et al. 2015). Our protocol follows the embryonic development of mice for the 
differentiation of ESCs in vitro into DG granule neurons. It can be divided into the following 
five main stages: the ectodermal, neuro-ectodermal, telencephalic, DG induction, and fully-
differentiated granule neuron stage. 
By reanalyzing the expression profiles of all known growth factors in DG development, we 
came to the conclusion that, in addition to Wnt3a and BDNF and blocking SHH signaling, the 
main key players are the growth factors DKK1 and DKK3, and the transcription factors EMX2, 
Prox1 and NeuroD1. 
 
The Growth Factors  
 
Dkk1 
Within gastrulating embryonic cells, the DKK1 expression is observable on day E6.5, a region 
in which the conjunction between anterior visceral endoderm and epiblast takes place (Glinka, 
Wu et al. 1998); (Pearce, Penny et al. 1999); (Zakin, Reversade et al. 2000). 
During the neural induction process, the posterior-positioned cells are particularly disposed to 
patterning factors like WNTs and RA, and then progress towards the caudal pattern. Yet, the 
cells which are placed in the anterior sector of the neural plate are less affected by factors 
influencing caudal patterning. They maintain their anterior feature ,due to the endogenous 
expression of their inhibitors, such as Dkk1 as a WNT inhibitor signal (Glinka, Wu et al. 1998); 
(Wilson and Houart 2004).  
Shortly after the formation of the neural tube, a substantial portion of the anterior region extends 
to form the telencephalon. In turn, the telencephalon region is segregated into two separate areas 
by the gradients of dorso-ventral patterning factors: the dorsal and the ventral telencephalon 
(Wilson and Rubenstein 2000). 
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Dkk1 is a member of the dickkopf family and encodes a secreted protein with two cysteine rich 
regions. It is involved in embryonic development by the inhibition of the Wnt signaling 
pathway. 
In fact, the dickkopf protein encoded by DKK1 is an antagonistic inhibitor of the WNT 
signaling pathway that isolates the LRP6 co-receptor (Bafico, Liu et al. 2001); (Mao, Wu et al. 
2001); (Semenov, Tamai et al. 2001) and Kremen. It thus constitutes a triplet complex which 
stimulates fast internalization and diminution of the cell-surface LRP6, so that it cannot help 
inactivating the WNT signaling pathway (Lewis, Khoo et al. 2008). The WNT signaling has 
proven to play a key role in stem cell differentiation and embryogenesis. The pluripotency of 
human and mouse ESCs has been discovered by the activation of WNT signaling by a 
pharmacological inhibitor of GSK-3 (Sato, Meijer et al. 2004). 
In Dkk1 knockout mice, the forebrain development is impaired (Mukhopadhyay, Shtrom et al. 
2001). The extensive contribution of WNT and DKK family genes in the differentiation of 
multiple cell lineages during embryonic development is an indication that DKK is possibly 
involved in turning on the differentiation of mouse ESCs into primary germ layers.  
Kong et al. investigated the roles of Dkk1 in ESC differentiation. They have shown that the 
over-expression of DKK1 in ESCs pushes the differentiation of mouse ESCs and EBs towards 
the neuroectodermal lineage (Kong and Zhang 2009). 
Dkk1 has been identified for having a patterning role and increasing the expression of Foxg1, 
which is an important regulator of telencephalic cell cycles (Manuel, Martynoga et al. 2011).  
The Foxg1 knockout causes premature prolongation of telencephalic progenitor cell cycles and 
increased neurogenic divisions, leading to severe hypoplasia of the telencephalon (Martynoga, 
Morrison et al. 2005). 
By the addition of DKK1, we observed NPC colony-like structures with specified boundaries 
during differentiation and even proliferation. We named these structures the DG progenitor-
like colonies. The landmark of these structures is that they did not proceed towards the 
neuronal-like structures with axon, dendrite formation, and branching-while remaining at the 
stage of DG precursors. The observation of Kong and colleagues also confirmed that DKK1 
treatment did not result in further neural differentiation (Kong and Zhang 2009). They have 
suggested that this may be due to the need for additional factors for differentiation in this 
direction. In other words, the effect of a single growth factor or an overexpression of one 
transcription factor may not be sufficient for further differentiation. 
In fact, the ICC data has shown that growth factor cocktails with DKK1 on day 10 induced the 
ESC differentiation towards an early specified neuroectodermal stage with co-expression of 
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Foxg1, Blbp, Pax6, and other generic neuroectodermal markers such as Nestin, GFAP, and 
Sox1.  
The proliferation of telencephalic progenitors is controlled by Foxg1.  Foxg1 regulates Pax6 
activity, which in turn regulates the cell proliferation autonomously in a regional manner. There 
is strong evidence that one of the primary functions of the transcription factors Foxg1 and Pax6 
is to regulate telencephalic cell cycles (Martynoga, Morrison et al. 2005); (Estivill-Torrus, 
Pearson et al. 2002); (Quinn, Molinek et al. 2007); (Manuel, Georgala et al. 2007); (Xuan, 
Baptista et al. 1995). 
The colony formation in the DKK1 treatment group proved that WNT signaling pathways are 
not sufficiently suppressed by DKK1; there the neuronal progenitor cells could pass this stage 
and become fully-differentiated neurons. 
As a consequence, the growth factor treatment with DKK1on d37 might have induced DG 
neuronal progenitor cells which remained morphologically in the same status, yet a full 
differentiation was suppressed. 
The upregulation of HES5 on d37 demonstrated that DG progenitors could not differentiate 
completely. Other studies have shown that the over-expression of HES5 in the hippocampus 
down-regulates the expression of some pro-neuronal genes and delays cell differentiation. In 
fact, the up-regulation of HES5 had an influence on the notch-signaling pathways to the point 
that neurogenesis was inhibited, but the differentiation of neuronal stem cells and progenitor 
cells was continued (Mendes-da-Silva, Lemes et al. 2015).In addition, HES5 marks putative 
NSCs in granule neuron lineages and DCX neuronal precursors (type 2-b and type 3 cells) 
(Lugert, Basak et al. 2010).  
The NPC colony-like structures on d37 were positive in ICC for Nestin, βIII-tubulin, GFAP, 
NeuN, Neurod1, Prox1, Calretinin and Calbindin, but most of these cells were not fully 
differentiated. The neurotransmitter glutamate specific for differentiated DG neurons was not 
expressed under DKK1 supplementation. The genetic data analysis showed that the treatment 
with DKK1 resulted in the up regulation of HES5, DCX, CALB2, LEF1, TBR1, SYP, NEUN 
and CALB1.  
 
Dkk3 
Dkk3 is another member of the DKK family which is a putative WNT inhibitor. During the 
mouse embryogenesis, the expression of DKK3 is detectable in the hippocampus at E15.5 
developmental stage. The expression level of DKK3 is high in the CA1–CA3 region of the 
hippocampus and low in the DG. Moreover, the high level of DKK3 expression observed in the 
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cortex, hippocampus, and brain stem has suggested a role of DKK3 neuroplasticity in cortex 
and hippocampus (Krupnik, Sharp et al. 1999); (Zhang, Moseley et al. 2004).  
During adult neurogenesis, the expression of DKK3 is restricted to NPCs in the SVZ and was 
absent in the SGZ. In contrast, DKK1 initially expressed in the SGZ and granule neurons and 
at a low level in the SVZ region (Seib, Corsini et al. 2013). This different expression patterning 
emphasizes the regional specification of mechanisms controlling neurogenesis. 
The DKK3 knockout mouse analysis has remarkably proven a particular role of DKK3 in 
neurogenesis in vivo, namely a regulation of neuronal commitment, but no proliferation or self-
renewal of NPCs. This function of DKK3 is entirely consistent with the role of Wnt signaling 
in the neuronal fate commitment (Song, Stevens et al. 2002); (Lie, Colamarino et al. 2005).  
In comparison with DKK1, the treatment by DKK3 did not appear to be much effective in our 
studies. This treatment in the early stages of cell culture had a similar role in the induction of 
markers like BLBP, GFAP, Nestin, and Sox1 (neuroectodermal induction), but ICC analysis 
did not reveal any significant effect in the induction of specific DG markers such as NeuN, 
Prox1, Calretinin or Calbindin at day 37 of differentiation. 
Zhang et al. also showed that the DKK3- EGFP–positive cells were able to form primary 
neurospheres merely in vitro. Indeed, the neurogenesis was attenuated by DKK3 expression. In 
accordance with this observation, DKK3 treatment did not have significant influence on ESCs 
differentiation to DG neurons. 
 
The Transcription Factors 
 
Emx2 
During the mouse embryonic development, the Emx2 expression was detectable in 
telencephalon at E11.5 and at early stages of hippocampus development at E13.5.  
In vivo studies have revealed that in Emx2 knockout mice, the hippocampus fails to form a 
normal DG as well as the normal layering of principal neurons in the hippocampus proper (Tole, 
Goudreau et al. 2000). At the same time in Emx2 overexpressing mice, the progenitors induce 
the production of granule neurons of the DG (Hamasaki, Leingartner et al. 2004). 
In this study, the overexpression of Emx2 by the inducible tetracycline system suppressed the 
differentiation of telencephalic neuronal progenitor cells towards DG progenitor cells and DG 
granule neurons.  
The gene expression analysis illustrated that EMX2 overexpression induced a strong 
upregulation of HES5. During mouse development, HES5 expression covers almost all regions 
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of the developing nervous system of mouse embryos around embryonic day 10.5 (E10.5) 
(Hatakeyama, Bessho et al. 2004). Later on, HES5 expression becomes restricted to the 
ventricular zone, which contains the neural precursor cells and cell bodies of radial glia 
(Akazawa, Sasai et al. 1992); (Sasai, Kageyama et al. 1992).  
It has been demonstrated that overexpression of HES genes in mouse embryos inhibits 
neurogenesis and maintains neural stem cell pools (Ishibashi, Moriyoshi et al. 1994); (Ohtsuka, 
Sakamoto et al. 2001). 
HES genes are downstream targets of the Notch pathway. They encode transcriptional 
repressors that predominantly control the proneural basic helix-loop-helix genes and thus 
regulate the maintenance of undifferentiated cells (Ohtsuka, Sakamoto et al. 2001); (Kageyama 
and Ohtsuka 1999).The characterization of the SGZ in Hes5 GFP reporter mice revealed that 
Hes5 GFP is expressed in cells which have both radial (54%) and horizontal (46%) 
morphologies. However, only 60% of Hes5 GFP+ cells overlapped with Sox2, BLBP and 
GFAP, thus indicating that Hes5 GFP labels are only a subset of the NSC population (Lugert, 
Basak et al. 2010).  
Furthermore, it has been shown that Emx2 overexpression in cortical stem cells inhibits the 
astrocyte progenitor proliferation by repressing EgfR and Fgf9 (Falcone, Filippis et al. 2015). 
In our study, the Emx2 overexpression decreased the expression of Nestin and GFAP known 
as astrocyte markers on d37. It seems that the overexpression of Emx2 suppressed cell 
proliferation and inhibited neurogenesis and gliogenesis, leading to a quiescent stage by a high 
expression of HES5.  
In fact, considering the role of Emx2 in DG development during embryogenesis, we initially 
supposed that the upregulation of this gene may lead to DG neuroepithelial differentiation. 
Surprisingly, despite of our expectation, not only DG differentiation was absent, but also, both 
neurogenesis and gliogenesis were suppressed. This requires a more accurate investigation in 
the future.  
The overexpression of Emx2, induced the expression of Neurog2, LHX2, which are expressed 
in intermediate progenitor cells (IPCs) type 2a and 3a, while most of the neurogenesis and 
neuroectodermal markers such as βIII-tubulin, Gfap, Sox1 were suppressed. It seems that the 
overexpression of Emx2 causes the IPCs to enter a quiescent phase.  
In fact, the expression level and time interval of Emx2 expression both have a critical effect on 
DG induction during embryonic development. By using the Tet-inducible system, the 
sequential and transient expression of Emx2 can therefore regulate the induction of IPCs into 
DG differentiation. 
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Prox1 
During the mouse embryonic development at E13.5, the Prox1 expression is detectable in the 
DG, regulated by canonical WNT signaling and has a stage-specified role in embryonic and 
adult hippocampal neurogenesis. Prox1 expression is highly restricted to DG during embryonic 
(dentate neuroepithelium) and adult hippocampus development (Galichet, Guillemot et al. 
2008); (Lavado and Oliver 2007). Therefore, Prox1 was identified as a suitable marker to 
recognize the migration and targeting of DG granular neurons during development. 
Lavado and colleagues have shown that Prox1 is necessary for the maturation of granule cells 
in the DG during development and for the maintenance of intermediate progenitors during adult 
neurogenesis. But it has been proven that ectopic expression of Prox1 can induce premature 
differentiation of neural stem cells (Lavado, Lagutin et al. 2010). 
This group has also verified that Prox1 is expressed in the DG stem cells up to the fully 
differentiated granular cells. However, Prox1 expression is not restricted to granular cells in the 
DG. Therefore, it is only possible to characterize the granule cells in combination with other 
markers such as NeuroD1, Calretinin, Calbindin, and Glutamate. 
The overexpression of Prox1 resulted in the expression of the markers Nestin and GFAP. 
Moreover, the expression of the telencephalic neuronal marker Foxg1 was positive by ICC. 
Foxg1, formerly BF-1, is expressed continuously in the postnatal and adult DG. This 
transcription factor is involved in the Rett syndrome, which is characterized by a reduced 
hippocampus size, indicating its important role in hippocampal development. Conditional 
ablation of Foxg1 resulted in the loss of the subgranular zone and a severely disrupted 
secondary radial glial scaffold, leading to the impaired migration of granule cells (Tian and 
Macdonald 2012, Tian, Xu et al. 2012). Moreover, a detailed characterization of these mutants 
revealed that Foxg1 may be necessary for the maintenance of the DG progenitor pool, and that 
the lack of Foxg1 promotes both gliogenesis and neurogenesis. Prox1 overexpression leads 
NPCs to neuronal differentiation and increased neuron-like structures in vitro. Moreover, our 
gene expression analysis showed that Prox1 overexpression had a positive feedback on Lef1, 
TBR1, CALB1 and CALB2 expression. When the data was aligned side-by-side with the Allen 
Brain Atlas, it was confirmed that the genes mentioned above are active during the development 
of the DG. Moreover, the data showed that the overexpression of Prox1 had a negative 
regulation on HES5 and did not activate a Notch signaling pathway contrary to the Emx2 
overexpression that conducted the cells to enter the quiescent state. The ICC analysis revealed 
that the overexpression of Prox1 induced the expression of DG markers NeuN, Prox1, 
Calretinin, βIII-tubulin, synaptophysin, and Map (2a+2b). In contrast, the expression of Emx2, 
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NeuroD1, Calbindin, and glutamate was not observed. The in vitro observation thus indicated, 
that the overexpression of Prox1 alone is not sufficient to induce mESCs to fully-differentiated 
granule neurons. 
 
NeuroD1 
During the mouse embryonic development, the NeuroD1 expression is detectable in the 
hippocampus at E14.5.  
NEUROD1 is a bHLH transcription factor required for the survival and maturation of adult-
born granule cell neurons. The data showed that NeuroD1 has a transient and dynamic 
expression profile which is restricted to progenitors/neuroblasts (type 2b and type 3 cells) which 
are transient from immature to mature granule neurons.  
The gene analysis indicated that the overexpression of NeuroD1 repressed the expression of 
Sox2 three-folded. Some evidence suggests that the suppression of Sox2 is also required for 
granule neuron differentiation, which is mediated by WNT/β-catenin transcriptional activation 
of NeuroD1 and the removal of Sox2 repression on the NeuroD1 promoter (Kuwabara, Hsieh 
et al. 2009). This Sox2-dependent repression of NeuroD1 must be eliminated in order that 
neurogenesis can progress (Ehm, Goritz et al. 2010). In this regard, the overexpression of 
NeuroD1 resulted in an increase of the neurogenesis, while the expression of glial markers such 
as Nestin and GFAP were decreased in comparison with the control group. In the same way, it 
seems that the overexpression of NeuroD1 and the suppression of Sox2 as a result of 
neurogenesis were both born by a decrease in gliogenesis.  
The co-expression of NeuroD1 and DCX revealed that these cells are committed to the neuronal 
fate. On d37, the overexpression of NeuroD1 upregulated some genes, including HES5, 
CALB2, EMX1, SYP, NR2E1, LEF1, DCX, NueroD2, and TBR1. Once again when the data 
was aligned side-by-side with the Allen Brain Atlas, it was confirmed that the genes mentioned 
above are responsible for the development of the hippocampus during embryogenesis. 
Interestingly, given the role of NeuroD1 in immature precursor/neuroblasts, we expected that 
the overexpression of NeuroD1 can merely induce the immature transient precursor cells to 
mature granule neurons which express Prox1. Our data, however, indicated that the in vitro 
treatment of ES: Lt-EGFP-NeuroD1 clones resulted in the expression of DG markers such as 
NeuN, NeuroD1, Prox1, βIII-tubulin, and Map (2a+2b). But, in this group, the co-expressions 
of Prox1 with Calbindin, Calretinin, and glutamate/ βIII-tubulin were not observed. In 
conclusion, the overexpression of the NeuroD1 transcription factor alone was not sufficient to 
induce fully-differentiated DG neurons.  
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Combined overexpression of Prox1 and NeuroD1 
The conditional activation of Prox1-NeuroD1 in ESCs resulted in a considerable increase in the 
expression of the markers Prox1, NeuroD1, NeuN, and βIII-tubulin, compared with the growth 
factor and transcription factor groups. In fact, it seemed that the combined overexpression of 
these transcription factors had also a synergic role in the induction of calbindin and calretinin. 
The morphological observations also demonstrated a considerable increase in neurogenesis 
compared with other groups. 
In addition, in this group, the expression of the synaptic and neurotransmitter markers 
synaptophysin and glutamate increased.  
In comparison with other groups the length of the axons and dendrites in this group did equally 
demonstrate a profound increase, while the processes became amazingly long and branched. In 
other groups, such a general development of these distinctive structures was not recognized. In 
the growth factor group, the cells principally remained in a/the progenitor state and only 
partially developed on the DKK1-treated group. 
The results of the effects of growth factors, and comparing them with transcription factors have 
shown that the growth factors will more lead to the induction of neuro-progenitor cells than the 
transcription factors. In vice versa, the transcription factor and especially the combined 
overexpression of Prox1 and NeuroD1 pushed the cells to a neuronal phenotype. The colony-
like structures inducted by the growth factors were no longer observed in the transcription factor 
groups. 
The strongest granule cell differentiation expression profile was reached with the combined 
overexpression of PROX1 and NEUROD1. 
The combined overexpression of NeuroD1 and Prox1 initiated an overexpression of neuronal 
differentiation markers and DG specific genes including, Emx2, FABP7, NCAM1, SYP, TBR1 
NeuN, NeuroD2, DCX, CALB2, Synaptophysin and βIII-Tubulin. Moreover, many of the 
genes substantial for DG development were induced by this programming approach of directed 
differentiation (see also Appendix, Figs. 10.10, 10.11).  
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5. Summary 
  
ESCs have the capacity of unlimited self-renewal and pluripotency, which are promising tools 
ranging from basic research in developmental biology to future therapeutic applications. 
Following the establishment of basic techniques for ESC cultivation and neuronal 
differentiation, the main objective was to direct the differentiation towards specific types of 
neurons. For instance, our goal was to direct the differentiation of ESCs towards the DG granule 
neurons. 
So far, two major reports have been published in regard to the hippocampal induction from ESC 
and IPS cells (Yu, Di Giorgio et al. 2014); (Sakaguchi, Kadoshima et al. 2015). Both strategies 
are based on the role of growth factors related to the hippocampus development. Initially, the 
online platforms GenePaint.org and Allen Brain Atlas as well as previous studies dealing with 
the cellular localization of both growth factors and transcription factors in the DG and molecular 
mechanisms contributing to DG differentiation were used as underlying scenario. Resulting 
from that the question arised which growth factor combination would be of stronger influence 
to the differentiation into DG granule neurons from mESCs. 
The growth factor cocktail with DKK1 has proven to be more inductive in telencephalic 
neuronal progenitor cells and also more prone to the generation of highly enriched mouse DG 
progenitor-like colonies - which expressed DG markers such as Prox1, Neurod1 and Tbr2. 
In the next part, the role of the transcription factors Emx2, Prox1 and NeuroD1 in the production 
and induction of DG granule neurons was investigated. A high expression of Emx2 suppresses 
the differentiation of telencephalic neuronal progenitor cells to DG progenitor cells and DG 
granule neurons, while NeuroD1 and Prox1 overexpression lead to a strong up-regulation of 
hippocampal progenitor markers. 
The strongest granule cell differentiation expression profile was reached with the combined 
overexpression of PROX1 and NEUROD1. Morphological observations clearly demonstrate a 
considerable increase in neurogenesis. This phenomenon can be seen in other groups as well. 
A comparison of the growth factor effects with those of the transcription factors do show that 
the growth factors will lead to an increase in the induction of neuro-progenitor cells. By 
contrast, the transcription factors, and especially the combined prox1 and neurod1, pushed the 
cells to neuronal phenotype. 
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In summary, it can be concluded that the combination of central DG transcription factors mainly 
influences DG granule neuron differentiation in vitro. Furthermore, it became obvious that the 
combination of a DG specific growth factor cocktail and transcription factors will lead to a 
significant differentiation of DG granule neurons. 
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5.1 Zusammenfassung 
 
ESCs haben die Fähigkeit unbegrenzter Selbsterneuerung und Pluripotenz. Es sind 
vielversprechende Werkzeuge, die von der Grundlagenforschung  in der Entwicklungsbiologie 
bis zu zukünftigen therapeutischen Ansätze reichen. Nach der Etablierung grundlegender 
Techniken für die Kultivierung und neuronalen Differenzierung der ESC war das 
Hauptanliegen dieser Arbeit die Differenzierung in spezifische Neuronen des Telencephalons.  
Und zwar bestand unser Ziel darin, die Differenzierung der ESCs auf die Körnerzellen des 
Gyrus dentatus auszurichten. 
Bislang wurden zwei wichtige Arbeiten über die Hippocampus-Induktion von ES- und IPS-
Zellen publiziert (Yu, Di Giorgio et al. 2014) (Sakaguchi, Kadoshima et al. 2015).  Beide 
Methoden basieren auf der Rolle der Wachstumsfaktoren in Bezug auf die Hippocampus-
Entwicklung.  Zu Beginn der Arbeit wurden sowohl die Online-Plattformen GenePaint und 
Allen Brain Atlas als auch frühere Studien bezüglich zellulärer Lokalisation von Wachstums- 
und Transkriptions-Faktoren studiert. Daraus ergab sich die Fragestellung, welche der 
Wachstumsfaktor- Kombinationen einen größeren Einfluss auf die Differenzierung der 
Körnerzellen des Gyrus dentatus aus mESCs haben. 
Der Wachstumsfaktor-Cocktail mit DKK1 zeigte eine ausgeprägtere Induktion der neuronalen 
Progenitor-Zellen im Telencephalon. Zudem bewirkte dieser eine stärkere Generierung von 
Kolonien hochangereicherter Gyrus dentatus-Zellen. Diese zeigen Ähnlichkeit mit Progenitor-
Zellen und exprimieren die Gyrus dentatus-Marker Prox1, Neurod1 und Emx1. 
Im nächsten Teil wurde die Rolle der Transkriptionsfaktoren  Emx2, Prox1 und NeuroD1 im 
Hinblick auf Produktion und Induktion von Körnerzellen des Gyrus dentatus jeweils separat 
untersucht.  Eine hohe Expression von Emx2 unterdrückt die Differenzierung von telencephalen 
neuronalen Progenitor-Zellen in Körnerzellen. Eine Überexprimierung von NeuroD1 und 
Prox1 hingegen führen zu einer starken Hochregulierung hippocampaler Progenitor–Marker. 
Die stärkste Differenzierung in Körnerzellen wurde mit einer kombinierten Überexpression von 
PROX1 und NEUROD1 erreicht.  Morphologische Beobachtungen zeigen deutlich einen 
signifikanten Anstieg der Neurogenese. Dies zeigt sich ebenfalls im Vergleich zu anderen 
Gruppen. Der Vergleich zwischen den Differenzierungs-Effekten von Wachstums- und 
Transkriptionsfaktoren zeigt, dass die Wachstumsfaktoren eine stärkere Induktion von Neuro-
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Progenitorzellen als Transkriptionsfaktoren herbeiführen.  Im Gegensatz dazu  führen die 
Transkriptionsfaktoren, und insbesondere die Kombination von Prox1 und Neurod1,  zu einer 
Ausbildung des neuronalen Phänotyps der Zellen. 
Aus all diesen Beobachtungen ergibt sich Folgendes: Die Kombination von zentralen 
Transkriptionsfaktoren  des Gyrus dentatus beeinflussen hauptsächlich die Differenzierung in 
Körnerzellen in vitro. Weiter zeigte sich, dass ein Gyrus dentatus spezifischer 
Wachstumsfaktor-Cocktail und Transkriptionsfaktoren zu einer effektiveren Differenzierung 
der Granula Neurone des Gyrus dentatus führen. 
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Figs. 10.1 EMX2 cortical area-specific gene expression with an increasing ventral-dorsal 
gradient along the ventricular zone. Both DG precursor cells and CR cells are labeled. 
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Figs 10.2 During mouse telencephalic development, Prox1 expression is restricted to the DG. 
Prox1 expression  
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Fig. 10.7 mESc transduced with Lt-Tet-O-Fuw- EGFP and Fuw-M2rtTA  were enzymatically dispersed and 
sorted by FACS to remove of cells with leaky EGFP expression.  
FACS sorting gates for EGFP
+
cells in Tet-O-FUW-EGFP clone G1 analysis. 
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Fig. 10.8 mESc transduced with Lt-Tet-O-Fuw- EGFP and Fuw-M2rtTA were enzymatically dispersed and 
sorted by FACS to remove of cells with leaky EGFP expression.  
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Nestin S100B GFAP 
A B C 
Fig 10.9 Pure primary astrocyte culture. Immunostaining of primary mouse astrocyte cultures with 
the markers GFAP, S100B (green) and Nestin (red) revealed pure primary astrocyte culture. Nuclei are 
stained with 4',6'-diamidino-2-phenylindole (DAPI) (blue). Scale bar: 100 μm. 
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